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GLOSSARY OF TERMS USED IN THIS THESIS 
 
Black and white women: This thesis uses the term “black women” when referring to 
women of African ancestral origin as an ethnic group. With regards to the cohort of 
women referred in this study, the term black women refers to a cohort of Xhosa women 
requited in and around the Cape Town (South Africa) area for participation in this 
study. However, black women from other geographical areas are referred to in the 
context of their country of origin or in which the sampling was done, e.g.  African 
American-, African Caribbean- or South African women. The term “white women” is 
used to describe women of European ancestral origin (also “Caucasian women”) as 
an ethnic comparator group.  
Diabetes Mellitus: Most analyses do not distinguish type I from type II diabetes. 
However, as most cases (85-95 %) of diabetes in South African adults are classified 
as type II, the disease prevalence trends are therefore most likely due to cases of type 
II diabetes 3. The term diabetes is used when no distinction between type I and type II 
is being made. 
Glycemic metabolism: Insulin sensitivity (SI) refers to the ability of endogenous 
insulin to promote glucose clearance into peripheral tissues and inhibit hepatic 
gluconeogenesis; Insulin resistance is defined as the decrease in insulin sensitivity. 
Hepatic insulin sensitivity relates to the ability of the liver to remove insulin from 
circulation and suppress gluconeogenesis (endogenous glucose production).  
Insulin sensitivity and secretion measures: The hyperinsulinemic euglycemic 
clamp is widely considered to be the gold standard for measuring insulin sensitivity, 
and can differentiate between hepatic and systemic insulin sensitivity 4. However, it is 
 
xvi 
expensive and technically challenging to undertake 5. Due to the nature of the clamp 
procedure, no information is generated regarding pancreatic insulin response to a 
glucose load (AIRg).  In contrast, the frequently sampled intravenous glucose tolerance 
test (FSIGT) provides a reliable, cost effective alternative to the clamp method, 
including measures of peripheral insulin sensitivity, as well estimates insulin secretion 
(AIRg) 6.  
HOMA-IR is a less invasive alternative compared to both clamp and FSIGT. Although 
associated with the clamp technique, HOMA-IR does not provide information on 
postprandial glucose metabolism and skeletal / and adipose tissue insulin resistance 
and does not provide insight into beta-cell secretory capacity 7 
Body composition and body fat distribution determination:  
Quantitative assessment of body fat mass and its distribution is important for 
evaluating the potential risk of development of obesity related pathologies 8 . Body 
fatness and composition in this thesis is quantified by using various direct measures 
and imaging technologies. BMI and WHR is used as a crude measure of obesity and 
central fat accumulation. In contrast, dual energy X-ray absorptiometry (DXA) is used 
as a sensitive measure to further characterize adipose tissue distribution across 
android- and gynoid regions of interest. Further, to characterize the intra-abdominal 
(central) adipose tissue depot, computerized tomography (CT) is used to estimate 
VAT, deep and superficial SAT accumulation and is also considered the gold standard 
for estimating these body composition measures 8. 
Inflammatory products: The CC-chemokine family is secreted by macrophages and 
epithelial cells and include macrophage inflammatory protein 1α (MIP1α, also called 
CCL3) and monocyte chemoattractant protein 1 (MCP1, also known as CCL2). 
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Macrophage Markers include CD68, CD14 and CD163. Adipokines are proteins 
synthesized and secreted by adipocytes and include pro-inflammatory leptin and anti-
inflammatory adiponectin. In addition, pro-inflammatory cytokines include interleukin 
(IL) -18, IL-6, tumour necrosis factor-α (TNF-α), colony stimulating factor-1(CSF-1) 





The global burden of non-communicable diseases (NCD’s) is unacceptably high and 
disproportionately affects developing countries such as South Africa (SA). Black SA 
women have a higher prevalence of obesity and a greater associated risk for 
developing metabolic diseases (such as type 2 diabetes mellitus) than their white 
counterparts. An improved understanding of the ethnic-specific mechanisms 
underlying the increased risk of T2DM in black SA women is needed to inform future 
studies aimed at reducing the prevalence of this diseases.  
One of the major determinants of insulin resistance is android/central body fat 
partitioning, with visceral adipose tissue (VAT) enlargement, in particular, being 
closely associated with increased risk. Conversely, lower-body fat accumulation is 
considered to be protective. However, these relationships between body fat 
distribution and its metabolic effects are altered by ethnicity. Black SA women have 
less abdominal and greater gluteal-femoral subcutaneous adipose tissue (SAT) but 
are more insulin resistant compared to BMI- and waist circumference-matched white 
SA women. A similar profile has been described in black African-American women. 
The reduced protective effect of peripheral fat distribution in black women remains to 
be understood.  
The primary aim of this thesis was positioned within the context of adipose tissue 
expandability hypothesis, and aimed to examine the hypothesis that differences in 
SAT extracellular matrix (ECM)- and hypoxia-related gene expression and their ethnic-
specific associations with body composition and insulin sensitivity may explain, in part, 
the higher rates of insulin resistance in black compared to white South African women. 
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Therefore, it was hypothesized that, as a consequence of increased adipose tissue 
hypertrophy in the gluteal depot of obese black compared to obese white women, 
gluteal SAT adipose tissue hypoxia and ECM component gene expression is higher in 
black compared to white women, and associates with their reduced insulin sensitivity 
(SI) and higher insulin response. In order to address this hypothesis, four research 
studies were designed. 
The first study (Chapter 3) in this thesis aimed to compare depot-specific (abdominal 
vs. gluteal) expression of hypoxia and ECM genes in normal-weight and obese black 
and white women, and to examine the ethnic-specific associations between these 
genes and body composition, measures of insulin sensitivity and secretion and 
inflammatory gene expression in black and white SA women by using a gene 
expression (Reverse transcription polymerase chain reaction (RT-PCR)) analysis. 
This thesis showed for the first time that hypoxia inducible factor 1 (HIF-1α), collagen 
type V α1 (Col5A1) and type VI α1 (COL6A1) gene expression were higher in the 
gluteal, but not the abdominal SAT depots, of black compared to white women, and 
associated with reduced insulin sensitivity in black women only. The expression of the 
hypoxia and ECM genes associated with inflammatory gene expression in both the 
gluteal and abdominal SAT depots of black women, whereas the expression of these 
genes associated with the inflammatory gene expression mostly in the abdominal SAT 
depots of white women.  
The second study (Chapter 4) tests the hypothesis that higher hypoxia and ECM 
related gene expression would associate with higher central fat mass accumulation in 
black women and that the expression of these genes may be associated with changes 
in the measures of insulin sensitivity in black and white women. Thus, this longitudinal 
study aimed to determine whether changes in body composition and insulin sensitivity 
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variables over a 5 year follow-up period associated with variations in hypoxia and ECM 
related gene expression in the gluteal SAT of black and white women. Over the 5-year 
follow-up period, increased body fat mass in white women associated with increased 
PPARγ mRNA expression whereas increased body fat mass in black women 
associated with lower COL5A1 expression. Furthermore, HIF-1α, and COL6A1 
expression correlated positively with the change in fasting insulin concentrations in 
black but not in white women. 
It is not clear whether high circulating insulin may directly increase HIF-1α expression 
and contribute to the formation of excess ECM, or whether increased insulin may 
simply be a concomitant downstream effect of increased insulin resistance, as a 
consequence of increased fibrosis and the generation of inflammation. By using a cell 
culture based study, the third study in this thesis (chapter 5), investigated the effects 
of increasing insulin concentrations on the expression of hypoxia and ECM related 
genes under normoxic and hypoxic conditions in mature 3T3-L1 adipocytes. It was 
found that insulin and hypoxia treatment significantly elevated HIF-1α mRNA and 
protein levels but that the observed effects were not additive. Further, hypoxia, but not 
insulin treatment, increased the expression of Col5a1 and Col6a1 protein but not 
mRNA levels in mature 3T3-L1 adipocytes. 
By using a genotyping analysis, the fourth study (Chapter 6) aimed to determine 
whether variants within two ECM component gene polymorphisms, collagen type 5α1 
(COL5A1) rs12722 (C/T) and type 6α1 (COL6A1) rs35796750 (C/T) associates with 
body fat distribution and insulin resistance in black and white women. Allele and 
genotype distributions of the COL5A1 rs12722 and COL6A1 rs35796750 
polymorphisms, as well as body fat distribution were significantly different between 
black and white women, the T- variant of the COL5A1 rs12722 polymorphism was 
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associated with significantly less central fat mass, characterised by a smaller waist 
circumference and lower VAT, and this effect was independent of ethnicity. In addition, 
T- variant of the COL5A1 rs12722 polymorphism was associated with lower fasted 
insulin concentrations and HOMA-IR in white but not in black women. In contrast, no 
genotype associations between COL6A1 rs35796750 and any of the body fat mass, 
its distribution and insulin resistance measures in black or white women were reported. 
This thesis used a hypothesis driven approach to provide preliminary evidence that 
the gluteal depot of obese black women has higher expression of hypoxia and ECM 
genes compared to that of obese white women and provides novel insight into the 
apparent paradox of reduced insulin sensitivity despite lower VAT and greater 
peripheral SAT accumulation in black compared to white women. An improved 
understanding of the ethnic-specific mechanisms underlying the increased risk of 
T2DM in black SA women will enable the development of cost-effective preventative 




CHAPTER ONE  
THEORETICAL FRAME 
1.1 INTRODUCTION  
Obesity is recognised as the major risk factor for multiple chronic diseases including 
diabetes, heart diseases, fatty liver syndrome and some forms of cancer 9. The exact 
mechanisms that link these disorders to obesity are still unclear and may be specific 
for each disease 10. Importantly, the most likely contributing factors are believed to be 
insulin resistance and hyperinsulinaemia, body fat distribution- including ectopic fat 
deposition in peripheral depots, and inflammatory pathways 10, 11. Prior work in this 
area suggests that there are distinct ethnic differences in these obesity-related 
phenotypes that are evident form a young age and may help to explain the ethnic 
differences in non-communicable disease (NCD) prevalence and their outcomes 12-16. 
Of particular relevance in South Africa is the high proportion of type 2 diabetes (T2DM) 
in the economically active (20-59 year old) age group 17. Recent data suggests that 
the prevalence of T2DM is higher in black African women compared to their white 
counterparts 18-20 regardless of country in which the sampling took place. Currently, 
the reasons for the ethnic disparity in T2DM prevalence is still unclear. However, the 
prevalence of insulin resistance, a major risk factor for the development of T2DM, is 
also higher in black woman compared to age- and BMI-matched white women 
independent of variances in body fat distribution 21, 22.The mechanisms that contribute 
to the increased risk for insulin resistance in women of African ancestry remain largely 
unknown 23.  
Chapter One 
2 
A better understanding of the relevant predisposing factors for the development of 
insulin resistance and T2DM in the South African context and their biological 
underpinnings is important for early disease detection and prevention. Therefore, the 
purpose of this thesis was to describe and investigate these differences in insulin 
resistance phenotypes and their biological underpinnings in two distinct ethnic groups 
in South Africa namely black African women and their white counterparts. However, 
the focus of this thesis falls mainly on South African women because of their markedly 
higher obesity prevalence compared to the South African men (69.3% in women vs 
38.8% in men) 24-27. Moreover, although the T2DM disease complications are not 
different by gender, women tend to have a 1.7 times higher T2DM-attributable 
mortality compared to men, with over half of these T2DM-related deaths in women 
occurring before the age of 40 years 17, 28, 29. The higher risk of insulin resistance 
described for black compared to white women warrants further investigation. 
Investigating these two different insulin resistance phenotypes could identify putative 
pathways/ mechanisms underlying the different outcomes of obesity -related diseases 
in black and white women, and could highlight culturally appropriate intervention 
strategies.  
1.2 AFRICAN PARADOX IN THE CONTEXT OF ADIPOSE TISSUE 
EXPANDABILITY 
Obesity, characterised by the excess accumulation of adipose tissue, is strongly 
associated with insulin resistance, and is regarded as a major risk factor for the 
development of T2DM, although the causative molecular mechanisms that link obesity 
to the development of T2DM are not clearly understood. Epidemiological and clinical 
studies have suggested that 10-40% of individuals (depending on the criteria used, 
Table 1.1) are regarded as being obese but metabolically healthy (MHO) 30, 31. MHO 
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individuals are characterised as having high insulin sensitivity, absence of 
hypertension, and favourable lipid, inflammation, hormonal and liver enzyme profiles 
32. In contrast, recent analysis of the NHANES III cohort have estimated that 10 % of 
the US population who are normal-weight and have a BMI of below 25 kg/m2, are 
metabolically unhealthy (MUNW) and display body fat related metabolic abnormalities 
33 such as hyperinsulinaemia, insulin resistance, hypertriglyceridemia and 
arteriosclerosis 34. Interestingly, based mainly around their better blood lipid profile 
(triglycerides ≤ 1.7mmol/L, TC ≤ 5.2 mmol/L HDL-C ≥ 1.3mmol/L and LDL-C≤2.6 
mmol/L) and lower fasted glucose levels, earlier investigations into the adverse effects 
of obesity in black South African women reported that about 87% of these women 
could also be regarded as MHO and that their apparent “health” was likely due to their 
lower fat intake and high levels of physical activity 35, 36. Black African and African 
American women have consistently been shown to have a more favourable lipid 
(higher HDL-C and lower TC) profile compared to BMI matched white women 37-39. 
However, this high level of “health” described in the black women may be more 
dependent on the criteria used to characterise MHO because in spite of their 
favourable lipid profile, black women are more insulin resistant and maintain higher 
Table 1.1 Criteria typically used to define MHO. 
  
Factor MHO definition 
Metabolic syndrome (MetS) * Absence of MetS or <3 MetS criteria 
Insulin resistance  HOMA-IR <75th percentile, 
 HOMA-IR <1.95 
Blood lipid profile Triglycerides ≤ 1.7mmol/L, 
 TC ≤ 5.2 mmol/L  
 HDL-C ≥ 1.3mmol/L 
 LDL-C≤2.6 mmol/L 
Inflammation C-reactive protein levels ≥3.0 mg/L 
 White blood-cell count <75th percentile 
Obesity BMI ≥ 30 kg/m2 or body fat > 25% in men and 30% in women 
Criteria used to define MHO are not universal but are typically characterised according to MetS criteria *(Based 
on NCEP ATP III definition), cut-points for insulin sensitivity (by HOMA-IR), blood-lipid profile, and recently also 




levels of fasted insulin compared to white women 40. These studies suggest that 
absolute fat mass is not the only determinant in the association between obesity and 
insulin resistance. 
Rather, the regional distribution of adipose tissue has been shown to be an important 
determinant of metabolic risk 41-43 (for review see 44 ). Different regional adipose tissue 
depots have different structural and functional characteristics, depending on their 
anatomical location within the body, and consequently differentially impact on the risk 
of development of metabolic disease such as T2DM. A major determinant of reduced 
insulin sensitivity is the centralisation of body fat (that is, upper body obesity) 45, and 
particularly visceral adipose tissue (VAT) 46 accumulation, while peripheral 
accumulation of body fat (that is lower body obesity) is considered protective 47-51, 
independent of BMI. Indeed, the MUNW individuals with centralised obesity (higher 
waist-to hip ratio) are more insulin resistant and have a higher mortality risk compared 
to either normal weight or obese individuals without central obesity (MHO) 52, 53. 
However, this this notion has also been questioned 54 where metabolically healthy 
individuals (MHO) were found to still have some level of metabolic disorders.  
However, contrary to this prevailing hypothesis, black African and African American 
women have less VAT, and more SAT, but have consistently been found to be more 
insulin resistant than white women of comparable BMI and % body fat percentage 
(%fm) or waist circumference 22, 55-57. This paradox suggests that the relationship 
between body composition and insulin resistance may be ethnic-specific. The bulk of 
the physiological investigations into the determinants of insulin resistance have been 
undertaken in predominantly white/Caucasian populations, with the mechanisms 
underlying the ethnic disparity in insulin resistance prevalence between black women 
and their BMI matched white counterparts mostly unknown.  
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The metabolic effects of excess adipose tissue on individual disease risk are highly 
heterogenic in nature. Insulin resistance exists on a continuum within individuals at 
varying levels of body fat mass rather than a defined set point of adipose tissue mass 
that once reached defines the start of metabolic disease. Originally proposed by Vidal-
Puig and colleges 58, 59 in an attempt to explain this phenomenon, the adipose tissue 
expandability hypothesis suggests that the link between obesity and metabolic 
complications is not dependent on total fat accumulation, but does depend on the 
remaining capacity for expansion and metabolic function of adipose tissue depots 58-
60. Once expansion capacity is reached, adipose tissue becomes dysfunctional and 
ceases to store excess nutrients effectively. SAT is the largest adipose tissue depot 
and also the preferred site to store excess nutrients from prolonged positive nutrient 
intake in the form of lipid 61. A widely held view is that failure to store the excess 
nutrients in the SAT depot results in the storage of these products as lipid in various 
ectopic sites such as muscle, liver and pancreas 62. Lipid spill-over from metabolically 
dysfuntional SAT results in lipotoxicity in these organs leading to central-obesity, 
dyslipidaemia, fatty liver, and beta-cell failure, complications which are typically 
associated with morbid obesity 62.  
Studies in human and mouse models of obesity and insulin resistance have identified 
various environmental-, physiological- and genetic-predisposing factors that 
potentially contribute to a highly individualised expansion capacity of SAT 63, 64 (for 
review see 58, 59, 65). However, mechanistically, it may be hypothesized that expanding 
adipose tissue causes oxygen deprivation in large adipocytes as their distance from 
the vasculature increases 66-68. This local hypoxic environment (defined as a deficiency 
of O2 in tissues) induces dysregulated adipokine secretion that contributes to the 
development of inflammation and the recruitment of immune cells into the adipose 
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tissue depot 69. Hypoxia is also associated with the increased expression and 
deposition of extracellular matrix (ECM) components in adipose tissue, resulting in 
fibrosis 70. It is proposed that increased adipose tissue fibrosis, through its mechanical 
constraints on adipocyte expansion, is one of the main triggers for the pro-
inflammatory response and concomitant insulin resistance that characterizes adipose 
tissue of obese humans 71, 72.  
Based on the increased prevalence of insulin resistance in obese black compared to 
obese white women despite the lower levels of VAT and more favourable lipid profile, 
it may be hypothesised that adipose tissue expansion in black women is associated 
with increased hypoxia and fibrosis and may account for the ethnic disparity insulin 
resistance between black and white South African women. Therefore, in this thesis I 
aimed to explore the black African paradox of lower VAT accumulation but greater 
insulin resistance compared to white women within the context of adipose tissue 
expansion. In the next section, a literature review provides a brief overview of the 
current research exploring the disproportionate prevalence of T2DM and insulin 
resistance in black African women when compared to their white/Caucasian 
counterparts (Section 2.1). Ethnic differences in body fat distribution and the 
associations with insulin sensitivity are explored (section 2.2). Possible mechanisms 
through which regional adipose tissue distribution (section 2.3) and limited SAT 
expansion (section 2.4) may contribute to increased local and systemic insulin 
resistance are discussed with a specific focus on hypoxia and extracellular matrix 
dysregulation in adipose tissue. Lastly, a potential model that assimilates the factors 
that distinguish between insulin sensitive and insulin resistant adipose tissue 





CHAPTER TWO  
LITERATURE REVIEW 
2.1 INTRODUCTION 
Globally, the burden of non-communicable diseases (NCD’s) is steadily on the rise, 
with more than 38 million of the world’s 56 million deaths in 2012 attributed to these 
diseases of lifestyle 73. According to data from the World Health Organisation (WHO) 
it was reported that of this 38 million, 16 million deaths occurred from preventable 
causes, -an increase from 14.6 million in 2000 73. This burden is rising disproportionally 
in lower income countries in which over three-quarters of deaths in 2012 were 
attributed to preventable NCD’s, and in which almost half of these deaths occurred 
before the age of 70 73. Together, the four main NCD’s recognised by the WHO 
(cardiovascular diseases (CVD), cancers, diabetes and chronic respiratory disease) 
make up the leading causes of global mortality 73. Although CVD, cancers and 
respiratory disease account for the highest NCD mortality rate, diabetes accounts for 
over 1.6 million deaths annually 73 and according to the International Diabetes 
Federations (IDF) represents a significant contributor to global disease burden, with 
particularly costly effects reported for low- and middle-income countries 29, 74.  
Once described as a disease of affluence, diabetes now disproportionately affects the 
poorest of countries where the burden of diabetes, in terms of both prevalence and 
number of adults affected, has increased more rapidly compared to the higher-income 
countries 74, 75. According to a pooled analyses of 751 population-based studies from 
across the world, low- and middle-income countries such as Indonesia, Pakistan, 
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Mexico and Egypt have, over the last three decades, replaced high-income countries 
such as Germany, Ukraine, Italy, and the UK on the list of top ten countries presenting 
with the highest adult diabetes prevalence * (1980-2014) 75. For example, while there 
was little change in age-standardised diabetes prevalence in adult women in 
continental western Europe (less than 5% increase) over the same time period, 
diabetes prevalence increased rapidly in low- and middle-income countries such as 
Polynesia and Micronesia, at nearly 25%, followed by the Middle East and North Africa 
at 15% 75. This disparity in diabetes prevalence and disease growth rate between the 
developed and developing countries is not fully understood. However, rapid 
urbanisation and increasing population age have been proposed as some of the major 
contributing factors to the increasing burden of diabetes in these lower-income 
countries 17, 76.  
In accordance with the global trends, a steep increase in the diabetes prevalence has 
also been reported for sub-Saharan Africa (SSA) region where the IDF Atlas has 
estimated that 14.2 million people had diabetes in 2015 and that this number would 
rise to 34.2 million by 2040 - exceeding the predicted global increase of 55% 29. The 
unavoidable consequence of this higher prevalence of T2DM will be a substantial rise 
in diabetes-related disability and mortality. Currently in the African region, age-
standardised, high blood-glucose-related mortality rate (about 111.3 deaths per 
100 000) was estimated to be almost double that of the European region (about 55.7 
deaths per 100 000) 77. 
 
* Importantly, this study does not distinguish type I from type II diabetes. Nevertheless, as most cases (85-95 %) of diabetes in 
adults are classified as type II, the disease prevalence trends are therefore most likely due to cases of type II diabetes 
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Notably, the prevalence of diabetes in Africa is not uniformly distributed. Nearly half of 
all adults living with diabetes in the African region live in some of Africa’s most 
populous countries, including South Africa (2.3, [1.2-4.6] million), Nigeria (1.6, [1.2-
3.8] million), and Ethiopia (1.3, [0.8-3.5] million) * 29. In these countries, diabetes is 
posing an ever increasing threat to economic development not only because it is 
associated with increased mortality in the productive worker class category 29, but also 
associates with various psycho-social factors such as adverse life events 78 and a 
lower sense of coherence (SOC) 79, factors that may contribute to lower economic 
participation. For example, in South Africa a recent analysis of 1099 urban-dwelling 
black participants found that having T2DM was associated with a lower SOC in women 
and increased adverse life event score in women and men 76. Therefore, to reduce the 
immense fiscal burden of these preventable diseases of lifestyle and their associated 
co-morbidities in these developing countries, an increased understanding of the 
socioeconomic and health-related risk factors are clearly warranted to identify specific, 
culture-appropriate interventions that would enable the development and 
implementation of effective preventative-care strategies 80, 81.  
High levels of overweight and obesity, together with physical inactivity across all age 
groups are responsible for a substantial proportion of the global diabetes burden 82. 
Results from the Global Burden of Disease (GBD) 2013 study, showed that the global 
prevalence of overweight and obesity, the major preventable risk factor for the 
development of T2DM, had risen by 27.5% for adults and 47.1% for children between 
1980 and 2013 25. Moreover it was reported that by gender, the proportion of adults 
with a BMI of 25 kg/m2 or greater increased from 28.8% (28.4-29.3) in 1980 to 36.9% 
(36.3-37.4) in 2013 for men, and from 29.8% (29.3-30.2) to 38.0% (37.5-38.5) for 
 
* * Uncertainty range displayed in parenthesis. 
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women 25. In SSA, the highest prevalence of obesity was found among South African 
women, where the prevalence of overweight and obesity was 69.3% compared to 
52.6% in Botswana, 42.4% in Namibia and 41.9% in Zimbabwe 25.  
Moreover, in an earlier population based survey, the South African Demographic and 
Health Survey (2003), the prevalence of obesity was found to be different between 
ethnic groups, with the highest estimates being 28.5% for black women, compared to 
13.7% for white women; whereas 7.1 % of black men were affected compared to 23% 
of white men 27, 83. More recent survey data demonstrated that compared to mixed-
race (34.9%) and Asian/Indian (32.4%) populations, black women had the highest 
prevalence of obesity (39.9%) 25. Notably, similar ethnic trends have been described 
for black women living in the United States of America (USA) and the United Kingdom 
(UK). According to NHANES (2014-2014), black women living in the USA have a 
higher age-adjusted obesity prevalence compared to non-Hispanic white- and Asian 
women (57.2% vs 38.2% and 12.4% respectively) 84 whereas survey data from the 
Health Survey for England (2014) also showed the prevalence of overweight and 
obesity was highest among black African women (70%) women residing in the UK 
compared to the general population (62%), whilst the lowest prevalence was found in 
Asian women (56%) 85.  
As expected, the high prevalence of over-weight/obesity among ethnic-populations is 
also associated with a larger T2DM prevalence compared to their white counterparts. 
A recent meta-analysis of T2DM prevalence in ethnic-minority groups living in Europe 
revealed that South Asian, Sub-Saharan African and Middle Eastern and North African 
populations living in Europe were more than two-times more likely to be diabetic 
compared to the host populations 18 consisting mostly of white Europeans. Similarly, 
in the USA, the Nurse’s Health Study, a large prospective cohort study ranging over a 
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20-year interval (1980-2000), reported that Asian, African and Hispanic-women living 
in the USA also had a higher risk of T2DM compared to their white counterparts 19. 
Notably, this study showed that the high prevalence of T2DM could not wholly be 
attributed to the increased obesity prevalence of these ethnic groups, as adjusting for 
BMI only slightly attenuated the age-adjusted relative risk, whilst these ethnic 
differences still remained significant 19. Indeed, previous studies have shown the risk 
of T2DM to be significantly higher among black African women than white women 
before and after accounting for differences in BMI 20, 86. For example, in South Africa, 
young urban black women (30-44 years of age) have a 2-times higher T2DM 
prevalence (%) compared to their white counterparts 80. Although the reasons for this 
disparity in T2DM prevalence are not clear, ethnic differences in tissue sensitivity to 
insulin (SI) have been demonstrated, and may represent an ethnic-specific risk factor 
for the development of T2DM 22, 57.  
Indeed, black women have been consistently shown to have lower SI (measured by 
FSIGT) compared to white women and women from other ethnicities independent of 
adiposity 57 87, 88 89. When comparing European American and African American 
women and girls, Chandler-Laney et al., found significantly lower SI in African 
American females across all age groups, and that these difference remained 
significant when adjusting for differences in adiposity 90. Similar results have been 
described for BMI-matched black and white South African women 57. Notably, to 
compensate for their increased insulin resistance and to maintain normo-glycaemia, 
black Africans and African Americans (men and women) tend to hypersecrete and 
maintain higher basal levels of insulin 21, 91, 92, a compensation also evident during 
childhood 93. This greater hyperinsulinaemic response has been clearly demonstrated 
when examining the acute insulin response to glucose (AIRg) during a FSIGT in black 
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South African women compared to their white counterparts 57. Similar results were 
also described in a large meta-analysis examining studies of ethnically homogenous 
cohorts in which SI and AIRg were measured 87 . In black women, this increased insulin 
response is partly due to increase β-cell response (first-phase secretion in response 
to intravenous glucose) and lower insulin clearance from the liver 21, 89, 94, 95. These 
studies underscore the remarkable β-cell compensation ability in black Africans.  
Whereas the exact scientific basis of increased obesity-induced insulin resistance and 
higher T2DM prevalence in black women compared to white women are still being 
defined, several mechanistic pathways have been identified as crucial, including the 
pattern of body fat distribution, rate of ectopic fat accumulation and dysregulated 
adipo/cytokine secretion. The next section investigates the contribution of these 
components to the ethnic disparity in T2DM risk in black and white women.  
2.2  ETHNIC DIFFERENCES IN BODY FAT DISTRIBUTION AND IT’S 
ASSOCIATIONS WITH INSULIN RESISTANCE 
2.2.1 Metabolic effects of abdominal/central vs peripheral fat mass 
accumulation in black and white women 
One of the major determinants of insulin resistance is android/central body fat 
partitioning, with VAT enlargement, in particular, being closely associated with 
increased risk for obesity-mediated disease, including T2DM. Thus, it has been 
proposed that disparities in disease risk between black and white ethnic groups, may 
be explained, at least in part, by differences in whole body adiposity and/or body fat 
distribution 23. Indeed, differences in body fat distribution have been described in black 
and white women. For the same level of adiposity, black South African and African 
American women have less central fat mass, specifically less VAT, and more 
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peripheral SAT (femoral and gluteal) compared to white women. Sumner 96 compared 
the waist-circumference and VAT mass relationship in black and white women and 
found a significantly higher increase in cross-sectional VAT area per unit increase in 
waist circumference of white women compared to black women. Similar results have 
also been described in smaller studies for black South African women 22, 37, 97 and 
African American 98 women when compared to their BMI-matched white counterparts. 
In addition, Conway et al. 98, showed that although waist circumference correlated 
significantly with VAT in both ethnicities, abdominal SAT levels were not different 
between these women, but black women had less VAT (cross-sectional area at level 
L2-L3) than white women.  
A small study in South Africa showed that while VAT and abdominal SAT depots are 
similarly associated with insulin sensitivity in the white population, abdominal SAT, 
rather than VAT, was more closely associated with insulin sensitivity (SI, as measured 
by FSIGT) in the black women 23. These studies demonstrate that central fat mass 
may not be the most relevant factor differentiating MHO from NWMO in women of 
different ethnicities. Notably, abdominal SAT is anatomically divided by the stromal 
fascia into two distinct compartments namely, superficial subcutaneous adipose tissue 
(SSAT) and deep subcutaneous adipose tissue (DSAT) 99. Ethnic differences in these 
abdominal SAT compartments have been reported, where obese black women have 
higher SSAT, but similar DSAT compared to white women 23, 40. In black women, the 
relationship between SI (as measures by FSIGT) and DSAT was stronger than for 
SSAT. It has been shown that DSAT has a positive association with insulin resistance 
with a similar magnitude as that described for VAT 40, 100 and therefore may be 
metabolically distinct to SSAT (Table 2.1). 
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The association between increased central fat mass accumulation and the risk for 
developing T2DM have been known for more than 50 years since Vague 101 described 
two different patterns of fat accumulation, namely android (upper-body obesity) and 
gynoid (lower-body obesity) each with distinct associations with CVD and T2DM 
development. Subsequent research has shown that having a higher proportion of 
abdominal adipose tissue (crudely estimated by WHR) was predictive of metabolic 
abnormalities increasing the risk of T2DM and CVD 102, 103.   
 
Table 2.1 Studies investigating adipose tissue depot-specific associations with insulin resistance in black and white 
women 
Study 
Relationship with glucose 
metabolism 
Additional comments  
Body fat distribution 
Kelley et al  100   aDSAT > VAT > SSAT á ↑ fasted glucose; VAT 
but not DSAT or SAT á ↑fasted insulin  
SSAT is a  weak determinant of SI 
Smith et al 99 VAT + SSAT > DSAT á ↑fasting insulin in obese 
women 
 
Preis et al 45 VAT > SAT á ↑HOMA-IR and ↑fasted insulin 
levels 
VAT á with fasted insulin concentration stronger in 
obese compared to normal-weight (VAT ˟ BMI 
interaction) 
Lovejoy et al  104 & 40 VAT+SAT á ↓SI and ↑fasted insulin in AA 
whereas only VAT in WA;  
SAT > VAT á ↑fasted insulin in AA; SSAT > 
DSAT á ↑fasted insulin in AA but DSAT >SSAT 
á in WA 
 
Goedecke et al 23  Abdominal SAT > VAT á ↓SI in SA black women  Body fat distribution is differentially á with SI in black 
and white women. VAT seems to be less important 
determinant of SI in black 
Goedecke et al 105 Gluteal SAT á ↓SI  in black but not white women Gluteal SAT not protective in obese black women 
Keswell et al 88 Trunk/fat mass ratio á ↑fasted insulin and 
↑HOMA-IR whereas leg fat mass á ↓fasted 
insulin and ↓HOMA-IR in SA black and white 
women  
Independent and opposite á of central and peripheral 
fat mass in ethnically diverse population  
Chantler et al 106 Baseline trunk:leg á ↓HOMA-IR in black SA (5.5 
years follow-up); ↑trunk/leg á ↑fasted insulin and 
↓HOMA-IR  
 
Weight gain in black women associates with 
centralization % fm and predicted CVD 
á , association; AA African American women, WA, white American women, HOMA-IR homeostatic model of insulin resistance; DSAT, 
deep subcutaneous adipose tissue; SSAT, superficial subcutaneous adipose tissue; VAT, visceral adipose tissue; % fm, a percentage 
of fat mass; SI, Insulin Sensitivity; BMI, body mass index;  
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Paradoxically, however, less VAT in black women does not associate with a better 
insulin resistance profile as they are more insulin resistant compared to BMI matched 
white counterparts 40, 57, 107, 108. This suggests that the relationship between body 
composition and insulin resistance may be ethnic-specific. Ethnic differences in the 
relationship between metabolic disease risk and body composition have been 
described 23, 44, 88, 109. When matched for BMI, white women with upper-body obesity 
exhibited lower glucose tolerance, hyperinsulinaemia, and significant insulin 
resistance compared to white women with lower-body obesity 110. However, in black 
women there were no differences in fasting glucose and insulin levels and/or 
peripheral insulin sensitivity measures between women with upper- body or lower-
body obesity 110. These findings suggest that the relationship of lower-body obesity 
and the development of insulin resistance appears to be attenuated in black women 
compared to white women.  
Lower-body fat comprises of adipose tissue in the subcutaneous gluteal/femoral 
region and is considered to be protective against the development of metabolic 
disorders. In the AusDiab study, a large population based survey (n= 8400), Snijder et 
al., 49 reported that a larger hip circumference was associated with a lower prevalence 
of undiagnosed T2DM and dyslipidaemia, independent of age, BMI and waist 
circumference. Similarly, in the Hoorn study, where men and women (n=1357) were 
followed up after 6 years, it was found that larger hip and thigh circumferences were 
associated with a lower risk of T2DM, independently of BMI, age, and waist 
circumference, whereas a larger waist circumference was associated with a higher 
risk 47. Although black women have been shown to have large peripheral fat depots, it 
is not clear whether these stores confer lower risk with increasing obesity in this 
population. This does not seem to be the case as having less central fat mass and to 
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a lesser extent, having more peripheral fat, was associated with lower fasting glucose 
levels in black women 88. Using dual-energy X-ray absorptiometry (DXA), Keswell et 
al 88 showed that although a larger peripheral fat mass associated with lower fasted 
insulin levels and lower HOMA-IR in both black and white women, having a greater 
trunk fat mass explained significantly more variance in fasting glucose levels in the 
black compared to white women. Having lower central fat accumulation is thus vital 
for the prevention of metabolic disease in black women and it may be important to 
determine at which point storing fat in the peripheral depots no longer provides 
protection against higher metabolic disease risk. The attenuated protective effect of 
peripheral fat distribution in black women remains to be understood. 
Ethnic differences in the relationship between abdominal adipose tissue distribution 
and insulin sensitivity may be explained by differences in chronic low-grade 
inflammation between the adipose tissue depots of white and black women. Adipose 
tissue inflammation plays a crucial role in the development of obesity- related insulin 
resistance with animal and human studies providing an increasing amount of 
correlative and causative evidence 111-113. Inflammation leads to the development of 
insulin resistance by impairing insulin action at the post-receptor level by inhibiting the 
functions of the insulin receptor substrate (IRS) 1 and 2 114-116. Studies from our 
laboratory have shown that inflammation- and macrophage- specific gene expression 
are up-regulated in the gluteal SAT and DSAT depots of black women independent of 
age, total adiposity and amount of VAT 55. However, in black women, the SAT 
inflammatory gene expression only accounted for 20.9% of the variance in insulin 
sensitivity, compared to over 56% in the white women. These findings were mirrored 
by circulating levels of leptin, adiponectin and hpCRP correlating significantly with SI 
in white women but not in black women. The relationship between adipose tissue 
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inflammation and SI, being stronger in white women compared to black suggests that 
there are other factors that may also be contributing to reduced SI in the black 
population.  
2.2.2 Ectopic fat and insulin sensitivity in black and white women 
Increased ectopic fat, the spill over of triglycerides into peripheral organs such as liver, 
pancreas and muscle, represents another factor linking obesity to greater metabolic 
disease risk. Studies have shown that ectopic fat deposition in liver and skeletal 
muscles may differ by ethnicity 117, 118 (Table 2.2).  
The Dallas Heart study, the largest study measuring hepatic fat accumulation showed 
that black women had lower prevalence of hepatic fat accumulation and a favourable 
lipid profile but still were more insulin resistant (lower SI) compared to white (and 
Hispoanic) women 119 Additionally, in African American women, having greater hepatic 
fat content, associated with 49 % lower SI vs African American women with a low 
hepatic fat content whereas in Hispanic women, having higher hepatic fat content 
associated with 24% lower SI vs those women with a low hepatic fat content 12.. 
Importantly, these observations may be explained, in part, by the different 
physiological implications of insulin action as measured at different sites in the body, 
that is, peripheral vs hepatic insulin action (see also 7). For example, hepatic insulin 
sensitivity in black women is more closely associated with their reduced VAT mass 
than with SAT mass, whereas peripheral (skeletal muscle and adipose tissue depots) 
SI is more closely associated with SAT than VAT 57, 120. In a cohort of black and white 
women who were matched for body fatness and fat distribution (BMI, fat free mass 
and VAT mass) and SI, black women had higher hepatic insulin sensitivity, expressed 
as the % suppression of endogenous glucose production, as measured by low-dose 
euglycemic, hyperinsulinemic clamp 120. In this study, liver fat was more strongly 
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associated with SI in black compared to white women. These results underscore the 
significant role that the liver plays in maintaining normal glycaemia in black women.  
In sum, ethnic differences in the relationship between VAT/liver fat content and insulin 
resistance have been investigated by several studies. Black African and African 
American women have consistently been found to have higher serum insulin levels 
and reduced SI compared to women of other ethnicities despite their lower VAT and 
liver fat.  
2.2.3 Genetic control of fat mass and body composition  
As discussed, not all obese individuals have the same risk of developing insulin 
resistance, hyperlipidaemia, CVD and T2DM. For example, individuals with peripheral 
Table 2.2 Studies investigating adipose tissue depot-specific associations with insulin resistance in black and 
white women  
Study Relationship with glucose metabolism Additional comments  
Ectopic fat distribution 
Browning et al 
119 
AA have ↓hepatic steatosis compared to WA and 
Hispanics, independent of BMI and insulin 
sensitivity 119.  
Despite lower peripheral insulin sensitivity, AA have 
higher hepatic insulin sensitivity. Ethnic differences in 
hepatic steatosis may be explained by the smaller 
VAT in AA compared to WA. Inadequate SAT depot 
may lead to ectopic fat storage with its associated 
metabolic sequelae 121 
Alderete et al 12 AA LF < Hisp LF. 
LF á ↑VAT in AA and Hispanics.  
AA with ↑LF had 49% lower SI compared to AA 
with ↓LF whereas Hisp with ↑LF had 24% lower SI 
compared to Hisp with ↓LF  
AA stronger inverse relationship between LF and SI 
when compared with Hisp.  
LF in AA especially detrimental to DI (AIRg 
compensation for ↓SI) and may underlie β-cell failure 
Taksali et al 121 AA have ↓VAT vs Hisp & white obese. 
When stratified by VAT, the highest VAT tertile á 
↑ LF and á ↓ BMI and ↓ BF%.  
Highest VAT tertile á ↑ fasted insulin and ↑ 
HOMA-IR 
Ability to retain and expand SAT(SSAT) á ↓VAT and 
↓LF and more favourable metabolic profile  
Goedecke et al 
120 
↓LF fat in BSA vs WSA women.  
↑LF á ↓ SI in BSA only.  
EMCL & IMCL not different in BSA and WSA 
The paradox of ↑hepatic SI but similar basal EGP in 
black vs white SA women may be explained by lower 
hepatic insulin clearance in obese BSA 
Lawrence et al 
56 
↑EMCL in AA. 
IMCL á ↓ SI in EA only (ethnic ˟ IMCL interaction) 
↑EMCL in AA vs EA but was not á ↓ SI. Ethnic 
difference may exist in DAG, ceramide or other FFA 
metabolites.  
á, association; LF, liver fat; AA, African American women; WA, white American women; Hisp, Hispanic women; BSA, black South African women; 
WSA, white South African women; HOMA-IR, homeostatic model of insulin resistance; SSAT, superficial subcutaneous adipose tissue; VAT, visceral 
adipose tissue; BF%, a percentage of fat mass; SI, Insulin sensitivity; BMI, body mass index. IMCL, intra-myocellular lipid; EMCL, extra-myocellular 
lipid; EGP, endogenous glucose production; ↑, higher; ↓ lower. 
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obesity have a reduced risk of obesity associated metabolic abnormalities compared 
to individuals with central obesity who are more prone to these complications. While 
considerable research have been done in the physiological and metabolic 
determinants of appetite and energy expenditure that underlie obesity development,  
much less is known about the genetic factors that determine adipocyte number, body 
fat distribution or their associations with metabolic disease.  
 Genetic regulation of BMI and body fat distribution 
Studies undertaken in monozygotic twins have consistently demonstrated a significant 
genetic influence on the development of obesity and body fat distribution 122-124. For 
example, a study in free-living middle-aged female monozygotic twins found that up to 
65% of total variance in fat mass (%) could be attributed to genetic variation 125 while 
another monozygotic twin study (males) found a significant genotype effect to the 
responsiveness to an overfeeding stimulus 126. Furthermore, a study comparing the 
interclass associations for all body fat mass (%) parameters among monozygotic and 
dizygotic twins found a significant genetic (heritability, h2) component for total- and 
regional fat mass distribution (lower-body fat mass % and trunk/lower-body fat mass 
%) in both young and elderly twin pairs 123. These studies highlight that body fat mass 
and its distribution are under extensive genetic control.  
In support, large genome-wide association studies (GWAS) have also confirmed the 
profound role of genetic regulation on BMI and suggested that common genetic 
variation may account for 40-70% variation in obesity-related phenotypes 127, 128. 
Based on findings from these studies, several different metabolic pathways implicated 
in higher obesity-related pathophysiology risk have been proposed, and may include 
a role for the central nervous system in obesity susceptibility, along with other novel 
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pathways related to insulin signalling, energy metabolism, lipid biology and 
adipogenesis 128. Notably, these GWAS studies have identified over 100 different loci 
associated with BMI 128 129-131 and other obesity-related traits such as MetS 131. 
In a meta-analysis of GWAS, Heid et al., 132 demonstrated that genetic regulation of 
body fat distribution involved loci and regulatory pathways that are distinct from those 
that influence BMI and risk of obesity. In support, another meta-analysis of GWAS 
conducted by Lindgren et al., 133 investigated the genetic regulation of waist 
circumference (WC) and WHR, and found that variation near the lysophospholipase-
like protein 1 gene (which is thought to act as a triglyceride lipase and is up-regulated 
in SAT of obese individuals) was associated with variation in WHR (BMI-adjusted) in 
women, although further investigations are still warranted. 
Importantly, the heritable effect on fat mass and its distribution is likely a result of 
genetic variation at several different regulatory sites that may either be dependent or 
independent of extrinsic influence. For example, Gesta et al., 134 showed expression 
differences of multiple embryonic-developmental genes (HoxA5, Gpc and Tbx15) that 
were independent of interstitial factors such as innervation, vascularization, 
oxygenation or other factors between adipocytes sourced from VAT and SAT in mouse 
models prone to, or protected against obesity-related pathology. This study also 
showed similar inter-depot differences in developmental gene expression in lean 
humans with comparable WHR. These differences in gene expression were shown to 
be intrinsic, and persisted during in vitro culture and differentiation, suggesting that 
they are cell-autonomous and are independent of the microenvironment 134. These 
results suggest that genetically programmed developmental differences in adipocyte 
biology may play important roles in body fat distribution that may be independent of 
obesity and therefore, by extension, associated with higher T2DM risk. Notably, 
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although these cell-autonomous characteristics may be independent of adipose tissue 
depot-interstitial microenvironment, a subset of factors may also be influenced by 
extrinsic (environment) factors such as glycaemia. It therefore follows that cell-
autonomous factors may exaggerate this risk for T2DM by augmenting adipocyte 
biology in a depot-specific manner leading to differences in the pattern of body fat 
distribution. 
 Effects of ethnicity 
Genetic explanations for the phenotypic differences in body composition and the 
disparity in metabolic disease risk between African and European/white populations 
remain to be elucidated. Few studies have demonstrated ethnic differences in allelic 
frequencies for multiple genes affecting a single biological mechanism in a way that 
might produce a biologically significant effect that is able to explain a significant 
proportion of the variation in disease risk 135. 
Previous GWAS studies have mostly been conducted in European cohorts. However, 
recent studies aiming to replicate these findings in different ethnic populations have 
not only confirmed some significant relationships between risk loci and body 
composition measures, but have also identified others 130 132, 136, 137. Due to ethnic 
differences in allele frequencies and haplotype structures, conducting GWAS across 
ethnically diverse populations may highlight important disease risk loci not readily 
detected in European populations 130 131. For example, a recent GWAS found ethnic-
specific associations were involved in the genetic determination of BMI, highlighting 
the importance of ethnic-specific approaches in discovery of genetic associations with 
obesity-related phenotypes. This may have implications for the development of gene-
based therapies 130. Moreover, another GWAS conducted in African Americans 
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identified credible candidate loci associated with fasted insulin levels and insulin 
resistance with successful replication within another independent sample of West 
Africans, but failed to do so in a European population 138.  
Taken together, these studies show that BMI and body fat distribution are under 
considerable genetic regulation and that the increased risk for T2DM could be 
exacerbated by obesity-independent genetic risk factors. Currently, it remains to be 
investigated whether genetic variation could potentially explain the ethnic-specific risk 
factors contributing to increased insulin resistance and higher T2DM risk in women of 
African ancestry, providing a strong rational for studies investigating genetic and 
extrinsic factors regulating adipose tissue depot development. 
2.3 ADIPOSE TISSUE DEPOT SPECIFIC DETERMINANTS OF INSULIN 
RESISTANCE 
Unlike other organs, adipose tissue exists throughout the body in distinct depots. VAT 
surrounds the inner organs in the abdominal cavity and comprises both the greater- 
and lesser omentum and mesenteric adipose depots while SAT lies directly under the 
skin in the upper and lower body and connects with the fasciae surrounding the 
muscles. Functionally, while the combination of these adipose tissue depots serve as 
energy repositories to maintain normal systemic equilibrium during energy intake and 
expenditure, each depot adopts certain constitutive morphologic and physiological 
characteristics that enables them to fulfil distinctive primary metabolic functions in 
energy regulation. These functions are maintained through integrated neural and 
hormonal regulation of lipid metabolism, cellular proliferation and differentiation, 
adipo/cytokine signalling and vascularization, and are discussed next. 
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2.3.1 Depot specific differences in lipid metabolism and associations with 
insulin resistance 
After a meal, non-esterified free fatty acids (FFA) are transported into the cell through 
lipoprotein lipase (LPL) breakdown of circulating triacylglycerol (TAG) attached to 
chylomicrons from the gut and very low-density lipoprotein lipase (VLDL) from the liver, 
but may also be directly taken up from the circulation 139, 140. A proportion of these 
FFAs released by LPL activity remain in the circulation as non-esterified fatty acids 
(NEFA). On the other hand, when energy demand increases during energy 
expenditure, for example during bouts of exercise, TAG stored in the adipocyte are 
then again hydrolysed into FFA and glycerol through adipose triglyceride lipase 
(ATGL) and hormone sensitive lipase (HSL), and are exported from the adipocyte to 
be used as an energy substrate for β-oxidation in mitochondria of other tissues, such 
as muscle 141. In response to insulin, glucose is also transported into the cells and 
utilised in the production of TAG for storage through de novo lipogenesis 142. The 
various characteristics within VAT compared to SAT with regards to their differences 
in lipid storage and metabolism are shown in Table 2.3. In brief, human studies have 
demonstrated that compared to SAT, VAT has a higher turnover of triglyceride/FFA, 
at least in part due to a combination of its high lipolytic and lipogenic rates, along with 
a lower sensitivity to the anti-lipolytic effects of insulin 143, 144. VAT therefore serves as 
short term lipid buffer, protecting other organs from the lipotoxic effects of high 
circulating levels of lipid in the post-prandial state. In accordance with this function, 
VAT displays small, insulin sensitive adipocytes with a high capillary density. In 
contrast, the SAT depots have been shown to have larger cells which are more 
sensitive to the anti-lipolytic effects of insulin and therefore are considered to be 
metabolically more inert, in accordance with their long term energy storage function 
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143, 144. Thus, during normal physiological conditions, VAT and SAT function 
synergistically to facilitate the flux of excess dietary energy for storage in the peripheral 
SAT depots until mobilisation from these depots during times of metabolic demand. 
Metabolic dysregulation during the pathological expansion of adipose tissue 
associates with the development of central obesity, a process characterised by the 
increased storage of fat in the central depots (VAT and abdominal SAT) rather than 
peripheral depots (leg or gluteal/femoral SAT), and correlates closely with metabolic 
abnormalities underlying increased risk for T2DM and CVD 100, 162-165. Excess VAT 
accumulation has been shown to be a critical characteristic that distinguishes MHO 
Table 2.3 The Morphologic and physiologic characteristics of VAT compared to SAT: Lipid Metabolism 
Lipid metabolism characteristic 
Depot differences in primary 
metabolic function 
Contribution to IR 
Lipogenesis 
VAT > SAT 
 
Basal rate of glucose uptake 145, 146  
Insulin stimulated glucose uptake 145, 147 
FFA and TAG uptake 148, 149  
LPL protein levels  
Lipid synthesis150  
VAT has a high lipid turnover 
rate that constitute its major 
functional role in post-prandial 
lipid buffering  
Increased lipogenesis in VAT 
contributes to enlarged, insulin 
resistant adipocytes. 
VAT < SAT Insulin stimulated LPL activity in women151 
Adipocyte size 
Larger adipocyte size in SAT 
may allow for larger storage 
capacity in this depot. 
Increased VAT hypertrophy á with 
increases splanchnic FFA delivery 
and increases hepatic IR. 
gSAT < VAT Insulin-regulated FFA uptake 152 GSAT is favoured for FFA 
sequestering excess and safe 
storage. 
VAT is more resistant to insulin's 
antilipolytic effects than leg and 
non-splanchnic upper body fat 
Lipolysis 
VAT > SAT ATGL 
HSL content153 
Catecholamine-induced lipolysis149, 154, 155 
β-Adrenoreceptor lipolysis156 
Inhibition of lipolysis is more 
pronounced in SAT than VAT 
adipocytes.  
Decreased insulin receptor 
affinity and signal transduction in 
VAT. SAT protects against 
lipotoxicity and ectopic fat 
deposition  
 
Dysfunctional SAT during obesity 
leads to elevated circulating FFA’s 
and results in lipotoxicity and 
ectopic fat deposition, which leads 
to peripheral and hepatic IR VAT < SAT Basal rate of lipolysis150, 153, 154, 157 
HSL activity153, 157 
α-Adrenoreceptor-dependent anti-
lipolysis158, 159 
Anti-lipolytic effect of insulin149, 160 
abSAT > gSAT β-Adrenoreceptors mRNA 161 Enhanced catecholamine induced 
lipolysis in abSAT compared to 
gSAT 161 
 
Á, associates; LPL, lipoprotein lipase enzyme; FFA, free fatty acid,  VAT, visceral adipose tissue, SAT subcutaneous adipose tissue; IR, insulin 
resistance, ATGL,  adipose triglyceride lipase; HSL, hormone-sensitive lipase; TAG, triglyceride 
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from obese people with metabolic abnormalities and from those characterised as 
MUNW (for review, see 166). In a large cohort of Caucasian women (n=1452) 
participating in the Framingham Heart Study, it was shown that although both SAT 
and VAT were correlated with metabolic risk factors, VAT remained more strongly 
correlated with an adverse metabolic risk profile, even after accounting for standard 
anthropometric indexes such as BMI and total body fat % 167. One hypothesis aimed 
at explaining the added risk of VAT over SAT is the portal/visceral hypothesis. 
Originally proposed by Björntorp 144, this hypothesis proposes that the direct release 
of FFA as products of the increased lipolytic rate of VAT into the portal vein reduces 
hepatic insulin sensitivity, impairs peripheral glucose utilisation and increases hepatic 
glucose overproduction 168-170 and thereby results in glycaemic abnormalities that may 
predispose individuals to developing T2DM. Chronic exposure of the liver to elevated 
FFAs influence several important hepatic functions, including gluconeogenesis, VLDL 
secretion, and insulin clearance 171 and thereby can contribute to both the 
development and exacerbation insulin resistance 152, 172. FFAs release from VAT into 
the portal vein increases with increasing VAT mass, although its relative contribution 
of total circulating FFAs varies greatly at a given visceral adiposity 170. Additionally, 
Fabbrini et al., 173 demonstrated that intrahepatic triglyceride content has a stronger 
association with the development of the metabolic disturbances associated with 
obesity than does VAT volume per se.   
Obesity-induced pathophysiology of the liver may also be a result of the inability of 
SAT to effectively store excess energy. Nielsen et al., demonstrated that SAT may 
account for up to 90% of circulating FFAs, with almost 70% of these FFAs coming 
from the abdominal SAT depot 170, 174. In contrast, lower-body/peripheral fat, which 
comprises the hip and gluteal-femoral SAT areas, is considered to act as a metabolic 
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“sink” to store excess FFA when there is an energy surplus 50, 175. The protective effect 
of peripheral fat mass is believed to result from increased FFA sequestration from 
circulation for storage in this depot, and thereby protect from ectopic fat distribution 
into organs less adapted for this purpose 47. Votruba and Jensen 176 reported that 
women preferentially store post-prandial FFA in the gluteal femoral adipose tissue 
depot, demonstrating its important role in excess FFA disposal into the lower-body 
SAT. Thus, it may be hypothesised that the ability of peripheral SAT to effectively 
sequester excess FFAs from circulation for storage within this depot rather than in 
VAT may be protective against the lipotoxic effects of ectopic fat deposition. In support 
of this notion, higher TAG sequestration was demonstrated to be a determinant of 
insulin sensitivity in insulin sensitive compared to insulin resistant BMI-matched 
individuals 177. On the other hand, when the ability to safely store FFA in SAT is 
inhibited, these FFAs may be deposited in VAT and/or other ectopic sites less adapted 
for this purpose where they may contribute to the deterioration of systemic and hepatic 
insulin sensitivity. 
2.3.2 Adipo/cytokine production 
Another consequence of expanding adipose tissue, described as the endocrine 
hypothesis, relates to increased VAT mass affecting insulin sensitivity through the 
increased secretion of products other than FFA, such as adipo/cytokines (Table 2.4). 
VAT and its associated macrophages have been shown to secrete higher levels of 
pro-inflammatory adipokines than SAT 107. Measures of visceral adiposity have been 
shown to correlate with increased serum levels of pro-inflammatory cytokines (eg. IL6, 
IL8) 178, 179, and VAT adipocytes secrete these cytokines in larger quantities than SAT 
adipocytes 180, 181. Serum levels of both IL-6 and IL-8 have been show to negatively 
influence insulin resistance, and that IL-6 has predictive value in the risk of T2DM 
ECM & Hypoxia 
27 
development 182. Importantly, DSAT and SSAT of obese individuals are not 
homogenous in terms of inflammatory profile. DSAT has been reported to have higher 
inflammatory gene expression compared to SSAT 183, and suggest a distinct role for 
this depot in obesity-associated metabolic complications.  
Other common adipo/cytokines associated with insulin resistance is adiponectin, leptin 
and angiotensin. Notably, leptin was first identified as the product of the obese (ob) 
gene in mice in which the expression of a non-functional protein product results in 
profound obesity and T2DM 187, a phenotype considered synonymous to morbid 
obesity in humans. Leptin is an adipocyte-derived factor that communicates the level 
of fat stores to the energy regulating centres of the brain (e.g. hypothalamus) 187. 
Leptin levels have been measured to be approximately 4 times higher in the peripheral 
circulation in obese compared to normal-weight individuals 192. However, during 
obesity, although high amounts of leptin are produced from the abdominal SAT depots, 
adipocytes become resistant to its actions, termed leptin resistance 193. Notably, 
Table 2.4 The Morphologic and physiologic characteristics of VAT compared to SAT: Adipo/cytokines production 
and secretion 
Depot adipo/cytokine secretion characteristics Primary metabolic function Contribution to IR 
 




Inflammatory cytokines (IL-6, IL-8, PAI-1) 
Adiponectin and leptin function in 
the regulation fat metabolism 
throughout different depots.  
Endocrine hypothesis 
 
VAT < SAT Leptin secretion 154, 184 185 
 
Leptin expression from abdominal 
SAT relays nutritional status to the 
energy regulating centres of the 
brain 186, 187  
Resistance to leptin may promote 
ectopic fat deposition and further 
exacerbate insulin resistance. 
Additionally, defects in leptin signal 
transduction may lead to insulin 
resistance 188 
VAT > SAT Glucocorticoid receptor (GR-α) 189 
11β-hydroxysteroiddehydrogenase 1 
(11β-HSD-1)190 
Conversion of inactive cortisone to 
active cortisol by 11β-HSD-1. 
Elevated 11β-HSD-1 activity in 
VAT associates with increased 





increased IL-6 and lower leptin levels have been demonstrated in the portal vein 
compared to the peripheral artery in vivo, and demonstrates the close association 
between increased VAT and reduced insulin sensitivity 172, 194. 
2.3.3 Structural component differences between adipose tissue depots and 
associations with insulin resistance 
In addition to the metabolic/secretory differences described between VAT and SAT 
depots and their respective effects on insulin sensitivity, depot-differences in cellular 
and structural components have also been reported to differentially impact insulin 
sensitivity, and are discussed next. 
 Cellularity 
During adipose tissue development, depot enlargement can occur either by 
hyperplasia, the recruitment of progenitors/pre-adipocytes to form new lipid laden 
adipocytes, or by hypertrophy, the development and enlargement of existing 
adipocytes. These two process are tightly regulated in each adipose tissue depot and 
the result is that adipose tissue compartments such as VAT and abdominal SAT differ 
in both cell number and cell size, the ratio of which is often referred to as the cellularity 
of a depot 195. Apart from the mature lipid filled adipocytes that make up the bulk of 
adipose tissue volume, the cellularity of the depot also refers to the non-adipocyte 
component present in adipose tissue, which is known as the stromal vascular fraction 
(SVF). These include pluripotent mesenchymal stem cells (MSC’s), fibroblasts, 
vascular endothelial cells of blood and lymphatic vessels, macrophages, mast and 
dendritic cells 196. Additionally, pre-adipocytes are generated during adipogenesis from 
fibroblast-like MSCs cells. In this process, MSC’s that reside in perivascular locations 
197-200 are recruited into adipose tissue to form new adipocytes. 
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Differentiation of these MSC’s into mature lipid-laden adipocytes is a two-step 
developmental process. Firstly, the commitment stage involves a reduction of the 
developmental potential of the stem cell that ultimately renders it incapable of 
differentiating into other cell types. This determination step is an irreversible 
commitment of the pluripotent MSC to a pathway of differentiation to the adipocyte 
lineage 199. In the second step, the terminally differentiated pre-adipocyte, now 
incapable of further mitotic division then acquire the features of mature adipocytes and 
undergo lipogenesis to acquire its characteristic lipid droplet. Therefore, the formation 
of all “new” mature adipocytes during depot expansion is a result of the proliferation 
and differentiation of pre-adipocytes and their more primitive from, MSC’s, in response 
to the metabolic demand. It is estimated that the half-life of a mature adipocyte is about 
8 years and that approximately 10% of adipocyte are renewed annually 201. 
Experiments using the murine 3T3-L1 and 3T3-F442A pre-adipocyte cell lines have 
become the “gold standard” for investigating the in vitro transcriptional cascade that 
promotes adipocyte differentiation 209, 210. CCAAT-enhancer-binding proteins 
Table 2.5 The Morphologic and physiologic characteristics of VAT compared to SAT: Structural characteristics: 
Cellularity 
Structural characteristic: Cellularity 
Primary metabolic 
function 
Contribution to IR 
Adipocytes  
VAT > SAT Mesentric adipocyte size150, 184, 202 
Apoptosis susceptibility /senescence203, 204 
Omental adipocytes are 20- 
30% smaller than abdominal 
adipocytes over large BMI 
range. However, lower-body 
adipocytes can develop rapidly 
into mature adipocytes to 
buffer incoming lipid. 
Mean adipocyte size from all adipose 
depots increase with obesity. During 
weight gain, having a lower 
differentiation capacity in lower body 
SAT depot results in enlarged 
abdominal (VAT and SAT) adipocytes. 
These large adipocytes are more 
insulin resistant. 
VAT < SAT Omental adipocytes150, 184, 202 
Higher proliferation and differentiation 
capacity in vitro154, 205, 206 
PPARy production207, 208 
Increased cell size150, 184, 202 
Cells of the SVF 
VAT > SAT Macrophage infiltration 
Endothelial cells 206 






(C/EBPs), basic leucine-zipper class of transcription factors and peroxisome 
proliferator-activated receptor γ (PPARγ), a member of the nuclear receptor subfamily, 
function together as pleiotropic transcriptional activators of a large group of genes that 
produce the adipocyte phenotype 210-212. The sterol regulatory element-binding 
proteins (SREBP’s), basic helix-loop-helix-leucine zipper proteins, regulate gene 
expression involved in cholesterol and lipid metabolism. SREBP1c mRNA expression 
is activated downstream of C/EBPα and PPARγ-induced induction of differentiation. 
Under insulin regulation, SREBP1c is cleaved to its activated form after which it is 
translocated to the nucleus. Here it initiates the transcription of lipogenic enzymes 
which induce lipid biosynthesis and produce the mature adipocyte characteristics 213. 
 Adipocyte hypertrophy versus hyperplasia and metabolic health 
The ratio of adipocyte hyperplasia to hypertrophy during adipose tissue expansion 
ultimately determines the cellularity of each adipose tissue depot and as such, its 
relationship with energy metabolism. In contrast to the recruitment of new progenitor 
cells and their differentiation into adipocytes, mature/differentiated adipocytes 
increase their cell size/volume predominantly by the taking up FFA from circulation 
and increasing TAG storage. It is accepted that the lager adipocyte cell-size is 
associated with increased BMI, and is directly related to the development of metabolic 
dysregulation 214. However, the relationship between cell size and metabolic 
abnormalities is now increasingly being shown to be depot- and gender-dependent.  
The dimorphic nature of hypertrophic versus hyperplastic depot expansion of VAT and 
SAT depots is most clearly demonstrated murine models. Studies in mice have shown 
that the epididymal fat pad increases in cell number up to a certain age, and then 
mainly expands by hypertrophy 215. However, in the subcutaneous depot and 
retroperitoneal depots of rodents, prolonged fat feeding results in depot growth mainly 
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by hyperplasia 215, 216. VAT tissue growth occurs mostly through hyperplasia in both 
mice 217, 218 and humans 219,while SAT does not seem to show significant hyperplasia 
in response to high fat feeding 217, 218 during which depot enlargement mainly occurs 
through increased cell size. In contrast, in response to bariatric surgery-induced weight 
loss, abdominal SAT adipocyte cell size is significantly reduced with no significant 
reduction in adipocyte number noted 201. The differences in adipocyte growth rate 
and/or differentiation and proliferation responses between the different adipose tissue 
depots have been proposed to be dependent on both intrinsic and extrinsic factors 220, 
and are discussed next. These studies indicate that depot-specific mechanisms are 
important in the regulation of adipose tissue growth during obesity 220 and determines 
its relationship with insulin sensitivity and metabolic disease.  
 The microenvironment 
 The structure of the microenvironment 
Human adipose tissue consists primarily of large spherical cells in which a large lipid 
droplet fills almost the entire volume. Adipocytes vary widely in size and can range 
from 30-200 µm in diameter 221, 222. Since only a lipid monolayer forms the boundary 
between the large fat droplet and the cytosol, mechanical stress could easily lead to 
the disruption of the organelle 223, 224. To structurally support the cell, a strong external 
connective tissue framework is needed.  
Napolitano, using a murine model, was the first to demonstrate adipose tissue ECM 
as fibrillar collagen structures that surround adipocytes 225. This extracellular 
framework is formed by the pericellular basement membrane, situated around each 
adipocyte, and the interconnecting interstitial fibres. The ECM is made up of structural 
proteins (collagens I-VI) and various adhesion molecules including fibronectin, 
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laminins, elastins and proteoglycans (decorin and lumican) and matricellular proteins 
such as MMP’s, secreted proteins acidic in nature (SPARC) and thrombospondins 
(THBS) 226. Table 2.6 lists the key matrix adhesion and structural collagen components 
and their functional relevance in adipose tissue. In short, Triple-helical type I collagen 
molecules form interwoven bundles and provide the major ECM network necessary to 
sustain the structure and function of all mesenchymal tissues 227 , while type IV 
collagen forms the pericellular basement membrane 228. The basement membrane 
provides the structural support to the mature adipocyte and also interacts with cell 
surface integrins for cell ECM signalling. Collagen IV and laminins make up the major 
components of the basement membrane. These molecules are assembled in the 
extracellular space and form a basket-like ultrastructure of the basement membranes 
that surrounds each adipocyte. Nidogen and perlican bridge the laminin and type IV 
collagen network to stabilize and maintain basement membrane integrity 229 (Figure 
2.1). 
ECM & Hypoxia 
33 
Matricellular proteins are non-structural, extracellular regulators of cell function and 
facilitate ECM cell interactions 234. The matricellular protein SPARC also contributes 
to the basement membrane integrity 234. Type VI collagen, a non fibrillar collagen binds 
various other ECM components in the basement membrane and interstitial fibres and 
Table 2.6 Adhesion molecules and collagen components of the ECM in adipose tissue 
 
Component Composition Matrix structure Function Refs 
Adhesion proteins    
Fibronectin Dimers, non-collagenous 250 
kDa multidomain subunits 
Fibrillar meshwork, Stromal 
ECM 
Modulates cell shape, Inhibits 
adipogenesis. Communication 
between cell and ECM. 
Organization of other ECM 
components 
191 
Laminins Triple-helix of α, β and γ 
chains 
Integrates with Col IV to form 
basement membrane 
Major component of basement 
membranes. Signalling ECM-cell 
interactions 
230 
Elastic fibres Hierarchical assembly and 
cross-linking of multiple 
tropoelastin (60kD) monomers 
that accumulate on a micro-
fibrillar skeleton. 
Asymmetric coil, contains cell 
binding domains. Pericellular 
distribution around adipocytes 
and are associated with blood 
vessels 
Provides flexibility and extendability 
in tissue enabling long-range 
deformability and passive recoil 
without energy input 
231-233 
SPARC Matricellular glycoprotein 
momomer 35kD 
Bound to collagen network Mediator of collagen deposition and 
promotes fibrosis. Inhibits adipocyte 
differentiation and adipogenesis, 
and adipose tissue hyperplasia 
234
 
MMP’s Ca2+-dependent Zn-containing 
endopeptidases. Consists of 
N-terminal pro-domain, 
catalytic domain, hinge region, 
and C-terminal hemopexin-like 
domain  
Secreted by fibroblasts, 
osteoblasts, endothelial cells, 
macrophages, neutrophils, 
and lymphocytes. 
Responsible for tissue remodelling 
and degradation of the ECM, 
including collagens, elastins, 
gelatin, matrix glycoproteins, and 
proteoglycans 
235 
THBS Matricellular glycol-protein 
momomer includes THBS 1 
and 2 
Resides in pericellular space THBS 1 regulates TGF-β activity 
and correlates with inflammation. 
THBS2 clears MMP 2 from 
pericellular space 
234 
Structural components    
Collagen Type I 
(ColI) 
Triple-helix of [α1(I)]2 α2(I) 
heterotrimers 
Interwoven with each other to 
form thick collagen bundles   
ECM framework for adipocyte 





Triple-helix of [α1(I)]2 α2(I) 
heterotrimers 
Forms major component of 
basement membranes around 
adipocytes 
Structural support to mature 
adipocytes. Mechano-signal 
transduction between adipocyte 




minor-fibrillar α 1(V) α 2(V) 
heterotrimers 
Pericellular ECM. Co-
assembles with type I collagen 
to form heterotypic fibril 





Non-fibrillar α 1(VI) α 2(VI) α 
3(VI) heterotrimers 
Micro-fibrils in the interspace 
between basement 
membranes and thick ColI 
bundles 
Regulates adipocyte hypertrophy. 






links the adipocyte to the ECM through its interaction with cell surface integrins 238. 
Integrins are heterodimeric transmembrane receptors that bind externally to the ECM 
and internally to the adipocyte cytoskeleton 239. Integrins transduce mechanical 
information from the ECM to regulate gene expression and function. In doing so, 
integrins may provide the adipocyte with a means to sense its own size 240, 241.  
Type V collagen molecules also form part of the basement membrane assembly 242, 
243 where they exist as micro-fibers that are closely associated with type I collagen 
bundles, and have been demonstrated to regulate fibril assembly and thickness 237, 
244. Early ECM development has mostly been investigated in vitro in differentiating 
3T3-L1 adipocytes. Studies on the differentiating adipocyte secretome indicate that 
the induction of ECM expression is one of the earliest events induced during 
differentiation when the collagen/fibronectin-rich matrix surrounding the pre-adipocyte 
is replaced by type IV collagen, laminin, and heparin sulphate proteoglycans that form 
the basement membrane which is more characteristic of the mature adipocyte. This 
conversion is crucial for the fibroblast-like cell to accomplish its new spherical form 209.  
ECM synthesis has also been shown to be a prerequisite for pre-adipocyte 
differentiation and TAG accumulation. Mouse 10T1/2 pre-adipocytes treated with a 
collagen synthesis inhibitor, ethyl-3,4-dihydroxybenzoate (EDHB), fail to develop into 
mature, lipid laden adipocytes 245. Similarly, upon EDHB treatment, bovine 
intramuscular pre-adipocytes (BIP) cells do not accumulate collagens (types I-VI) or 
triglyceride, which are generally associated with mature adipocytes. However, when 
exogenous type V and type VI collagens were supplied to the culture dishes, these 
cells were able to differentiate and restore the mature adipocyte phenotype 246, 
highlighting the importance of these matrix components, as well as other matrix 
remodelling enzymes (Table 2.6) to adipocyte development . 
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 Regulation of ECM expression in soft connective tissue 
Adipose tissue has a unique plasticity demonstrated by its ability to quickly expand 
during times of nutrient excess and to retract during nutrient scarcity. To accommodate 
the ever-changing adipose tissue organ, the ultra-structure and the composition of the 
ECM needs to be regularly remodelled. The factors regulating ECM remodelling in 
adipose tissue are not fully understood. However, as a soft connective tissue, the 
 
 
Figure 2.1 Structural organization of the ECM and basement membrane components around the adipocyte. a.) 
Fibroblastic pre-adipocyte associates with ECM comprising of large Collagen type 1 (Col1) fibers (cross-banded tan 
lines), fibronectin (FN) fibers (thin blue lines) and Collagen type VI (ColVI) red beaded lines. The matrix 
metalloproteinases (MMP’s) are depicted by the scissors and b) mature adipocyte and ECM and basement membrane 
components. Pre-adipocyte differentiation –Adapted from Haung and Greenspan 2012 2 
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mechanisms that regulate adipose tissue ECM turnover may reflect those that regulate 
ECM remodelling within other connective tissues such as tendons, ligaments and bone 
247.  
The expression of structural proteins in soft connective tissues are regulated by 
signalling cascades in response to stimuli such as repetitive mechanical loading. This 
process results in adaptive ECM reorganization which allows for tissue repair and 
healing 248. Macrophages respond to tissue injury with the ultimate goal of wound 
healing and phagocytosis of contaminating components. Activated macrophages 
secrete pro-inflammatory factors (e.g. MCP-1, -2, -3; MIP-1α, -1β; osteopontin) that 
exacerbate inflammatory cell infiltration into the sites of tissue injury 249. They are 
considered the master regulators of the ECM turnover 249 through their production of 
pro-fibrotic factors such as transforming growth factor β (TGF-β1) and platelet-derived 
growth factor (PDGF) 250, 251. Macrophages are also the main source of several types 
of matrix metallopoteinases (MMPs), the major enzymes involved in ECM degradation 
252, and their endogenous suppressors, tissue inhibitors of MMPs (TIMPs). The 
inflammatory mediated tissue repair process consists of two stages. Normal tissue 
repair, prompted by an acute inflammatory state, involves an orderly remodelling of 
ECM components and removal of dead or damaged cells. However, failure to resolve 
the inflammatory state results in maladaptive ECM remodelling and the formation of 
fibrosis.  
Hypertrophic adipocytes may experience increased mechanical stress due to 
increasing static strain of the enlarging lipid droplet. Indeed, cell stiffness (resistance 
to deformation) has been shown to increase during adipogenesis as preadipocytes 
mature and acquire their characteristic lipid droplet 253. Increased mechanical loading 
has also been reported to influence stochastic events in the adipocyte life cycle (e.g. 
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cell proliferation, commitment and differentiation) 254. Shoham et al., 254 demonstrated 
that stretching in 3T3-L1 adipocytes promoted differentiation but did not have effects 
on mitosis. Shear stress and cyclic strain altered the structure and cytoskeleton of the 
cells in a dose-dependent manner and are also subject to threshold levels 255.  
Additionally, Chien et al., 256 showed that cultured human aortic endothelial cells 
responded to sustained shearing but that the resulting mRNA and protein expression 
was dependent of the direction of the stress (stress with a forward component vs stress 
without a significant forward component). These studies show that adipocyte function 
is regulated by cytoarchitecture and suggests that chronic exposure to adipocyte cell 
deformation e.g. increased weight-bearing fat tissue mass, may contribute to 
alterations in ECM in adipose tissue which may have exacerbating effects on 
inflammation and insulin resistance.  
Intrinsic factors  
Excessive mechanical loading is often reported as a risk factor for soft tissue injuries 
257. Carpal tunnel syndrome in the hands 258, Achilles tendinopathy in the heel 259, 
anterior cruciate ligament (ACL) injuries in the knee 260 and rotator cuff tendinopathy 
in the shoulder 248, 261 are commonly found in sporting activities that involve sudden 
deceleration or change in direction 262. Although the mechanisms of these overuse 
and acute exercise-associated soft-tissue injuries are poorly understood, the 
expression of collagens, proteoglycans and/or glycoprotein content have been 
demonstrated to be altered in disease states such as tendinopathy and ligament 
injuries 248. These injuries are considered multifactorial disorders since several 
extrinsic and intrinsic risk factors for developing these disorders have been identified 
259. With genetic and familial factors being important intrinsic risk factors 248, 
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susceptibility to these injuries are determined by exposure to extrinsic risk factors such 
as repetitive mechanical loading. 
Rare Mendelian connective-tissue disorders that are independent of environmental 
exposures such as classic Ehlers-Danlos syndrome (cEDS) 263, Bethlem myopathy 264-
266 and Ulrich congenital Muscular dystrophy 264-266 have highlighted the importance of 
genes encoding type V and type VI members of the collagen protein family in the 
normal structure and function of connective tissues. Although the phenotypes resulting 
from these mutations occur without any input from environmental factors, similar 
mutations resulting in less severe/extreme phenotypes may require sufficient 
environmental exposures interacting on a genetic background to result in the 
multifactorial phenotypes such as those observed in soft tissue pathology.  
One such polymorphism, COL5A1 rs 12722 (C/T) in the type V collagen gene occurs 
within the 3’untranslated region (URT), and has previously been shown to be 
associated with soft tissue injuries and connective tissue pathology 267-269,and shows 
an association with body weight and BMI 270, 271. The COL5A1 BstU1 rs12722 has 
been suggested to be functional. Specifically, the T-allele is thought to increase mRNA 
stability and increase α1(V) chain synthesis 272, which may have an impact on 
fibrillogenesis and influence tissue elasticity. Further, the TT-genotype has been 
associated with increased risk for developing achilles tendinopathy, whereas the CC- 
genotype was over-represented in the apparently healthy control group 267.  
COL6A1 rs 35796750 (C/T) in the type VI collagen gene has been associated with a 
number of multi-factorial conditions such as ossification of the posterior longitudinal 
ligament of the spine (OPLL) 273 and ossification of the ligamentum flavum (OLF) 274. 
Epidemiological studies have identified a variety of risk factors associated with the 
development of OPLL 274 including diabetes, high BMI, hormonal imbalance, dietary 
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habits, trauma, gender and ethnicity 275. Specifically, the COL6A1 rs 35796750 (T/C) 
was significantly associated with both OPLL and OLF in two independent Japanese 
populations 274 where a high BMI after age 20 years and T2DM were independent risk 
factors for developing these disease states 276.The COL6A1 rs 35796750 SNP has 
also been proposed to be functional. Although a splice variant has not yet been 
identified, the T→C substitution at intron 32 [-29] occurs near the branch site of the 
intron and consequently may affect the lariat-shaped structure resulting in aberrant 
protein splicing 277. 
 Vascularisation and adipose tissue blood flow (ATBF) 
Adipose tissue comprises a dense capillary network that delivers oxygen and energy 
substrates to the adipocytes. Moreover, the vascularization provides a transport route 
for hormones and cytokines and energy substrates to and from the adipocytes 278. 
Dietary lipids from the small intestinal enterocytes are transported within the circulation 
and delivered to the adipocytes for storage. In addition to its role in FFA delivery, the 
microvasculature of adipose tissue serves as a transport route for immune and 
adipocyte progenitor cells 279.  
Gluteal SAT is considered to be less metabolically active compared to abdominal SAT 
based mainly on its reduced β-adrenergic lipolytic-response and its increased 
sensitivity to the anti-lipolytic effects of insulin stimulation (summarised above in Table 
2.3). Further, post-absorptive ATBF in lean individuals has been shown to be higher 
in the abdominal SAT compared to the gluteal-femoral depot, perhaps reflecting its 
special metabolic role for meal FFA uptake 280. These depot differences are best 
illustrated through the markedly different depot response to catecholamine-induced 
lipolysis in abdominal- compared to the gluteal SAT depots 281. 
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Depot differences in ATBF between VAT and SAT depots in the obese state are less 
clear. Villaret et al 282 found increased capillary density in VAT compared to SAT in 
paired samples from 29 obese patients undergoing bariatric surgery282. In contrast 
Gealekman et al 283 demonstrated that SAT from obese individuals had higher capillary 
density per adipocyte in vivo and higher capacity for angiogenic growth ex-vivo 
compared to VAT. Further, Lemoine et al 284 investigated vessel density in 29 obese 
humans undergoing bariatric surgery and found no differences in vessel number per 
adipocyte in VAT compared to SAT depot. These authors also reported a significant 
positive association between waist circumference and capillary density in VAT, but not 
in the SAT depot. 
Notably, vascular density not only differs between adipose tissue depots, but also 
within each depot. For example, in rodents, Cho et al 285 demonstrated that the tip 
portion of epididymal adipose tissue depot contained a higher density of vasculature 
compared to the rest of the depot. These findings suggests that different gradients of 
oxygen and nutrient supply may exist not only between different adipose tissue depots, 
but also within a given adipose tissue depot. Therefore, it is conceivable that the 
degree of vascularization throughout each adipose depot may have different 
implications for hypoxia and inflammatory signalling.  
2.4 REDUCED ADIPOSE TISSUE EXPANSION AND INSULIN RESISTANCE  
Adipose tissue dysfunction represents one of the earliest abnormalities in the 
development of obesity, and constitutes an important contributor to individual risk to 
develop metabolic and CVD diseases. Adipose dysfunction may develop under 
conditions of excess calorie intake in patients with an impaired expandability in the 
SAT depot. Fat storage deficiency, as a major determinant of insulin resistance and 
dyslipidaemia, has been demonstrated in genetic forms of lipodystrophies in human 
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and murine models and are characterised by the complete or partial loss of adipose 
tissue, severe insulin resistance and ectopic fat deposition (see Medina-Gomez., 286 
for review). In contrast, a transgenic mouse model of morbid obesity that displayed 
increased amounts of body fat mass, but limited VAT accumulation and lower fat 
accumulation in the liver and muscles, had a better metabolic profile compared to its 
wild type litter mates 287. Results from a seminal study utilising adipose tissue 
transplantation into a lipoatrophic (low fat mass) mouse model showed that the 
addition of normal SAT reversed insulin resistance, hepatic steatosis and 
hypoleptinemia 288. These results suggest that the lack of adipose tissue was 
causative in the metabolic abnormalities displayed in these lipodystrophic phenotypes 
288. The mechanisms leading to these improvements are still unknown but may involve 
the enhanced FFA uptake by adipocytes and concomitant improvement of 
inflammatory profile. 
2.4.1 Insufficient adipogenic capacity in SAT insulin resistance 
PPARγ is considered to be the master regulator of adipogenesis and lipogenesis in 
adipose tissue. Activation of PPARγ promotes adipocyte differentiation through FFA 
storage whilst it simultaneously represses lipolysis genes and the release of FFA from 
the adipocyte 289. Reduced expression of this factor results in dysregulation of lipid 
storage and mobilization. Adipose tissue hypertrophy (due to increased cell diameter) 
has been shown to be a major determinant of obesity development 201 and correlates 
with parameters of insulin sensitivity and lipid metabolism 290. Obese patients with 
larger cell size in their SAT are more hyperinsulinaemic and glucose intolerant 
whereas similarly obese patients with a larger proportion of smaller adipocytes are 
more insulin sensitive 291. Extremely filled adipocytes are insulin resistant and 
therefore less effective metabolic buffers. Adipocyte hypertrophy is a feature of non-
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obese T2DM patients 292. Adipocyte hypertrophy reflects both reduced pre-adipocyte 
recruitment along with impaired differentiation capacity in the setting of increased TAG 
demand.  
 Hypoxia 
Atmospheric oxygen tension at sea level is about 160 mmHg (21%). However, 
physiological oxygen levels vary dramatically between different tissues, and can range 
from about 150 mmHg in the upper respiratory tract to 1- 10 mmHg in the retina 66, 293. 
In adipose tissue, oxygen tension can vary dramatically depending on species studied, 
adipose tissue depot and obesity level. For instance, by using O2-electrodes, it was 
shown that obese rodents had lower in vivo oxygen partial pressure than normal-
weight rodents (15mm Hg vs 48 mm Hg respectively) 294. Similarly, obese humans 
had lower adipose tissue partial pressure (46 mmHg) compared to lean controls (55 
mmHg) 295. 
Generally, hypoxia occurs when oxygen demand from cells or tissue exceeds the 
supply, resulting in reduced oxygen tension. Specifically, in adipose tissue, hypoxia 
may result from inadequate blood flow to the adipose tissue depot, increased cell size 
and/or enhanced oxygen consumption by the tissue 296. It is postulated that the 
increased cell size of hypertrophic adipocytes associated with obesity increases the 
distance that oxygen has to diffuse from the microvasculature into the cells 221. As a 
result, oxygen partial pressure reduces 297, causing a local hypoxic environment 294, 
298-301. Hypoxia has been measured in adipose tissue of obese humans 70, 301 and 
rodents 294, 302 (Table 2.7). Cellular adaptation to hypoxia is accomplished through the 
activation of an array of oxygen-sensing transcription factors, including hypoxia 
inducible factor-1 (HIF-1α) 303, 304. HIF-1α is a heterodimer that consists of an oxygen-
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regulated α subunit and a constitutively expressed β subunit 304, 305. Under normoxic 
conditions, HIF-1α is targeted for proteasomal destruction by proline hydroxylation by 
an E3 ubiquitin ligase complex containing the von Hippel-Lindau tumor suppressor 
protein (pVHL) 306. During hypoxic conditions, the lack of molecular oxygen, an 
absolute requirement for HIF-1α hydroxylation, results in increased HIF-1α protein 
accumulation. Upon stabilization, HIF-1α translocates to the nucleus where it 
heterodimerizes with HIF-1β and other co-activators in order to bind to the hypoxia 
response element (HRE), through which it activates its target genes 307, 308.  
Table 2.7 Direct measurement of oxygen partial pressure (PO2) in human and mouse adipose tissue studies 
Study Population Measurement method PO2 
Human  
Kabon et al  300 Men and women 
under-going 
surgery (n= 46) 
Micro Clark type electrode, 
inserted 1cm into SAT (arm 
and abdomen) 
Lean vs obese: 57 vs 
36  mmHg 
Fleishmann et al 299 Men and women  
undergoing 
surgery (n= 35) 
Micro Clark type electrode, 
inserted 1cm into SAT (upper 
arm) 
Lean vs obese: 57 vs 
41 mmHg 
Pascarica et al 70 Men and women 
(n= 21) 
Micro Clark type electrode, 
inserted 1 cm into SAT 
(abdominal area) 
Lean vs obese: 55 vs 
47 mmHg 
Goossens et al 309  Men (n=20) Opto-chemical measurement 
system using microdialysis 
(Abdominal SAT area) 
Lean vs obese: 48 vs 
67 mmHg 
Murine 
Yin et al 310  Mice (♂), (aged 6 
-12 weeks) (n= 3)  
Optic-fiber oxygen micro 
sensor (epididymal fat pad) 
Wild-type vs ob/ob: 
6 weeks 57 vs 35 
mmHg 
12 weeks 57 vs 20 
mmHg 
Ye et al 294  Mice (♂) (n= 3) Optic-fiber oxygen micro 
sensor (epididymal- and 
retroperitoneal fat pad, 
Wild-type vs ob/ob: 
Epididymal: 48 vs 
15.2 mmHg 
Retroperitoneal: 48 vs 
21 mmHg 
Rausch et al 311  C57BL/6J Mice 
(♂) (n= 4) 
OxyLite fluorometric micro 
oxygen sensor.(perigonadal fat 
pad, 
C57BL/6J lean vs DIO 
+ ob/ob: 
35-40 vs 20-25 mmHg 
 




HIF-1α mediates the adaptation and survival to hypoxia by inducing the expression of 
pro-angiogenic proteins such as vascular endothelial growth factor (VEGFα) and 
pyruvate dehydrogenase kinase-1 (PDK1) 312, and by inducing the switch to 
anaerobic-glycolytic metabolism. In tumour biology, VEGFα expression in tumour cells 
313 allows for vascular development and tumour expansion. However, in hypertrophic 
obese adipose tissue, even though HIF-1α protein increases, VEGFα does not 
increase 70, 294, 301, 307 and is accompanied by reduced capillary density 116, 294. This 
unresponsiveness of VEGFα transcription to elevated HIF-1α levels was proposed to 
be related to hyperglycaemia in ob/ob mice, as VEGFα expression was previously 
shown to be inhibited by high glucose 294, 314.  
Hypoxia, via the induction of HIF-1α expression, has also been shown to directly 
reduce insulin signalling. Regazzetti and colleagues 315 showed that hypoxia treatment 
of 3T3-L1 cells decreased the ability of insulin to bind to its receptor and reduced the 
tyrosine phosphorylation of IRS without affecting their respective protein concentration 
levels 315. This reduction of insulin signalling was rapid and robust, with almost a 
complete inhibition of insulin-stimulated glucose transport, and was restored after re-
oxygenation. In addition, insulin signalling may be further reduced by hypoxia through 
the inhibition of adiponectin expression 302. 
The expansion of adipose tissue during obesity is characterised by a local chronic 
inflammatory state, in addition to increased circulating inflammatory markers. 
Inflammation is considered causal to the development of T2DM and links obesity to 
the metabolic syndrome 114, 316. Adipocytes respond to hypoxia though inflammatory 
signalling, possibly to attract macrophages into the adipose tissue to remove necrotic 
cells and tissue debris resulting from increased apoptosis 317. Yin et al., 310 reported 
that 3T3- L1 adipocytes under hypoxic (1% O2) conditions had increased adipocyte 
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death, as measured by triglyceride release into culture medium and flow cytometry. 
However, the cause of adipocyte death during hypoxic conditions is still unknown 310. 
Hypoxia through the stabilisation of HIF-1α has been shown to induce inflammatory 
gene expression not only from adipocytes but also from the resident macrophages 
and other cells of the SVF, which are also exposed to reduced oxygen partial pressure. 
In vitro exposure of human VAT SVF to hypoxia results in increased expression of 
tumour necrosis factor α (TNFα), Interleukin (IL)-6, IL-10 and Chemokine (C-C motif) 
ligand 2 (CCL-2) 318. It is proposed that the increased inflammatory signalling from the 
resident macrophages and endothelial cells which are stimulated by the lower adipose 
tissue PO2 from the expanding adipocytes, may be necessary to induce angiogenesis 
and subsequent vasculature formation in adipose tissue to alleviate effects of hypoxia 
319.  
2.4.2 Aberrant vascularization: 
One of the earliest events during adipose tissue depot growth is the formation of 
capillaries 285. Concomitant with increased adipogenesis, increased expression of 
potent pro-angiogenic factors such as fibroblast growth factors (FGFs) and VEGF, 
facilitate the migration of endothelial cells and pre-adipocytes into the adipose tissue 
and induce the formation of new vasculature that is required for adipose tissue growth 
320. However, during obesity development, vascular development does not always 
match the level of hypertrophy and results in the development of a local hypoxic state. 
Pasarica et al., 301 showed reduced capillary density and reduced VEGF mRNA in 
adipose tissue of obese humans compared to lean suggesting adipose tissue 
rarefaction (capillary drop out). Thus, it is suspected that oxygen supply in obese 
adipose tissue may be restricted. One reason for which increasing obesity might 
correlate with lower capillary density in adipose tissue of obese individuals is insulin 
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resistance. Indeed, Gealekman et al., 283 demonstrated that HOMA-IR associated 
negatively with SAT angiogenic capacity in a group of obese patients. It is 
hypothesised that angiogenic capacity increases during the development of adipose 
tissue but it is unable to continue in the correct proportion to adipocyte size and/or 
number during the progression towards obesity 283. This lower capillary density would 
be unable to supply adequate O2 to the expanding adipocytes which leads to the 
development of a relative hypoxic sate and associates with increased insulin 
resistance.  
2.4.3 Dysregulated ECM remodelling 
ECM dynamics need to be altered around the expanding adipocyte during tissue 
expansion. As adipose tissue develops, the ECM and the connecting interstitial-
network is remodelled to accommodate the increasing adipocyte diameter and higher 
tissue mass. This process involves the enzymatic processing of the structural 
components within the tissue by synthesising new structures and degrading redundant 
ones. Previous studies have shown that during the pathological expansion of SAT, the 
expression of ECM components and their associated remodeling enzymes become 
dysregulated 72, 321, 322. This process results in increased adipose tissue fibrosis 323 and 
is considered a hallmark of pathological tissue alterations leading to the development 
of insulin resistance 324. Studies summarising the contribution of collagen and ECM 
accumulation in adipose tissue on the development insulin resistance is shown in 
Table 2.8. 
This phenomenon was highlighted in C57BL/6 mice by Strissel et al 325 who showed 
that during the progression of obesity, induced by overfeeding, extensive adipose 
tissue ECM remodelling occurred that was associated with enhanced collagen 
deposition and increased inflammatory markers 325. Moreover, Heneger et al., 326 
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demonstrated that red picrosirius staining collagens grouped in bundles in SAT of 
obese humans and that ECM, adipocyte metabolism and inflammatory markers 
associated with the degree of obesity 326.  
Increased mRNA and protein expression of type I, IV and VI collagen has consistently 
been shown to be higher in obese compared to lean subjects 295, 323, 327. Divoux et al., 
327 observed higher quantities of type VI collagen around adipocytes in obese than 
lean omental human adipose tissue. Further, Pasarica et al. 295, demonstrated that the 
expression of type VI collagen is up-regulated after overfeeding in humans, with a 
concomitant increase in inflammatory gene expression. Fibrosis and collagen 
accumulation in obese adipose tissue is closely correlated with BMI and inversely 
correlated with insulin sensitivity 295, 328. Because obese patients with smaller 
adipocyte cell size display a more favourable lipid profile compared to those who 
exhibit hypertrophy 290, the increased fibrosis generation around the expanding 
adipocytes has been considered as an adaptive response to restrain excessive 
adipose tissue hypertrophy in obesity 323. Fibrosis may thus act as an adaptive 
mechanism that contributes to the slowing down of the negative effects of adipocyte 
hypertrophy such as hypoxia, inflammation and insulin resistance 327. 
Conversely, other studies have shown that reduced fibrosis and/or collagen deposition 
is associated with reduced insulin resistance. In a murine model, a reduction in 
collagen protein content in adipose tissue has been shown to alleviate the negative 
metabolic effects of excess adipocyte hypertrophy. Using type VI collagen-null mice, 
Khan et al 323, demonstrated that the lack of type VI collagen improved several 
metabolic parameters, including insulin resistance and inflammation. They showed 
that collagen VI-null ob/ob mice have less weight gain on a high fat diet compared to 
mice with only the ob/ob mutation. The type VI collagen-null mice also showed 
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improved carbohydrate and lipid metabolism, despite having an increased adipocyte 
cell size. 
As a structural tissue, adipose tissue protects organs and muscles from mechanical- 
and sheer stresses that are generated through movement. Similar to other connective 
tissues such as ligaments, tendons, fascia and bone, repeated mechanical loading 
may similarly result in pathological alterations to the cellular components and 
composition of the ECM in the affected adipose tissue depot itself 257. Increasing 
adipose tissue mass during the development of obesity is indeed characterised by 
altered ECM expression and increased M1-activated macrophage infiltration.  
Table 2.8 The Morphologic and physiologic characteristics of VAT compared to SAT: Structural 
 
Structural characteristic: Microenvironment 
Primary metabolic 
function 
Contribution to IR 
Human 
VAT > SAT Tot Collagen (%)329 
 
ECM intrinsic determinant of 
differentiation capacity 330 
PC collagen (%) in VAT á with ↑ 
fasted Insulin and ↑HOMA- IR 329 
VAT<SAT Age á ↑Collagen (%) (Tot and PC) 
in SAT but not VAT 329 
Tot Collagen (%)á ↑Inflammation 
↑Col6a3 mRNA 321  
Strong tot collagen ECM 
framework supports adipose 
tissue mass. 
Dysregulated genes in SAT of IR vs 
IS women included ↑inflammation 
genes (TNF), insulin pathway genes 
(IRS), and angiogenesis (VEGF) 331  
VAT=SAT PC collagen (%) 
↑ Adipocyte diameter á ↑ PC 
collagen (%) 329; 
↑ PC collagen % á 
↑Inflammation329 
Fibrosis hypothesised to limit 
adipocyte hypertrophy in order to 
limit effects of large cell-size 332 
↑Collagen expression in both depots 
á ↑inflammation that may increase IR 
Dysregulated genes in VAT and SAT 
á ↑IR. Common pathgways include 
integrin cell-surface signalling, focal 
adhesion and ECM expression 
(COL5A1) 331 
Obese > lean PC collagen (%)329 
↑ColVI in VAT 
BMI and body weight á ↑ PC 
collagen (%) 
↑Areas of fibrosis in obese á ↓ SI and 
↑ macrophage number  
Murine 
VAT<SAT Col1a1, Col3a1, and Col5a1 
mRNA in rat in vivo. 
High SAT ECM gene expression 
in rats age 3-12 weeks. ECM 
intrinsic determinant of 
differentiation capacity 330 
 
VAT=SAT COL6a1 mRNA in rat 
 
 AT SVF secretes ECM that directly 
modulates terminal differentiation in 
depot-specific manner 330. 
á, associates with; Tot, total; PC, pericellular (%) 
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Another transcriptional target of HIF-1α is lysyle oxidase (LOX) 333. LOX facilitates 
collagen cross-linking and stabilisation, specifically type I and III collagen, and thereby, 
increases tensile strength of the ECM components 334 and increases ECM deposition 
in adipose tissue. HIF-1α over-expressing mice show elevated levels of LOX protein, 
increased adipose tissue fibrosis, laid down in adipose tissue as fibrotic streaks, and 
reduced glucose tolerance 307. Conversely, in HIF-1α over-expressing mice, inhibition 
of LOX activity by β-aminoproprionitrile (BAPN) treatment reduced fibrotic areas in 
adipose tissue, reduced inflammation and improved glucose tolerance 307. LOX is up-
regulated by HIF-1α in a dose dependant manner in transgenic mice. However, LOX 
is down-regulated by PPARγ treatment with a resulting improvement of metabolic 
phenotype. 
2.5 INSULIN SENSITIVE VS INSULIN RESISTANT ADIPOSE TISSUE EXPANSION 
The relationship between body composition and insulin resistance has been shown to 
be ethnic-specific. Black African and African American women have less VAT, and 
more SAT, but have consistently been found to be more insulin resistant than white 
women of comparable BMI and body fat percentage (%fm) or waist circumference 
(section 2.2) 22, 55-57. The notion of AT expandability has not been used to investigate 
the ethnic-specific associations of body composition, its distribution and measures of 
insulin sensitivity and secretion in black and white women (Section 2.2). Following this 
notion, the major factors that can influence the capacity of adipose tissue to expand 
are: 
(1) reduced adipogenic capacity (section 2.4.1), 
(2) insufficient and inappropriate vascularisation (section 2.4.2) and  
(3) aberrant ECM remodelling (Section 2.4.3 ).  
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Accordingly, it could be hypothesised that the increased systemic insulin resistance in 
obese black women may be a consequence of dysregulated gluteal SAT expansion 
following obesity development, resulting in the inability of this depot to effectively store 
excess TAG with a concomitant redistribution of fat to the central depots. In this 
context, the insulin sensitive vs insulin resistant model of adipose tissue expansion is 
proposed (Figure 2.2) with the specific aim of investigating whether these factors may 
differ by ethnicity and explain the ethnic-specific associations between body 
composition and insulin sensitivity measures in black and white South-African women.  
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1) During adipose tissue expansion, adipocytes take up excess calories to store as 
TAG, resulting in either a larger cell diameter (hypertrophy) and/or by recruiting and 
differentiating new adipocytes from the precursor cells in the SVF (hyperplasia). 
Adipocyte hypertrophy and hyperplasia are regulated by genetic and depot-extrinsic 
factors. PPARy induction activates gene transcription that promotes lipid storage. 
 
 
Figure 2.2 Model of insulin sensitive vs. insulin resistant adipose tissue expansionInsulin resistant adipose tissue 
expansion (Blue block to the left): Pathologic adipose tissue expansion results in local and systemic insulin resistance. 
Increased adipocyte cell size results in local hypoxic state in adipose tissue. Increased HIF-1α stabilization does not induce 
angiogenic response, but rather invokes an inflammatory state with a high degree of macrophage infiltration, limited 
vasculature development and fibrotic response. Such inflammatory activation ultimately results in systemic insulin resistance. 
Insulin sensitive adipose tissue expansion (Red block to the right): Healthy, insulin sensitive adipose tissue expansion 
encompasses the enhanced recruitment of adipocyte progenitors that may differentiate into small insulin sensitive 
adipocytes, appropriate increased vascularization, minimal induction of ECM and minimal inflammation 
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Increased PPARy expression during obesity development is associated with insulin 
sensitive adipose tissue expansion (right panel). In contrast, adipose tissue expansion 
characterised by low expression of PPARy is associated with reduced insulin 
sensitivity (left panel) and hypertrophic obesity. 
2) This increased adipocyte cell-diameter results in a local hypoxic state due to the 
greater distance that oxygen has to diffuse from the microvasculature to the cells 68, 
335. Cellular adaptation to hypoxia involves the activation of the master regulator of the 
hypoxia response, HIF-1α 336. HIF-1α aims to induce angiogenesis through the 
expression of pro-angiogenic factors, such as VEGFα, in order to induce vasculature 
formation in the adipose depot to satisfy the oxygen requirement of the expanding 
adipocytes (right panel). In contrast, during pathological adipose tissue expansion, 
increased HIF-1α expression does not result in adequate VEGFα expression 70, 294, 301, 
307, ultimately resulting in limited angiogenesis and the perpetuation of the hypoxic 
state (left panel). 
3) ECM is remodelled through matrix remodelling enzymes such as LOX and FGF1. 
However, during obesity, increased ECM production and aberrant remodelling leads 
to increased fibrosis which makes the tissue stiffer and less accommodating to 
adipocyte expansion and capillary development (left panel) with concomitant 
increased inflammatory signalling. 
4) Hypoxic adipocytes increase pro-inflammatory expression that associates with the 
influx of M1-activated macrophages. Adequate vascularisation and appropriate ECM 
remodelling resolves the hypoxic state which in turn reduces inflammation (right 
panel). In contrast, chronic inflammation can lead to further, more excessive ECM 
accumulation resulting in increased fibrosis around the adipocytes and in the adipose 
tissue depot (left panel). 
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5) A chronic higher inflammatory state, and resultant increased fibrosis, limits the TAG 
storage capacity of the adipose tissue and associates with increased local and 
systemic insulin resistance with resulting redistribution of adipose to the central depots 
(left panel). In contrast ECM remodelling that allows for appropriate adipocyte 
expansion, capillary development and TAG storage would provide protection against 
ectopic fat deposition in liver, muscles and pancreas, preserving the insulin sensitive 
state (right panel). 
6) A genetic contribution to the profibrotic state within adipose tissue has not yet been 
investigated. The T- variant of the COL5A1 rs 12722 polymorphism associates with 
connective tissue pathology 267-269, proposedly through its role in type I collagen 
fibrillogenesis and resultant tissue stiffness 272. However, having at least one copy of 
C- allele attenuates its impact on soft tissue pathology risk 267. It could be hypothesised 
that the T- allele of COL5A1 rs12722 polymorphism that associates with increased 
tensile strength of the collagen network in tendons and ligaments, may represent a 
mechanical limitation to adipose tissue expandability with a commensurate effect on 
body fat distribution. The COL6A1 rs 35796750 (T→C) SNP is strongly associated 
with ectopic bone formation in paravertebral ligaments, for which ethnicity, a high BMI 
after age 20 years, dietary habits and T2DM were independent risk factors for 
developing these disease states 274 273, 276. It remains to be elucidated whether genetic 
variation that associates with altered ECM component expression could potentially 
explain the ethnic-specific risk for insulin resistance and T2DM in black and white 
South African women. 
Therefore the primary hypothesis of this thesis posits that during the development of 
obesity, the excess generation and deposition of ECM components within adipose 
tissue may represent a mechanical limitation to adipose tissue expandability, and 
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result in adipose tissue depot-specific associations with ethnicity. This model of insulin 
sensitive vs insulin resistant adipose tissue expansion may be potentially implemented 
to explain the different associations between body composition and insulin sensitivity 
measures in black and white South African women.  
2.6 RESEARCH OBJECTIVES  
The primary aim of this thesis is positioned within the context of adipose tissue 
expandability hypothesis, and aims to examine the hypothesis that differences in SAT 
ECM- and hypoxia-related gene expression and their ethnic-specific associations with 
body composition and insulin sensitivity may explain, in part, the higher rates of insulin 
resistance in black compared to white South African women. This thesis was divided 
into four separate research studies to investigate different aspects of this central 
hypothesis as described below. 
Chapter Three 
In the first study, three hypotheses are investigated: a) gluteal SAT of black women 
has greater expression of ECM and remodelling components and genes relating to the 
cellular hypoxia than white women and b) that the expression of these genes differ 
between gluteal and abdominal SAT; c) the expression of these genes in SAT of black 
and white women are differentially associated with insulin sensitivity and inflammatory 
gene expression. Therefore, the aims of this study are to i) compare depot-specific 
expression of ECM and matrix remodelling components and genes relating to the 
cellular hypoxia response in normal-weight and obese black and white women; ii) to 
examine the ethnic-specific associations between these genes and body composition, 
measures of insulin sensitivity and secretion and inflammatory gene expression in 
black and white SA women.  
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Chapter Four 
The second study tests the hypothesis that higher hypoxia and ECM related gene 
expression would associate with higher central fat mass accumulation in black women 
and that the expression of these genes may be more closely associated with changes 
in the measures of insulin sensitivity in black women compared to white women. 
Therefore the aims of this study are to i) measure the expression of ECM and matrix 
remodelling components and genes relating to the cellular hypoxia response over a 5 
year free-living follow-up period in black and white women; ii) to examine the 
associations between the change in the expression of these genes and changes in the 
measures of insulin sensitivity and body composition in black and white women over 
5-year free-living period. 
Chapter Five 
The third study investigates the hypothesis that the expression of HIF-1α, COL5A1 
and COL6A1 will increase in a dose-dependent manner in insulin-treated 3T3-L1 
adipocytes under hypoxic compared to normoxic conditions. Therefore, the aim of this 
study is to determine the effects of increasing insulin concentrations on the mRNA and 
protein levels of HIF-1α, Col5a1 and Col6a1 under normoxic and hypoxic conditions 
in vitro in mature 3T3-L1 adipocytes.  
Chapter Six 
The fourth study investigates the hypothesis that differences in body fat distribution, 
and consequently insulin resistance, is associated with ethnic differences in the 
distribution of COL5A1 (rs12722) and COL6A1 (rs35796750) polymorphisms in black 
and white women. Thus, the aims of this study are to i) examine differences in the 
frequencies of the rs12722 polymorphism within the COL5A1 gene and the 
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rs35796750 polymorphism within the COL6A1 gene between black and white women, 
and to ii) examine the ethnic-specific associations with body fat, its distribution and 
insulin resistance.  
Chapter Seven 
In this final chapter, a summary of the main findings from the four research studies in 
this thesis are presented in the context of the main research question. Lastly, the 
strengths and limitations of the research design, are discussed.  
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CHAPTER THREE  
HYPOXIA AND EXTRA-CELLULAR MATRIX GENE EXPRESSION IN 
ADIPOSE TISSUE ASSOCIATES WITH REDUCED INSULIN SENSITIVITY 
IN BLACK SOUTH AFRICAN WOMEN 
Data from this chapter have been published in part in Kotzé-Hörstmann L M, 
Keswell D, Adams K, Dlamini T and Goedecke J H. Hypoxia and Extra-Cellular Matrix 
gene expression in adipose tissue associates with reduced Insulin Sensitivity in black 
South African women. 2017 Endocrine (55) p144-152 
3.1 INTRODUCTION 
Insulin resistance, a major risk factor for T2DM 337, is closely associated with central 
obesity, in particular visceral adiposity 162. In contrast, accumulating fat in the lower 
body (peripheral region) is considered to be protective against insulin resistance 50. 
Paradoxically, black South African and African American women accumulate more fat 
in the femoral-gluteal region and have less VAT than white women, but are more 
insulin resistant 23, 55, 338. This suggests that the relationship between fat deposition 
and insulin resistance differs by ethnicity 23.  
To gain a better understanding of the ethnic differences in body fat distribution and its 
relationship with insulin sensitivity, previous investigations in our laboratory explored 
the adipogenic and lipogenic capacity of abdominal and gluteal SAT of black and white 
women 105. It was reported that black women had reduced expression of adipogenic 
genes such as PPARγ and PPARγ-responsive genes in the gluteal SAT, which 
correlated with reduced insulin sensitivity in black women, but not white women 105 . 
Further, the reduced adipogenic capacity in the gluteal depot of black women was 
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associated with adipocyte hypertrophy (Keswell et al., unpublished data, 2013) and 
correlated with a higher inflammatory profile 105 339 and insulin resistance.  
Adipocyte hypertrophy has been proposed to be the underlying cause of local cellular 
hypoxia due to the greater distance that oxygen has to diffuse from the 
microvasculature to the cells 68, 335. The prevailing hypothesis around the pathological 
expansion of adipose tissue during obesity predicts that the increasing cell diameter 
and subsequent hypoxia results in increased cellular inflammatory signalling and 
dysregulated ECM remodelling, which leads to aberrant glucose metabolism 
(Reviewed in 67, 71 and section 2.4.3). Specifically, cellular adaptation to hypoxia 
involves the activation of the master regulator of the hypoxia response, HIF-1α 336, 
which aims to induce angiogenesis through the expression of pro-angiogenic proteins 
such as VEGFα and FGF1 340 . However, in obese adipose tissue, higher HIF-1α 
protein expression does not increase the expression of VEGFα 70, 294, 301, 307, but is 
rather associated with reduced adipose tissue vascularisation 70, 294, 301, 307 and the 
formation of ECM components such as collagen type V 341 and VI 295, 323, 327, 342 and 
ECM remodelling enzymes, LOX 307 and FGF1 343 and higher levels of inflammatory 
signalling molecules/proteins.  
Given the reduced adipogenic capacity and greater adipocyte size observed in the 
gluteal SAT depot of black compared to white women, it is hypothesised that the 
gluteal SAT of black women has greater expression of ECM- and hypoxia-related 
genes than white women. Further, it is proposed that the expression of these genes 
differs between gluteal and abdominal SAT and are differentially associated with 
insulin sensitivity and inflammatory gene expression in black and white women. 
Therefore, the aims of the study are to i) compare depot-specific expression of ECM 
and matrix remodelling components and genes relating to the cellular hypoxia 
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response in normal-weight and obese black and white women; ii) to examine the 
ethnic-specific associations between these genes and body composition, measures of 
insulin sensitivity and secretion and inflammatory gene expression.  
3.2 MATERIALS AND METHODS  
3.2.1 Participants 
This cross-sectional study included 14 normal-weight [body mass index (BMI) < 
25kg/m2] white; 12 obese [BMI > 30 kg/m2] white; 15 normal-weight black and 15 
obese black pre-menopausal women. These women were recruited from church 
groups, community centres and universities. Inclusion criteria were: aged between 18 
and 45 years of age, no previous diagnosis of, or not taking chronic medication for 
T2DM, hypertension, HIV, or other metabolic diseases; and not currently pregnant or 
lactating. Ethics approval was obtained from the Human Research Ethics Committee 
of the Faculty of Health Science at the University of Cape Town and written informed 
consent was obtained from all participants prior to testing.  
3.2.2 Testing procedures 
 Body composition assessment  
Basic body composition, including weight, height, hip (largest gluteal area) and waist 
(at level of umbilicus) circumferences were recorded. Total body fat mass (kg and %) 
and fat mass distribution were measured by dual-energy X-ray absorptiometry, (DXA) 
(Discovery- W, Software version 12.7.3.7, Hologic Inc., Bedford, MA,USA). Body 
measurements were divided into regions of interest corresponding to arms, legs, and 
trunk 344, 345 , according to cut-off lines positioned at anatomical markers (Figure 3.1) 
Trunk fat region/central fat compartment was determined by measuring fat content 
from below the chin to the waist (line above the iliac crest) with vertical borders lateral 
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to the ribs positioned to achieve separation from the upper arm and trunk at the glenoid 
fossa. The arm region was demarcated by placing a line from the crease of the axilla 
through the glenohumeral joint. The leg region (kg) or lower body segment was 
isolated from the trunk region by vertical lines extending downward from the waist cut-
line and diagonal cut lines (passing through the femoral neck) that intersect the central 
vertical line between the legs 344, 345. The android region (kg) was measured between 
the ribs and the pelvis and is totally enclosed by the trunk region with upper 
demarcation a 1/5th of the distance from neck to waist cut line and the lower 
demarcation at the top of the pelvis. The gynoid region (kg) overlaps the trunk and leg 
region and includes the upper thigh and hip area. The height of the gynoid region is 
twice the height the android region with the upper demarcation below the top of the 
iliac crest at a distance of 1.5 times the android height 346. The percentage of fat mass 
of each these regions of interest was calculated by dividing the body fat distribution 
variable (kg) by the total body fat mass (kg) and then multiplying by 100 (%fm). As a 
measure of body fat distribution, the central-to-leg fat mass ratio was calculated by 
dividing trunk fat mass (kg) by the leg fat mass (kg). Abdominal visceral adipose tissue 
(VAT), deep subcutaneous adipose tissue (DSAT) and superficial subcutaneous 
adipose tissue (SSAT), using the fascia superficialis to discriminate between DSAT 
and SSAT 99, were measured by computerized tomography (CT) at the level of L4-L5 
lumbar vertebrae.  
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 Insulin sensitivity measures (SI) 
Overnight fasted (10-12 hrs) participants underwent an insulin-modified frequently 
sampled intravenous glucose tolerance test (FSIGT). Baseline blood samples were 
collected at -15, -5 and -1 min prior to glucose infusion. Glucose (50% dextrose, 11.4 
g/m2 body surface area) was infused over 1 min. After 20 min, human insulin (0.02 
units/kg; Actrapid, Novo Nordisk) was infused at a constant rate for 5 min. A total of 
32 samples were drawn at 2, 3, 4, 5, 6, 8, 10, 12, 14, 16, 19, 22, 23, 24,25, 27, 30, 35, 
40, 50, 60, 70, 80, 90, 100, 120, 140, 160, 180, 200, 220, and 240 min following the 
infusion of glucose and was used to measure insulin and glucose concentrations. 
Insulin sensitivity (SI) and the acute insulin response to glucose (AIRg) were calculated 
based on Bergman's minimal model of glucose kinetics 347.  
 
Figure 3.1 Body composition analysis by DXA region of interest.  
Body measurements were divided into regions of interest corresponding to arms (red lines), legs (blue lines), and trunk 
(green boxes), according to cut-off lines positioned at anatomical markers. Purple boxes demarcate android and gynoid 




 Biochemical analyses 
Fasting plasma glucose concentrations were calculated using a glucose oxidase 
method (YSI 2300 STAT PLUS, YSI Life Sciences Yellow Springs, OH). Serum insulin 
concentrations were determined using a Microparticle Enzyme immunoassay (AxSym 
Insulin kit Abbot, IL, USA).  
 Adipose tissue biopsies 
Under ultrasound guidance, abdominal SAT biopsies were collected from above 
(SSAT) and below (DSAT) the fascia superficialis by mini-liposuction method. In short, 
a small incision was made directly above the umbilicus after which 200 ml saline 
containing 0.1% adrenalin (Intramed, Port Elizabeth, South Africa) and 0.75% 
Lidocaine (Intramed) was infused using an infiltration cannula (Lamis 14 ga x 15 cm, 
Byron Medical Inc., Tucson, AZ). After infusion, an aspiration cannula (Coleman, 12 
ga x 15 cm, Byron Medical Inc.) attached to a 10 ml syringe was used to collect 
approximately 2 ml of fat from each adipose tissue depot and washed 3 times in normal 
saline until no blood was visible. Gluteal samples were collected from the upper right 
quadrant of the gluteal depot using a similar procedure. Biopsy samples were 
immediately frozen in liquid nitrogen and stored at -80˚C until analysis.  
3.2.3 Gene selection  
Candidate genes were selected for their potential involvement in metabolic 
abnormalities related to obesity and insulin resistance as described in Chapter 2. 
Specifically, HIF-1α and VEGFα were chosen for their role in hypoxia signalling during 
obesity 116, 294, 348 and PPARγ for its role during adipogenesis. The COL5A1 gene 
encodes an α1 (V) chain found in all type V collagen isoforms and plays an important 
regulatory role in fibrillogenesis 259, whereas type VI collagen-null mice, produced by 
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type VI α1 collagen chain disruption 323, display increased adipocyte cell size and 
improved glucose tolerance compared to wild type ob/ob littermates 323. LOX 333, a 
transcriptional target of HIF-1α, was chosen as it facilitates collagen cross-linking and 
stabilization, and increases insoluble ECM deposition in adipose tissue. Finally, FGF1 
has been reported to be essential for ECM remodelling during adipose tissue 
expansion 343 and has recently been demonstrated as a therapeutic treatment for 
insulin resistance in obese mice and results in insulin dependent glucose lowering and 
whole body insulin sensitization 349. In addition, a previously generated RT-PCR data 
set from a panel of inflammatory genes was also included in this study 55. These genes 
included, chemokines (Chemokine (C-C motif) ligand 2 (CCL2) and its receptor 
CCR2), macrophage markers (CD14, CD68 and CD163) and colony stimulating factor 
1 (CSF-1), macrophage migration inhibitory factor (MIF), and cytokines (TNF-α, 
Interleukin (IL)-6, IL-10 and IL-18).  
3.2.4 RNA extraction and reverse transcription 
Total RNA was extracted using the TriPure Isolation Reagent (Roche Diagnostics Ltd, 
Burgess Hill, UK) and isolated using QIAGEN RNeasy Lipid Tissue Mini Kit, Qiagen 
GmBH (Hilden, Germany) according to manufacturer’s instructions, and purified with 
Ambion Turbo DNase treatment kit (Ambion Ink, Austian, USA). RNA was evaluated 
for purity and concentration using a Nanodrop ND-1000 Spectrophotometer (Thermo 
Fisher Scientific, Lafayette, CO). Total RNA was reverse transcribed to cDNA with 
High Capacity Reverse Transcription kit (Applied Biosystems, Foster City, CA, USA 
manufacturer’s protocol). A duplicate set of reactions were prepared without RT 
enzyme (RT-) and was used to calculate the amount of genomic DNA contamination. 
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3.2.5 Quantitative Real-time PCR for gene expression analyses 
RT-PCR was carried out on a StepOnePlus™ Real-Time PCR system (Applied 
Biosystems, Foster City, CA, USA), with inventoried gene specific TaqMan™ 
primer/probes gene expression assays for PPARγ (Hs01115513_m1), HIF-1α 
(Hs00153153_m1), VEGFα (Hs00900055_m1), LOX (Hs00942480_m1), COL5A1 
(Hs00609088_m1), COL6A1 (Hs00242448_m1) and FGF1 (Hs00265254_m1), using 
the StepOnePlus™ Real-Time PCR software Version 2. Inflammatory genes 
investigated were similarly amplified by using TaqMan™ inventoried primer/probes 
gene expression assays for CD14 (Hs00169122_g1), CD68 (Hs00154355_m1), 
CD163 (Hs01016657_m1), CCL2 (Hs00234140_m1), CCR2 (Hs00356601_m1), 
CSF-1 (Hs00174164_m1), MIF (Hs00236988_g1), TNF-α (Hs00174128_m1), IL-6 
(Hs00985639_m1), IL-10 (Hs00174086_m1), IL-18 (Hs99999040_m1). Transcript 
levels are presented as a ratio of abundance of the gene of interest to the mean of the 
expression of endogenous control genes, 60S acidic ribosomal protein P0 (RPLP0) 
(Hs99999902_m1) and 18S (Hs99999901_s1), and peptidylprolyl isomerase A (PPIA) 
(Hs999999904_m1) for the inflammatory genes, as determined by Normfinder 350.  
3.2.6 Statistical Analysis 
Results are presented as means ± standard deviation (SD) with significance being 
defined as p<0.05. All data sets were tested for normality according to the Shapiro-
Wilk test and non-normally distributed variables were logarithmically transformed for 
parametric analysis. Differences between body composition and gene expression in 
normal-weight and obese, black and white women in each SAT depot were determined 
using two-way ANCOVA, adjusting for age, with Fisher least significant difference 
(LSD) post hoc analysis. Pearson’s correlations (r) were used to explore the 
relationships between gene expression and body composition in black and white 
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women and partial correlations, adjusted for age and body fat mass (kg) to explore 
associations with insulin sensitivity measures, were used. Data were analysed using 
STATISTICA version 12 (Statsoft Inc., Tulsa OK, USA). 
3.3 RESULTS 
3.3.1 Participant characteristics  
The participant characteristics are shown in Table 3.1. Obese women were 
significantly older than normal-weight women (p<0.01) and consequently all 
subsequent analyses were adjusted for age. Black women were shorter than white 
women, but were similar in terms of BMI, DXA-derived measures of body fat (kg and 
%) and waist and hip circumferences. Normal-weight black women had higher gynoid 
fat (%fm) than obese black women, whilst this did not differ between normal-weight 
and obese white women. Android fat (%fm) was higher in obese compared to normal-
weight women, independent of ethnicity. Although VAT and abdominal SAT did not 
differ between normal-weight black and white women, obese black women had less 
VAT, but more SSAT than obese white women, while DSAT did not differ by ethnicity.  
Fasting glucose concentrations were not different by ethnicity, but were higher in 
obese compared to normal-weight women. However, fasting insulin levels were higher 
in black compared to white women, and were higher in obese compared to normal-
weight women. SI was lower, and AIRg was higher in black compared to white women. 
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3.3.2 Hypoxia and ECM related gene expression in gluteal and abdominal SAT 
of black and white SA women  
Transcript levels of ECM- and hypoxia related genes in gluteal and abdominal SAT 
(DSAT and SSAT) depots are presented in Figure 3.2. When examining the ethnic 
differences in gene expression within each of the adipose tissue depots, it was found 
that the gluteal depot of black women had higher HIF-1α and COL5A1 expression, 
Table 3.1 Body Composition and insulin sensitivity in normal-weight and obese white and black SA women 
 
White women Black women 
 
Normal-weight Obese Normal-weight Obese 
n 14 12 15 15 
Age (years) 25 ± 2a 32 ± 2b 24 ± 2a 28 ± 2b 
Body Composition     
BMI (kg/m2) 22.4 ± 1.5a 35.9 ± 5.8b 22.7 ± 1.2a 37.7 ± 3.7b 
Waist (cm) 80.0 ± 5.7a 107.9 ± 16.1b 76.2 ± 4.1a 113 ± 12.1b 
Body fm (%) 29.7 ± 6.5a 45.5 ± 3.7b 30.5 ± 5.6a 46.9 ± 3.1b 
Central fm (%fm) 44.9 ± 4.4a 49.0 ± 4.2b 42.7 ± 5.0a 51.5 ± 3.5b 
Leg fm (%fm) 44 ± 1.35a 40 ± 1.46b 47 ± 1.30a 37 ± 1.30b 
Cent/leg fat ratio 1.1 ± 0.2a 1.2 ± 0.3b 1.0 ± 0.2a 1.4 ± 0.3c 
Gynoid fm (%fm) 9.1 ± 1.2a 8.7 ± 0.8a 10.3 ± 1.4b 8.6 ± 1.6a 
Android fm (%fm) 5.1 ± 1.1a 7.8 ± 1.7b 5.3 ± 1.2a 9.1 ± 1.3b 
VAT (cm2) 55.5 ± 20.5a 144.2 ± 69.5b 60.5 ± 16.9a 101.5 ± 37.7c 
Total SAT (cm2) 178.4 ± 63.2a 510.0 ± 104.9b 169.3 ± 50.8a 591.2 ± 92.2c 
SSAT (cm2) 95.2 ± 14.1a 242.7 ± 16.0b 99.4 ± 13.5a 321.4 ± 14.1c 
DSAT (cm2) 83.3 ± 14.0a 267.3 ± 16.0b 70.1 ± 13.5a 269.9 ± 14.0b 
Insulin Sensitivity    
Glucose (mmol/l) 4.3 ± 0.1a 4.6 ± 0.1b 4.5 ± 0.1ab 4.6 ± 0.1b 
Insulin (mU/l) 4.2 ± 1.3a 8.4 ± 1.4b 8.7 ± 1.3b 15.1 ± 1.2c 
SI (x10-4 min-1/[pmol/l]) 6.1 ± 0.5a 4.0 ± 0.5b 2.4 ± 0.5c 1.8 ± 0.5c 
AIRg (µU/ml) 49.5 ± 52.2a 68.2 ± 54.6a 217.72 ± 46.7b 316.7 ± 46.7b 
Values represent unadjusted means ± SD. Means with different letters are significantly different as determined by Post hoc analysis 
(p<0.05) and adjusted for age. BMI, body mass index; DSAT deep subcutaneous adipose tissue; SSAT, superficial subcutaneous 
adipose tissue; VAT, visceral adipose tissue; % fm, a percentage of fat mass; SI, Insulin Sensitivity; AIRg, Acute Insulin Response to 
Glucose  
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and lower VEGFα expression compared to the gluteal depot of white women (ethnic 
effect, p<0.05).  
 In the DSAT depot, COL5A1 expression was higher, but FGF1 expression was lower 
in black women compared to white women (ethnic effect, p<0.05). In contrast, black 
women had lower HIF-1α and COL5A1 expression in the SSAT depot compared to 
white women (ethnic effect, p<0.05). 
When examining the between-depot differences in ECM- and hypoxia related gene 
expression in black and white women, it was found that in both black and white women, 
expression levels of PPARγ, VEGFα, and LOX were higher in the SSAT depot 
compared to the gluteal and DSAT depots whilst COL6A1 and FGF1 expression levels 
were higher in the gluteal depot compared to the abdominal SAT depots (depot effect, 
P<0.05). Although HIF-1α expression did not differ between the gluteal and abdominal 
SAT depots of the black women, HIF-1α expression was higher in both of the 
abdominal SAT depots (DSAT and SSAT) compared to the gluteal depot of white 
women (depot ˟ ethnicity interaction, p=0.01). In contrast, the expression of COL5A1 
did not differ between the gluteal and abdominal SAT depots of the white women, but 
COL5A1 expression was higher in the gluteal and DSAT depots compared to the 
SSAT depot in the black women (depot ˟ ethnicity interaction, p=0.01).  
It was then determined whether the expression of these genes were different in 
normal-weight and obese black and white women within each of the adipose tissue 
depots (BMI effect). In the gluteal depot of the obese white women, LOX and FGF1 
expression level were higher, while PPARγ, VEGFα, HIF-1α, COL5A1 and COL6A1 
expression did not differ between the normal-weight and obese white women. In 
contrast, COL5A1 and LOX expression did not differ between normal-weight and 
obese black women, but PPARγ and VEGFα expression were lower, and HIF-1α,  
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COL6A1 and FGF1 expression were higher in obese compared to normal-weight black 
women. Moreover, the lower VEGFα expression and the higher COL6A1 expression 
in the obese compared to the normal-weight black women was significantly different 
 
Figure 3.2 Gene expression in gluteal SAT, abdominal DSAT and SSAT depots of normal-weight and obese 
white and black women. 
Bars represent unadjusted means ± SD. Similar groups, as determined by post-hoc analysis, are denoted with the 
same letter. Δ, ethnic effect (white vs. black) p < 0.05; ϕ, BMI x Ethnicity interaction (white BMI effect vs. black BMI 
effect) p<0.05.  mRNA expression relative to internal control genes and expressed in arbitrary units (AU). GLUT, gluteal 
adipose tissue; DSAT, deep subcutaneous adipose tissue; SSAT, superficial subcutaneous adipose tissue 
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from the gene expression in the obese and normal-weight white women (BMI ˟ 
ethnicity interaction, p<0.05 for both).   
In the DSAT depot of both ethnicities, HIF-1α, LOX, COL6A1 and FGF1 expression 
were higher in obese compared to normal-weight women, while VEGFα and COL5A1 
did not differ by BMI group. In contrast, obese white women had higher PPARγ 
expression compared to normal-weight women, whereas PPARγ expression did not 
differ between normal-weight and obese black women (BMI ˟ ethnicity interaction, 
p=0.04).  
In the SSAT depot of both black and white women, LOX and FGF1 expression were 
higher in obese compared to the normal-weight women, while COL6A1 did not differ 
by BMI. Obese black women had lower PPARγ expression compared to normal-weight 
black women, while obese white women had higher PPARγ expression compared to 
normal-weight white women (BMI ˟ ethnicity interaction, p<0.01). Further, HIF-1α 
expression was significantly higher in obese white compared to normal-weight white 
women, but were similar in normal-weight and obese black women (BMI ˟ ethnicity 
interaction, p=0.04).  
3.3.3 Associations between the expression of hypoxia and ECM related genes, 
in gluteal and abdominal SAT depots, and body fat and its distribution, in 
black and white women 
Correlations (r) between SAT gene expression and body fat mass (kg) and central-to-
leg fat ratio (cent/leg fat ratio) are shown in Table 3.2. In black women, body fat (kg) 
correlated positively with HIF-1α, COL5A1, COL6A1 and FGF1 and reduced VEGFα 
expression in the gluteal depot, and with LOX and FGF1 expression in both the 
abdominal SAT depots (both DSAT and SSAT). Central obesity, as described by 
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cent/leg fat ratio, associated positively with COL6A1 and FGF1 expression, and 
negatively with PPARγ and VEGFα levels in the gluteal depot. In both the abdominal 
SAT depots, cent/leg fat ratio associated positively with LOX, COL6A1 and FGF1 
expression. 
In white women, body fat mass correlated positively with LOX expression in the gluteal 
depot. In both the abdominal SAT depots, body fat mass correlated positively with HIF-
1α, LOX, and FGF1 expression and in the DSAT depot with COL6A1 expression. 
Cent/leg fat ratio associated positively with HIF-1α and FGF1 and reduced VEGFα 
expression in the gluteal SAT depot. In both abdominal SAT depots cent/leg fat ratio 
associated positively and with LOX and FGF1expression and in the SSAT depot with 
increased HIF-1α expression. 
3.3.4 Associations between the expression of hypoxia and ECM related genes 
in abdominal and gluteal SAT and insulin sensitivity and secretion in 
black and white women  
The partial correlation coefficients (r), adjusted for age and body fat %, between 
adipose tissue gene expression in the gluteal and abdominal SAT depots and 
measures of insulin sensitivity and secretion are shown in Table 3.2. In the gluteal 
depot of black women, SI correlated with reduced HIF-1α, COL5A1, COL6A1, and 
FGF1 expression, whereas AIRg correlated with increased HIF-1α and COL5A1 
expression. In the SSAT depot of white women, fasting insulin concentrations 
correlated with increased expression of HIF-1α, COL5A1, COL6A1 and FGF1. In both 
the abdominal SAT depots, SI correlated with lower LOX and FGF1 expression. 
Further, AIRg correlated with increased COL5A1 expression in the DSAT depot.  
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Table 3.2 Associations between the expression of hypoxia and ECM related genes in abdominal and gluteal SAT and 
body composition and insulin sensitivity and secretion in black and white women  
  Body Composition Insulin Sensitivity 
  
Body fat mass Cent/leg fat ratio Fasting Insulin SI AIRg 
  White Black White Black White Black White Black White Black 
Gluteal SAT 
PPARγ -0.28 -0.35 -0.12 -0.43 a -0.46 -0.27 0.12 0.01 -0.11 0.23 
HIF-1α 0.37 0.53b 0.53 a 0.35 -0.28 0.14 0.07 -0.55b 0.04 0.41a 
VEGFα -0.16 -0.59b -0.43 a -0.54 b -0.30 -0.11 -0.08 0.04 0.30 0.12 
LOX 0.57b 0.32 0.30 0.26 -0.22 -0.09 -0.04 -0.13 0.24 0.09 
COL5A1 0.23 0.40a 0.25 0.16 -0.23 -0.13 0.30 -0.41a 0.03 0.47a 
COL6A1 -0.08 0.51b -0.09 0.44 a -0.15 0.17 -0.26 -0.47a 0.12 0.26 
FGF1 0.41 0.66b 0.45 a 0.62 b -0.17 0.14 -0.32 -0.45a 0.11 0.05 
Deep SAT 
PPARγ 0.28 -0.02 0.07 -0.43 -0.31 0.31 0.32 -0.28 0.16 0.13 
HIF-1α 0.51a 0.50 0.27 0.47 0.08 0.12 -0.15 0.14 0.35 -0.14 
VEGFα -0.07 0.00 0.01 -0.36 -0.03 0.23 -0.20 -0.27 0.36 0.10 
LOX 0.81b 0.86b 0.49 a 0.82 b 0.22 -0.23 -0.53a 0.01 0.07 0.19 
COL5A1 0.17 0.59a -0.21 0.21 -0.12 -0.38 0.17 -0.47 0.56a 0.36 
COL6A1 0.50a 0.74b 0.17 0.77 b 0.07 0.22 -0.15 0.09 0.32 0.03 
FGF1 0.68b 0.79b 0.47 a 0.74 b 0.23 0.38 -0.61a -0.16 0.05 0.17 
Superficial SAT 
PPARγ 0.35 -0.52a 0.19 -0.40 -0.31 -0.12 -0.24 -0.11 0.07 0.28 
HIF-1α 0.57a -0.17 0.56 a 0.37 0.32 0.54a -0.35 -0.09 -0.01 -0.04 
VEGFα 0.02 -0.16 -0.04 -0.03 -0.20 0.26 0.00 -0.21 -0.21 0.58 
LOX 0.63b 0.49a 0.54 a 0.70 b 0.29 0.58 -0.69b -0.19 0.16 0.14 
COL5A1 0.21 0.44 a 0.09 0.45 a 0.24 0.56a -0.35 -0.12 0.40 0.35 
COL6A1 0.40 0.16 0.24 0.60 b 0.35 0.64b -0.19 -0.31 0.12 0.34 
FGF1 0.78b 0.62b 0.55 a 0.78 b 0.71b 0.63b -0.76b -0.27 0.06 0.19 
Values are correlation coefficients (r). Values for fasting insulin, SI and AIRg are adjusted for age and body fat %. P values: a, p < 0.05 and b, p < 0.01.; Cent/leg 




3.3.5 Associations between the expression of hypoxia and ECM related genes 
and inflammatory genes in abdominal and gluteal depots of black and 
white SA women. 
Correlations between hypoxia and ECM related gene expression and inflammatory 
gene expression in gluteal and abdominal (SSAT and DSAT) depots of black and white 
women are presented in Table 3.3. In white women, with the exception of the 
association between LOX and the expression of CCR2 and IL-18 genes in the gluteal 
depot, hypoxia and ECM gene expression associated with higher inflammatory gene 
expression mainly in the abdominal SAT (SSAT and DSAT) depots. Specifically, LOX 
expression associated with higher expression of macrophage markers (CSF1, CD14, 
CD68 and CD163), pro-inflammatory cytokines (TNFα and IL-18) in both abdominal 
depots. Similarly, FGF1 expression associated with higher CD14, CD68 and CD163 
and IL-18 gene expression in the abdominal depots. HIF-1α expression was 
associated with higher TNFα and IL-18 expression in the SSAT depot. PPARγ, VEGFα 
and COL5A1 did not associate with inflammatory gene expression in white women. 
In the black women, PPARγ expression associated with lower CD14, CD68 and CCL2 
in the gluteal depot and with lower CD68, CD163, CCL2 and MIF in the SSAT depot. 
VEGFα expression associated with lower macrophage marker and pro-inflammatory 
cytokine gene expression in the gluteal depot only. HIF-1α expression was associated 
with higher macrophage marker gene expression, CCL2 and MIF expression in the 
gluteal depot and with higher CD14, CD163, CCR2 and IL-18 in the DSAT, with no 
associations in the SSAT depot. Similarly, COL6A1 expression associated with higher 
macrophage marker and pro-inflammatory cytokine- and chemokine gene expression 
in mainly the gluteal and DSAT depots. COL5A1 only associated with higher MIF gene 
expression in the gluteal and DSAT depots. Interestingly, LOX and FGF1 expression  
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Table 3.3 Associations between the expression of hypoxia and ECM related genes and inflammatory genes in abdominal 
and gluteal depots of black and white SA women 


































































CD14         * * *   * *  
CD68         * * *   * *  
CD163          *    *  
 
CCL2         * *    *  
 
CSF1           * *    
 
MIF          * *  * *  
 
CCR2    *            
 
TNFα                
 
IL-6              *  
 
IL-18    *       *    *  
IL-10              *  
 
SSAT 
               
 
CD14       *     * * * *  
CD68    *   *  *   *   *  
CD163    *   *  *   *   *  
CCL2         *   *   *  
CSF1    *        *   *  
MIF         *      *  
CCR2            *   *  
TNFα  *  *        *   *  
IL-6                
 
IL-18  *  *  * *     *   *  
IL-10       *     *   *  
DSAT 
               
 
CD14    *      *  *  * *  
CD68    *        *  * *  
CD163    *   *   *  *  * *  
CCL2                
 
CSF1    *            
 
MIF            * * *  
 
CCR2    *      *  *  * *  
TNFα    *          * *  
IL-6                
 
IL-18    *      *  *  * *  
IL-10          *  *  * *  
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Heat map of correlation coefficients between ECM and hypoxia gene expression and inflammatory gene expression. P <  0.05 *. Glut SAT, Gluteal 




associated with higher macrophage marker gene expression, pro-inflammatory 
cytokines and pro-inflammatory chemokines, mainly in the abdominal depots.  
3.4 DISCUSSION 
The main findings of this study were that obese black women had higher gluteal 
expression of HIF-1α, COL5A1 and COL6A1 and reduced VEGFα expression 
compared to obese white women. Higher HIF-1α, COL5A1, COL6A1 and FGF1 
expression in the gluteal and SSAT depots of black women were associated with their 
reduced SI and higher fasted insulin concentrations. However, in white women, LOX 
and FGF1 expression in the abdominal, but not in the gluteal depot, were associated 
with increased fasted insulin concentrations. Further, the expression of the hypoxia 
and ECM genes associated with inflammatory gene expression in both the gluteal and 
abdominal SAT depots of black women, while the expression of these genes 
associated with the inflammatory gene expression in the abdominal SAT, but not the 
gluteal SAT depot of white women. 
Hypertrophic obesity is more closely associated with insulin resistance than 
hyperplastic obesity 214, 351. Our group has recently shown that the adipogenic and 
lipogenic (PPAR, FASN and PEPCK) gene expression in the gluteal depot were 
down-regulated to a greater extent in obese black women compared to obese white 
women 105, and that the reduced adipogenic capacity was also associated with 
adipocyte hypertrophy (Keswell et al., unpublished data, 2013). The expanding 
adipocyte diameter has been proposed to induce localised hypoxia in the adipocytes 
furthest removed from the vasculature 67, 335. Hypoxic micro-environment remodelling 
is mediated by the oxygen sensitive transcriptional regulators such as the HIF-1α 
proteins. Studies done in tumour biology have shown that HIF-1α expression is 
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dependent on the availability of oxygen and is broken down under normoxic conditions 
352, 353. HIF-1α accumulates in hypoxic tissues and drives angiogenesis through the 
expression of pro-angiogenic proteins such as VEGFα 352, 353. However, during 
adipose tissue expansion, HIF-1α-stimulated VEGFα expression remains low and has 
been shown to be associated with increased body fat %, reduced capillary density, 
and a reduction in adipose tissue oxygen partial pressure (AT PO2, mmHg) 70, 116, 307, 
the magnitude of which is currently under investigation 70, 299, 300, 309. Accordingly, 
higher HIF-1α and reduced VEGFα expression in the gluteal depot of obese black 
women suggests increased adipose tissue hypoxia and reduced vascularization in this 
depot.  
Previous studies have shown that higher HIF-1α mRNA expression in obese mice fed 
a high fat diet associated with an increase in collagen and matrix remodelling enzymes 
307. Increased collagen and matrix remodelling enzymes in adipose tissue is described 
as fibrosis 307, 323, 327, 341, which has been associated with reduced insulin sensitivity. 
While COL6A3 has previously been shown to be higher in Asian Indians compared to 
Caucasians 307, 323, this study was the first to show higher COL5A1 and COL6A1 
expression in black compared to white women, and this associated with reduced 
insulin sensitivity in black women only. Type V collagen protein is localized around the 
large blood vessels in adipose tissue of obese individuals and can disrupt endothelial 
adherence to vascular structures 341, 354. In contrast, type VI collagen is localized 
around adipocytes, and is proposed by several studies to restrict adipocyte expansion 
by limiting lipid storage capacity 226, 327, 328. These studies provide insight towards a 
potential mechanism whereby reduced vascularization through COL5A1 expression, 
and reduced lipid storage capacity through COL6A1 expression, may reduce insulin 
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sensitivity/signalling either through inhibition of the insulin signalling pathway and/or 
through higher inflammatory signalling, and increased ectopic lipid deposition 323. 
Adipose tissue hypoxia is associated with macrophage infiltration 294, and the 
associated increased-inflammatory response has been shown to reduce insulin 
sensitivity 294, 302. Studies from our laboratory have shown that obese black women 
have higher SAT expression of inflammatory chemokines and cytokines in abdominal 
and gluteal SAT depots compared to white women 55. Interesting, hypoxia and ECM 
genes expression levels were positively associated with higher expression of 
inflammatory genes in both the abdominal and gluteal SAT depots of black women 
whereas hypoxia and ECM gene expression associated with inflammatory gene 
expression mostly in the abdominal depots of the white women. Hypoxia has been 
shown to induce the transcription of nuclear factor-kappa β which regulates the 
inflammatory response as reviewed elsewhere 355, 356. Thus, it may be suggested 
higher inflammatory signalling in the gluteal depot of black women may be mediated 
by hypoxia and increased HIF-1α signalling. During hypoxia, there is a greater 
infiltration of (M1) activated pro-inflammatory macrophages relative to the (M2) anti-
inflammatory phenotype into adipose tissue and a concomitant reduction in insulin 
sensitivity 357. These findings are in agreement with previous studies that show that 
the abdominal SAT depots contribute more to the development of insulin resistance 
compared to a protective effect shown for gluteal fat distribution 50, 61 . However, in 
black women, the gluteal depot does not seem to have the same protective effect but 
rather associates with their higher inflammatory profile 55 and lower insulin sensitivity 
105, potentially mediated by increased hypoxic and ECM gene expression in this depot.  
LOX, another transcriptional target of HIF-1α, facilitates collagen cross-linking and 
stabilization, and thereby increases tensile strength of the ECM components 334. 
ECM & Hypoxia 
77 
Although LOX expression has been reported to be higher in the adipose tissue of 
normal-weight compared to obese humans 358, 359, this investigation is the first to 
describe ethnic and depot differences in adipose tissue LOX expression. Specifically, 
this thesis reported increased LOX expression in the abdominal compared to the 
gluteal depots of obese black and white women, and that LOX expression in the 
abdominal depots associated with reduced SI in white women only. Transgenic mice 
over-expressing HIF-1α have increased LOX expression and fibrotic deposition in 
adipose tissue and reduced glucose tolerance 307. As a transcriptional target of HIF-
1α, LOX expression in the gluteal depot was expected to be higher in black compared 
to white women, but LOX expression did not differ between black and white women. 
This may be explained by a previous observation in our laboratory of increased 
expression of TNFα, a pro-inflammatory cytokine, in the gluteal depot of black women 
compared to white women, which was independent of differences in BMI 55. TNFα has 
been shown to reduce LOX mRNA expression in endothelial cells in a dose dependent 
manner 360, 361. It is possible that the lower LOX expression may be due to the high 
inflammatory profile as observed in the gluteal SAT of black women.  
In addition, higher FGF1 expression in the gluteal SAT depot of black women and both 
abdominal SAT depots of white women, associated with reduced insulin sensitivity, 
independent of body fatness. FGF1 under the regulation of PPARγ, has been shown 
to be critical for adipose tissue remodelling during metabolic changes 343, 349. Under 
excess caloric conditions, FGF1 knockout mice develop an aggressive fibrotic and 
diabetic phenotype that fails to resolve following normal calorie intake 343.343. In 
contrast, pharmacological treatment of insulin resistant, obese mice with FGF1 results 
in insulin dependent glucose lowering and whole body insulin sensitization 349. Along 
with its ECM remodelling function, elevated FGF1, primarily expressed by 
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inflammatory and fibroblast-like cells, has been shown to be essential for cardiac 
angiogenesis following myocardial infarction 362. Thus, FGF1 expression may be 
increased in obese adipose tissue as a compensatory mechanism to resolve the 
adverse metabolic effects of excessive ECM accumulation, such as increased 
inflammatory signalling and reduced SI. In line with this hypothesis, FGF1 expression 
associated closely with higher inflammatory signalling in the abdominal SAT depots of 
both black and white women.  
This study has several limitations. Firstly, the sample size of the cohort is small. 
However, this study may be viewed as a pilot study, from which some novel 
relationships that require verification have been identified. Secondly, due to the small 
size of the fat biopsies obtained, protein expression in the adipose tissue samples 
could not be measured. Further studies are warranted to evaluate the hypothesis that 
greater adipose tissue hypoxia and the accumulation of ECM components in 
peripheral body fat plays a role in the development of insulin resistance in black 
women 
In conclusion, this study showed that obese black women had higher expression of 
HIF-1α, COL5A1 and COL6A1 and reduced VEGFα expression in the gluteal depot 
compared to obese white women, independent of differences in body fat % and central 
fat mass. Higher HIF-1α and reduced VEGFα expression in the gluteal depot of obese 
black women suggests increased adipose tissue hypoxia and reduced vascularization 
that may contribute to higher inflammatory gene expression as previously observed in 
this depot. Based on these findings, it is proposed that reduced adipogenic capacity 
in the gluteal depot of black women may result in increased adipose tissue hypoxia 
and increased HIF-1α expression, which in turn induces a fibrotic and inflammatory 
response, rather than a compensatory pro-angiogenic response. 
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CHAPTER FOUR  
HYPOXIA AND EXTRA-CELLULAR MATRIX GENE EXPRESSION IN THE 
GLUTEAL ADIPOSE TISSUE DEPOT ASSOCIATES WITH INSULIN 
SECRETION IN BLACK SOUTH AFRICAN WOMEN  
- A 5 year pilot study - 
Data from this chapter have been published in part in Kotzé-Hörstmann L M, 
Keswell D, Adams K, Dlamini T and Goedecke J H. Hypoxia and Extra-Cellular Matrix 
gene expression in adipose tissue associates with reduced Insulin Sensitivity in black 
South African women. 2017 Endocrine (55) p144-152 
4.1 INTRODUCTION 
In the previous chapter (Chapter 3), it was demonstrated that at comparable BMI, 
normal-weight black women had greater gynoid fat mass (%fm) compared to their 
normal-weight white counterparts, whereas there were no differences in gynoid fat 
mass (%fm) between obese black and white women. When the black participants of 
the larger cohort were followed-up after 5 years of free-living, they gained an average 
9 % body fat, but the increase in fat mass was associated with a relative increase in 
central (trunk) fat mass (%fm), and a concomitant decrease in leg fat mass (%fm) 106. 
These findings suggest that the development of obesity in black women is associated 
with a relative redistribution of fat from the periphery to the central fat depots.  
Peripheral fat distribution appears to play a protective role in the maintenance of 
metabolic health 50, 51, 363, whereas accumulation of fat in the VAT depot has been 
implicated in the development of metabolic disturbances leading to insulin resistance 
45, 100, 214, 364. However, this relationship has been shown to be altered in black women 
in whom abdominal SAT correlates more closely with lower SI than VAT57, 120. This 
ethnic specific relationship between abdominal adipose tissue depots and measures 
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of insulin sensitivity and secretion might be explained, in part, by factors that influences 
the accumulation of fat in the different adipose tissue depots. 
Increasing adipose tissue mass during the development of obesity is characterised by 
altered extracellular matrix expression and increased M1-activated macrophage 
infiltration 226, 365. The excess generation and deposition of ECM components during 
adipose tissue expansion in obesity may represent a mechanical limitation to adipose 
tissue expandability (section 2.4) 58, 366. 
Given the previous findings of higher hypoxia and ECM component gene expression 
in the gluteal depot of obese black compared to white women, and the ethnic-specific 
associations with reduced insulin sensitivity (Chapter 3), this study hypothesises that 
higher hypoxia- and ECM-related gene expression is associated with higher central 
fat mass accumulation in black women and that the expression of these genes are 
more closely associated with changes in insulin sensitivity and secretion in black 
compared to white women. Therefore, the aims of this study are to i) compare 
expression of ECM and matrix remodelling components and genes relating to the 
cellular hypoxia response at baseline and after 5 year follow-up in free-living black and 
white women; and to ii) explore the associations between changes in expression of 
these genes and changes in body composition, insulin sensitivity and secretion in 
black and white women.  
4.2 MATERIALS AND METHODS 
4.2.1 Participants  
Fifteen women (black, n=10; white, n=5) from the cross-sectional study described in 
Chapter 3, were followed up after a 5-year free-living period. Inclusion criteria for the 
follow-up study were similar to those described in Chapter 3, and included: no previous 
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diagnosis of, or not taking chronic medication for T2DM, hypertension, HIV, or other 
metabolic diseases; and not currently pregnant or lactating. Of our original sample of 
56 women, 9 women were not contactable because they had relocated, 13 had altered 
contact details, 9 were not willing to participate, 3 were pregnant, 2 declined to 
participate due to illness, 1 woman was deceased and 4 women were excluded due 
to incomplete data. Therefore, 15 women were included in this follow-up study. Ethics 
approval was obtained from the Human Research Ethics Committee of the Faculty of 
Health Science at the University of Cape Town and written informed consent was 
obtained from all participants prior to testing 
4.2.2 Testing procedures 
 Body composition assessment  
Basic body composition assessment including height, weight, waist and hip were the 
same as described at baseline (Chapter 3). Total body fat mass, central (trunk) fat 
mass, gynoid and android fat mass regions of interest, were measured by DXA 
(Discovery- W, Software version 12.7.3.7, Hologic Inc., Bedford, MA, USA), as 
described previously (Chapter 3). The change in the variables over the follow-up 
period were calculated by subtracting the baseline measurement from the follow-up 
measurement. The body fat distribution variables (trunk, gynoid, android, and leg fat 
mass), as proportions of total fat mass (%fm), were calculated by dividing the body fat 
distribution variable by the total body fat mass (kg) and then multiplying by 100, as 
describe in Chapter 3. 
 Insulin sensitivity measures (SI) 
A frequently sampled intravenous glucose tolerance test was used to estimate insulin 
sensitivity and secretion in the follow-up sample, as described in Chapter 3.  
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 Adipose tissue biopsies 
From the right upper quadrant of the gluteal depot, approximately 2 ml of fat was 
collected via mini-liposuction method, as described in Chapter 3. Biopsy samples were 
then frozen and stored at -80˚C until analysis.  
4.2.3 RT-PCR  
RT-PCR on baseline and follow-up samples were carried out simultaneously on a 
StepOnePlus™ Real-Time PCR system (Applied Biosystems, Foster City, CA, USA), 
with inventoried gene-specific TaqMan™ primer/probes gene expression assays for 
PPARγ (Hs01115513_m1) HIF-1α (Hs00153153_m1), VEGFα (Hs00900055_m1), 
LOX (Hs00942480_m1), COL5A1 (Hs00609088_m1), COL6A1 (Hs00242448_m1) 
and FGF1 (Hs00265254_m1), using the Applied Biosystems StepOnePlus™ Real-
Time PCR software Version 2, as described in Chapter 3.  
4.2.4 Statistics Analysis 
Assumptions of normality were verified for continuous data by Shapiro-Wilk test. Non-
normally distributed variables (weight, BMI and SI) were log10 transformed prior to 
parametric analysis. Normal data are presented as mean and SD and non-normal data 
as median and interquartile range. If a parametric test was performed with non-
normally distributed variables, Levene’s test of variation was used to determine 
homogeneity of continuous data. Changes from baseline to follow-up in gene 
expression, body composition variables and measures of insulin sensitivity and 
secretion were assessed with paired-samples t-test in black and white women, 
separately. Pearson’s correlations (r) were used to explore the relationships between 
the change in gene expression and the change in body composition, and insulin 
sensitivity and secretion over the follow-up period in black and white women, 
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separately. DATA were analysed using STATISTICA version 13 (Statsoft Inc., Tulsa, 
OK). 
4.3  RESULTS 
4.3.1 Participant characteristics 
The baseline and follow up participant characteristics are shown in Table 3.1. Of the 
10 black participants, 2 women reduced their body fat mass [-6.0kg to -13.1kg] over 
the 5-year follow-up period, while 6 women increased their body fat mass [+4.3kg to 
23.5kg]. Of the 5 white participants, 3 women increased their body fat mass [+1.0kg 
to 2.4kg], while 2 women reduced their fat mass [-6.3kg to -7.0kg]. Over the 5-year 
follow-up period, in black women, BMI, android fat mass (%fm) and central/leg fat ratio 
(p< 0.05) increased, while gynoid fat mass (%fm) decreased, whereas in white women, 
there were no changes in body fatness and body fat distribution.  
Despite changes in body composition, there were no changes in fasting glucose and 
insulin concentrations, or insulin sensitivity and secretion in the black women over the 
follow-up period. In contrast, in white women, both fasting insulin and glucose 
concentrations increased over time, while insulin sensitivity and secretion did not 
change. 
4.3.2  Changes in Hypoxia and ECM related gene expression in gluteal SAT of 
black and white women over the 5-year follow-up period 
The changes in the transcript levels of hypoxia and ECM related genes in gluteal SAT 
of white and black women over the 5-year follow-up period are presented in Figure 
4.1. In both black and white women, PPARγ, VEGFα, HIF-1α, LOX and FGF1 
expression increased from baseline to follow-up. In contrast, COL5A1 expression 
decreased in black women over time, but did not change in white women. COL6A1 
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expression was not different between baseline and follow-up in both black and white 
women.  
4.3.3 Associations between changes in gluteal SAT Hypoxia and ECM gene 
expression and changes in body composition in black and white SA 
women over the 5-year follow-up  
The Pearson correlations coefficients (r), between the change in gluteal SAT gene 
expression and body fat distribution parameters from baseline to follow-up in black 
and white women are shown in Table 4.2. An increase in body fat mass (kg) from 
baseline to follow-up was associated with an increase in PPARγ expression in white 
Table 4.1 Change in body composition and insulin sensitivity measures over 5 year follow-up in white and black SA 
women 
 
White women  Black women  
 Baseline Follow-up p-value Baseline Follow-up p-value 
Age (years) 26 ± 4.3 32 ± 4.5  27 ± 8.4 32 ± 8.3  
Body composition 
Weight (kg) 67.2 (62 - 90) 65.3 (63-91) 0.75 91.0 (61 - 100) 92.4 (70- 108)  0.06 
Waist (cm) 95.4 ± 4.8 102.4 ± 8.4 0.33 106.2 ± 6.8 109.3 ± 5.9 0.45 
BMI (kg/m2) 23.8 (22 -24) 22.8 (20- 24) 0.75 36.7 (24 -40) 36.9 (29 -47) 0.03 
Body fm (%) 30.6 ± 12.9 29.6 ± 12.8 0.27 42.5 ± 9.4 44.2 ± 7.0 0.54 
Cent fm (%fm) 43.7 ± 8.1 40.7 ± 7.9 0.40 48.6 ± 5.6 50.1 ± 4.3 0.22 
Leg fm (%fm) 43.6 ± 8.3 44.6± 7.5 0.29 37.4± 5.7 36.02 ± 5.8 0.22 
Cent/leg fat ratio 2.04 ± 0.7 1.93 ± 0.5 0.23 2.82 ± 0. 8 3.11 ± 0.9  0.03 
Gynoid fm (%fm) 20.1 ± 2.4 21.4 ± 2.0 0.27 17.9 ± 2.8 16.9 ± 3.1  0.01 
Android fm (%fm) 6.5 ± 2.7 6.4 ± 2.1 0.81 8.4 ± 2.0 9.2 ± 1.7  0.04 
Insulin sensitivity 
Glucose (mmol/l) 4.3 ± 0.3 4.9 ± 0.6 0.01 4.6 ± 0.4 4.9 ± 0.7 0.21 
Insulin (mU/l) 6.1 ± 3.2 14.9 ± 9.7 <0.01 13.9 ± 6.9 15.5 ± 8.9 0.52 
SI (x10-4 min-
1/[pmol/l]) 
5.2 (3.9– 7.0) 4.7 (2.3 – 6.9) 0.97 1.1 (0.8 - 1.9) 1.4 (1.1 – 1.9) 0.69 
AIRg (µU/ml) 393 ± 208 407 ± 210 0.42 2834 ± 2575 2277 ± 1078 0.68 
Values represent unadjusted mean ± SD or median (interquartile range). Fm, fat mass; %fm, a percentage of  fm; Cent, Central fat mass; SI, Insulin 
Sensitivity; AIRg, Acute Insulin Response to Glucose.  
 
 
ECM & Hypoxia 
85 
women only, whereas an increased in body fat mass (kg) was associated with a 
decrease in COL5A1 expression in black women only. Further, an increase in the  
central fat mass (kg) over the follow-up period was associated with an increase in 
PPARγ and COL5A1 mRNA expression in white women only. 
 
Figure 4.1 Changes in gene expression from baseline to follow-up in gluteal SAT of white and black women. 
Circles represent unadjusted means for gene expression levels at baseline and at 5-years follow-up. P-value for paired 
samples Student’s t-test- baseline vs follow up, in black and white women separately. mRNA expression relative to internal 
control genes and expressed in arbitrary units (AU). 
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4.3.4 Associations between the changes in gluteal SAT hypoxia and ECM gene 
expression and changes in insulin sensitivity measures in black and 
white women over the 5-year follow-up 
The Pearson correlation coefficients (r) between the change in gluteal SAT gene 
expression levels from baseline to follow-up and measures of insulin sensitivity and 
secretion are shown in Table 4.2. In black women, an increase in fasting insulin 
concentrations were associated with an increase in HIF-1α and COL6A1 mRNA 
expression, whereas an increase in AIRg was associated with an increase in LOX and 
COL5A1 expression. These relationships remained significant when adjusting for 
baseline body fat mass and changes in body fat mass over time. Further, after 
adjusting for change in fat mass, an increase in fasting insulin concentrations was also 
associated with an increased COL5A1 expression, (partial correlation r= 0.71; 
p<0.033) in black women. In white women, there were no significant associations 
between the change in insulin sensitivity and secretion and changes in gluteal SAT 
gene expression. 
4.4 DISCUSSION  
This study investigated the changes in gluteal SAT hypoxia and ECM related gene 
expression and their associations with changes in body composition and insulin 
sensitivity and secretion of black and white South African women over a 5-year free-
living period. The main findings of this study were that PPARγ, HIF-1α, VEGFα, LOX 
and FGF1 expression increased over the follow-up period in both black and white 
women, whereas COL5A1 mRNA expression decreased in black women only. 
Notably, the increase in PPARγ expression in white women associated with an 
increase in total and central fat mass, whereas the decrease in COL5A1 mRNA 
expression in black women correlated with an increase in their total fat mass. Changes 
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in gene expression were not associated with changes in insulin sensitivity and 
secretion in white women. In black women, however, increases in HIF-1α and COL6A1 
mRNA transcription associated with increases in fasting insulin concentrations and 
changes in LOX and COL5A1 mRNA associated with changes AIRg. 
Similar to the black women from the larger South African cohort 106, weight gain in the 
black participants of this study associated with a relative redistribution of body fat from 
the periphery (gynoid) to the central (android) depot. Cross-sectional studies in pre-
menopausal women have shown that black women have greater peripheral fat 
distribution and a smaller central fat mass compared to white women 23, 108. However, 
these longitudinal findings suggest that with increasing age and weight gain, black 
women may be equally at risk of the metabolic abnormalities associated with the 
centralization of body fat as white women. Similar findings were reported from the 
Table 4.2 Associations between the change in hypoxia and ECM gene expression and the change in body fat 
distribution- and insulin sensitivity measures over the 5-year follow-up period in gluteal SAT of black and white SA 
women. 
 Body Composition Insulin Sensitivity 
 Δ Body fm Δ Cent fm Δ Insulin Δ SI Δ AIRg 
 White Black White Black White Black White Black White Black 
Δ PPARγ 0.89a -0.54 0.92a -0.47 0.61 -0.24 -0.14 0.16 -0.26 0.35 
Δ HIF-1α 0.80 0.25 0.87 0.23 0.39 0.77b -0.13 -0.15 -0.36 0.36 
Δ VEGFα -0.81 0.01 -0.87 0.09 -0.79 0.39 0.50 -0.40 0.02 0.43 
Δ LOX 0.05 -0.01 0.07 0.01 -0.34 0.16 0.16 -0.15 0.27 0.71a 
Δ COL5A1 0.86 -0.71a 0.89a -0.57 0.24 0.30 0.19 -0.30 -0.40 0.71a 
Δ COL6A1 0.70 -0.04 0.60 0.03 0.49 0.81b 0.32 -0.50 -0.18 0.59 
Δ FGF1 0.12 0.16 0.21 0.18 0.41 0.27 -0.59 -0.19 0.46 -0.15 
Values are Pearson correlation coefficients (r). P-values: a, p<0.05; b, p<0.01. Δ, Change from baseline to follow-up; Fm, fat 




IRAS Family study 367 in which a cohort of young African American (n=389) and 
Hispanic (n=844) women were followed up after a 5-year interval. Additionally, this 
study showed that the greater central fat accumulation of the African American 
compared to the Hispanic women was attributed to greater increases in both VAT and 
SAT area. The changes in body fat distribution may however be dependent on the age 
and or /starting BMI of the participants studied, as in an older cohort of African-
American women with a higher BMI, Lara-Castro et al 46 demonstrated that the 
increased body fat mass over a 5 year follow-up period was associated with an overall 
increase in body fat mass, without proportional changes to either central or peripheral 
fat mass.  
Change in body fat partitioning may be explained, in part, by adipogenic and lipogenic 
capacity in the gluteal depot of black and white women. In this study, it was shown for 
the first time that a gain in body fat mass in the black women did not associate with a 
proportional increase in PPARγ expression, as was shown in the white women. 
Pervious work in this cohort has demonstrated a greater down-regulation of PPARγ 
and other adipogenic and lipogenic genes in the gluteal depot of obese black 
compared to obese white women 105. The lower expression of these genes in the 
gluteal SAT of obese black women associated with their lower SI. Studies 
implementing thiazolidinediones (TZD’s), known PPARγ-agonists, have shown that 
higher expression levels of PPARγ during adipose tissue expansion are associated 
with the generation of smaller, more insulin sensitive adipocytes, without changes to 
the overall adipose tissue depot size 368. Taken together, these findings suggest that 
the reduced adipogenic capacity in the gluteal depot of black women may underlie the 
generation of more hypertrophied adipocytes, as was previously observed in this depot 
(Keswell et al., unpublished data) and the redistribution of fat to the central depots. 
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In this study, the gluteal expression of HIF-1α and its transcriptional target, VEGFα, 
were higher at follow-up compared to baseline of both black and white women, 
independent of their respective changes in body fat mass. An increase in HIF-1α 
mRNA expression is a well-known physiological response to the development of 
obesity and is hypothesised to stimulate increased VEGFα expression to increase 
angiogenesis in order to alleviate tissue hypoxia 307, 369, 370. In addition to their role in 
hypoxia signalling, increased HIF-1α and VEGFα may also contribute to normal tissue 
maintenance and development by inducing adipocyte differentiation- and maturation 
processes 371 372. Together, these results may be indicative of an adaptive increase in 
vasculature formation during fat accumulation and normal tissue maintenance in the 
gluteal depot of black and white women over the follow-up period. However, higher 
HIF-1α and VEGFα mRNA expression in the white women was surprising given that 
no changes in fat mass were observed which suggests that the expression of these 
genes in adipose tissue is not simply a consequence of increased obesity.  
In this study, higher HIF-1α expression in the gluteal SAT of black women associated 
with higher fasting insulin concentrations over the follow-up period. Insulin stimulation 
has previously been reported to induce HIF-1α protein and hypoxia-related gene 
expression in retinal epithelial cells in vitro 373. However, it is not known whether higher 
circulating insulin may also increase the in vivo HIF-1α mRNA expression in human 
adipose tissue. Studies from tumour biology have shown a direct correlation between 
activity of the phosphatidylinositol 3-kinase (PI3K) / AKT (protein kinase B) pathway, 
increased HIF-1α expression, HIF-1α mediated transcription and VEGFα expression 
374, 375. It is thus plausible that high circulating insulin (hyperinsulinaemia) may increase 
HIF-1α mRNA transcription in adipose tissue. Importantly, the association between the 
higher HIF-1α expression and increased fasted insulin levels in the gluteal depot was 
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significant only in the black women. A potential explanation for this finding may be the 
small sample size of the white women.  
Another unique finding of this study was that higher fat mass accumulation associated 
with a reduced COL5A1 mRNA expression over the follow-up period in black, but not 
white women. Given that pericellular collagen is proposed to result in increased 
mechanical constraint during cellular hypertrophy 358, it stands to reason that the lower 
COL5A1 mRNA expression in the gluteal SAT of black women may reflect the 
remodelling of the collagen network surrounding the adipocytes towards lowering 
these mechanical forces, and thereby restoring FFA storage capacity. In support, 
Abdenour et al., 366 recently suggested that diminished SAT stiffness of humans (i.e. 
reduced collagen accumulation) enables fat mass enlargement, which may protect 
against ectopic fat distribution 366.  
Interestingly, higher HIF-1α and COL6A1 mRNA expression associated with higher 
fasting insulin concentrations, whereas changes in COL5A1 mRNA associated with 
lower AIRg, in black, but not white women, independent of differences in baseline body 
fat mass (kg). Insulin has been reported to regulate the secretion of ECM components 
of 3T3-L1 adipocytes through the transcriptional regulation of the ECM processing 
enzymes 376. This suggests that high levels of circulating insulin in the black women, 
could contribute to ECM dysregulation in adipose tissue, even in the absence of 
obesity. ECM remodelling involves the induction of matrix remodelling enzymes, such 
as FGF1 and LOX, the induction of which were also observed in black and white 
women in this study. Accordingly, the increase in gluteal LOX and FGF1 expression 
suggest increased collagen cross-linking and matrix remodelling in this depot at follow-
up. LOX expression in SAT has been found to be higher in obese compared to normal-
weight humans and mice 358 377. Moreover, up-regulation of LOX expression in obese 
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rats fed a high-fat diet was associated with increased pericellular fibrosis, whereas 
LOX inhibition by BAPN treatment ameliorated these alterations 377. These findings 
suggest a role for this enzyme during obesity development 307. However, the 
expression of these components have been shown to be altered in insulin resistant 
compared to insulin sensitive humans and mice 332, 378 307 in a manner that is 
independent of obesity. In this study, increased LOX mRNA expression associated 
with increased AIRg in the black women, but not in the white women. Taken together, 
it may be hypothesised that increased collagen and matrix remodelling components in 
the gluteal SAT may represent an ethnic specific mechanism of increased adipose 
tissue insulin resistance. 
This study has some important limitations to consider. Firstly, the sample size of the 
follow-up cohort is small. Loss to follow-up is problematic in most cohort studies but 
nonetheless, has implications for the statistical power and for the down-stream 
generalizability of the results. With this in mind, statistical test were only conducted 
within each ethnic group. However, this study may be viewed as a pilot study, from 
which some novel relationships have been identified and that require further 
verification. Secondly, due to the small size of the fat biopsies obtained, protein 
expression in the adipose tissue samples could not be measured. In addition, 
methodological issues relating to measurement of insulin at different time points, and 
storage of baseline adipose tissue for ± 5 years may have confounded the results. 
However, the same technique was used for insulin analyses at both time points, and 
the quality of the adipose tissue was similar between baseline and follow-up tissue 
samples.   
Importantly, to my knowledge, this is the first study to show that the changes in mRNA 
expression levels of hypoxia- and fibrosis-related genes correlated with changes in 
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fasting plasma insulin concentrations (HIF-1α, and COL6A1) and insulin secretion 
(LOX and COL5A1) over time. It may be hypothesised that hyperinsulinaemia in black 
women may not simply be a consequence of increased insulin resistance but may also 
contribute to the exacerbation of insulin resistance during obesity development by 
inducing the expression of hypoxia- and fibrosis-related genes in adipose tissue. 
However, these findings warrant further investigation in a larger cohort of black and 





CHAPTER FIVE  
EFFECT OF HYPOXIA ON THE REGULATORY EFFECTS OF INSULIN ON 
ECM COMPONENT PRODUCTION IN 3T3-L1 ADIPOCYTES 
5.1 INTRODUCTION   
In Chapter 3 of this thesis it was demonstrated that obese black women were more 
insulin resistant than obese white women, and had higher fasting insulin levels and a 
greater insulin response to glucose in order to maintain normoglycaemia. The obese 
black women had higher mRNA expression levels of HIF-1α, COL5A1 and COL6A1 
and lower VEGFα expression in the gluteal SAT depot compared to obese white 
women. Further, in Chapter 4 it was reported that changes in gluteal HIF-1α and 
COL6A1 mRNA expression levels over the 5-year follow-up period in the black 
women, correlated positively with changes in fasting plasma insulin concentrations. In 
addition, changes in gluteal LOX and COL5A1 mRNA expression levels correlated 
positively with changes in insulin secretion in response to a glucose load. Based on 
these findings, it may be hypothesised that in black women, gluteal SAT HIF-1α 
expression may be increased by their high circulatory insulin concentrations, resulting 
in a concomitant increase in COL5A1 and COL6A1 mRNA expression levels, and a 
consequent decrease in insulin sensitivity. This hypothesis is based on murine 294, 302 
and human 70, 301 models of obesity, which have shown that adipose tissue of obese 
individuals is less vascularized 328 and has lower oxygen partial pressure (PO2) 
compared to adipose tissue of their non-obese counterparts 70, 301. The reduction in 
PO2, also referred to as hypoxia 67, has been attributed to increased cellular 
hypertrophy and is proposed to be a result of lower proliferation and/or differentiation 
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capacity of SAT adipocytes (section 2.4.1). Although the molecular mechanisms are 
not yet fully understood, hypoxia in adipose tissue of obese individuals does not result 
in a pro-angiogenic response aimed at alleviating low PO2 in adipose tissue, but 
produces a pro-fibrotic transcriptional program through the induction and stabilization 
of HIF-1α protein 307, 379. The generation of excess ECM and matrix remodelling 
components in adipose have been linked to the development of insulin resistance in 
murine 307 and human models 295. Several studies hypothesize that increased 
mechanical stress from a rigid fibrotic network of collagen leads to chronic low grade 
inflammation, which consequently, underlies the development of insulin resistance 
(For review see 71 and section 2.3.2). Ultimately, to maintain glucose homeostasis, β-
cells secrete more insulin which in turn result in increased circulating hormone levels. 
Insulin treatment has been shown to stabilize HIF-1α expression via a PI3K/mTOR 
dependent pathway 373 where it results in an increased accumulation of HIF-1α protein 
372, 373, 380 and mRNA 372 in a time-dependent manner. Therefore, chronically elevated 
circulating insulin may contribute to the generation of fibrosis through increased HIF-
1α protein expression in adipose tissue, in a manner that is independent of hypoxia. 
Further, insulin has been reported to regulate the secretion of ECM components of 
3T3-L1 adipocytes through the transcriptional regulation of ECM processing enzymes 
376. Col5a1 expression, along with the ECM processing enzymes, matrix 
metalloproteinase 2 (MMP2), metalloproteinase inhibitor 2 (TIMP2) and procollagen 
C-endopeptidase enhancer protein were significantly increased during insulin 
treatment of 3T3-L1 adipocytes in a microarray study 376. This suggests that high levels 
of circulating insulin, commensurate with insulin resistance, could contribute to ECM 
dysregulation in adipose tissue, and consequently reduce insulin sensitivity further.  
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Although the independent effects of hypoxia and insulin treatment on HIF-1α 
expression have been investigated, less is known about the concurrent effects of these 
conditions, such as those that may occur in adipose tissue of hyperinsulinaemic obese 
individuals. It is not clear whether high circulating insulin may directly increase HIF-1α 
expression and contribute to the formation of excess ECM, or whether increased 
insulin may simply be a concomitant downstream effect of increased insulin resistance 
as a consequence of increased fibrosis and the generation of inflammation. This study 
hypothesises that the expression of HIF-1α, Col5a1 and Col6a1 will increase in a 
dose-dependent manner in insulin-treated 3T3-L1 adipocytes under hypoxic- 
compared to normoxic conditions. Therefore, the aims of this study are to i) determine 
the effects of insulin on HIF-1α, Col5a1 and Col6a1 mRNA and protein expression in 
3T3-L1 adipocytes, and to ii) determine whether these effects may be different during 
hypoxic vs. normoxic conditions.  
5.2 MATERIALS AND METHODS  
5.2.1 Cell culture 
The 3T3-L1 mouse pre-adipocyte cell line Cl-173 (American Type Culture Collection 
(ATCC) number CL-173, Manassas, VA, USA) was seeded in CELLBIND 6-well plates 
(Corning, MA, USA) at 7.5 x 104 cells/well and grown to confluence in growth medium 
(Dulbecco’s modified Eagle’s medium (DMEM) containing 10% new-born calf serum 
(NCS) (The Scientific Group, JHB, SA) and 4 mM glutamine) at 37°C in humidified air 
with 5% CO2 for three days. When cells reached 80% confluence, growth media was 
removed and differentiation was induced by substituting with adipocyte differentiation 
medium (DMEM containing 10% fetal bovine serum (FBS) (Biochrom, Berlin, 
Germany), 1 µM dexamethasone, 0.5 mM 3-isobutyl-1-methylxanthine and 1µg/ml 
insulin). After 72 hrs of culture, the differentiation medium was replaced with adipocyte 
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maintenance medium (AMM) (DMEM containing 10% FBS, and 1 μg/ml insulin) and 
cells were cultured for 2 days, at the end of which the 3T3-L1 adipocytes were fully 
differentiated 381. AMM was then replaced by DMEM containing 10% FBS and the cells 
cultured for a further 3 days. On day 8, cells were refreshed in either DMEM containing 
10% FBS (control treatment), DMEM containing 10% FBS and 175 nM insulin 
(medium treatment) or DMEM containing 10% FBS and 1 µM insulin (high treatment) 
prior to incubation and assays. 
5.2.2 Cell viability in the hypoxia and insulin treatments  
Control, medium [175 nM] and high [1 µM] insulin treatment concentrations and 
treatment duration were selected based on previous reports that have investigated 
acute insulin stimulation 315, 372, 373, 382 and chronic high insulin treatment 376, 383 in 3T3-
L1 adipocytes. (See supplementary Table 4.a). Hypoxia was induced by incubating 
cells in the GasPak EZ Campy pouch system (BD Biosciences, San Diego, USA) 
which creates an atmosphere of >10% CO2 and 5% O2, according to the 
manufacturer’s guidelines. Cells under the normoxic condition remained in the 
incubator at humidified air with 5% CO2 and 21% O2 at 37˚C.  
Cells were evaluated for cell viability using the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) (Sigma-Aldrich, St Louis, MO, USA) based 
colorimetric assay. Cells were incubated with 2 µg/ml of MTT in PBS for 1 h at 37˚C, 
and the produced formazan dissolved in Dimethyl sulfoxide (DMSO) (Sigma-Aldrich, 
St Louis, MO, USA) and Sorensen’s phosphate buffer (0.1 M glycine, 0.1 M NaCl, pH 
10.5) before quantification at 570 nm using a BioTek® ELX 800 plate reader and Gen 
5® software (BioTek Instruments Inc., Winooski, VT, USA).  
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5.2.3 RNA extraction and reverse transcription  
Total RNA was extracted from whole cell-lysates under hypoxic and normoxic 
conditions from control, medium and high insulin treatments. After incubation, culture 
media was aspirated from the cells after which the cells were washed in phosphate 
buffered saline (PBS) (Lonza, Walkersville, MD, USA) and collected by scraping in 
TriPure Isolation Reagent (Roche Diagnostics Ltd, Burgess Hill, UK). Three wells from 
the 6 well culture plates were pooled into a 2 ml Eppendorf tube and stored at -20°C 
until extraction. The collected cells were homogenized using the Qiagen Tissue lyser 
at 25Hz for 2 min and this was repeated five times. Total RNA was then purified using 
the RNeasy Mini kit (QIAGEN, Hilden, Germany) according to the manufacturer’s 
protocol. Genomic DNA was removed using the Turbo DNase kit (Ambion Inc., Austin, 
TX, USA). RNA concentration (A260) and purity (A260/A280) were quantified 
spectrophotometrically (Nanodrop Technologies, Wilmington, DE, USA) and integrity 
was assessed using the Agilent bioanalyser (Agilent Technologies Inc., Santa Clara, 
CA) (Figure 5.1). One microgram of DNase treated total RNA was reverse transcribed 
to cDNA using the High Capacity Reverse Transcription kit (Applied Biosystems, 
Foster City, CA, USA) according to the manufacturer’s protocol. The reaction mix 
consisted of reaction buffer, dNTPs, random primers, RNase-inhibitor (5000 units/mL), 
reverse transcriptase (RT) enzyme and nuclease-free water. A duplicate set of 
reactions were prepared without RT enzyme and was used to calculate the amount of 
genomic DNA contamination (Supplementary Table 4.b for reaction conditions). 
5.2.4 Quantitative Real-time PCR for gene expression analyses 
Quantitative Real-Time PCR was conducted with Taqman® gene expression assays 
for HIF-1α (Hs00153153_m1), Col5a1 (Hs00609088_m1) and Col6a1 
(Hs00242448_m1), according to the manufacturer’s protocol (Applied Biosystems 
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Foster City, CA, USA). Briefly, 1µl cDNA was added to 0.5µl of the respective TaqMan 
probes, 5 µl of TaqMan® Universal PCR Master Mix and water in a final reaction 
volume of 10 µl. Reactions were run in duplicate on a 7500 Real Time PCR system 
(Applied Biosystems) using universal cycling conditions of 50ºC for 2 min and 95ºC for 
10 min, followed by 40 cycles of 95°C for 15 sec and 60°C for 1 min.  
Gene expression was determined by extrapolating against a standard curve defined 
by serial 1:10 dilutions of pooled cDNA. Tyrosine 3/tryptophan 5-monooxygenase 
activation protein (Ymhaz), TATAA-box binding protein (Tbp) and betaglucuronidase 
(Gusb) were evaluated as endogenous controls, based on previous studies of hypoxia 
384. From these, NormFinder was used to identify the most suitable endogenous 
 
Figure 5.1 RNA quality and integrity analysis with Agilent Bio-analyser. 
Typical representation of A) Bio-analyser gel result for samples extracted from insulin and hypoxia treated 3T3-L1 adipocytes. 
From the left, (L) represents the ladder followed by RNA samples in lane 1-12. On the gel photo, two bands are clearly visible in 
each sample lane and represents the 28S and 18S ribosomal subunits. B) Electropherograms generated by the Agilent Bio-
Analyser. For each RNA sample, a profile is generated that reports RNA integrity and concentration. RNA integrity number (RIN) 
value is generated to indicate the quality of the RNA samples and can range between 10 (for intact RNA) – 1 (most degraded).  
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control genes 350. The combination of Gusb and Tbp was identified as the most stable 
for use during hypoxic treatment conditions (stability value= 0.038).  
5.2.5 Protein extraction and Western blotting  
Whole cell-lysates were harvested from the control, medium and high insulin treated 
3T3-L1 adipocytes incubated under hypoxic and normoxic conditions. Three wells of 
the 6 –well culture plates were pooled by scraping each well in 150 µl lysis buffer (50 
mM KCl, 0.5%, Nonidet P-40, 25 mM HEPES [N-2-hydroxyethylpiperazine-N’-2-
ethanesulfonic acid] [pH 7.8], 1 mM phenylmethylsulfonyl fluoride, 10 µg leupeptin/ml, 
20 µg aprotinin/ml, 100 µM dithiothreitol) and combining in a 2 ml Eppendorf tube and 
placing on ice within 1 min. Samples were homogenised in a Tissue Lyser (Qiagen, 
Hilden, Germany) at 25 Hz in 60 sec increments which were repeated 5 times. After 
centrifugation at 16 000 x g for 1 min (4˚C), supernatant was collected.  
Protein concentrations were determined using Reducing Agent and Detergent 
Compatible (RC DC) protein assay kit (Bio-Rad, Hercules, CA, USA). Heat denatured 
protein was separated on a 10% SDS-PAGE gel and transferred to a PVDF membrane 
for 90 min at 160 V (4˚C). Non-specific protein labelling was blocked by incubating the 
membrane in 5% (w/v) low-fat milk powder in Tris-buffered saline with Tween 20 
(TBST) (TBS pH 7.2; 0.001% Tween 20) at room temperature for 2 hrs. Membranes 
were labelled with the relevant primary antibody at 4˚C over-night and followed by 
horseradish peroxidase (HRP) conjugated secondary antibodies (Supplementary 
Table 4.c for list of antibodies used). Proteins were visualized by chemiluminescence 
with Clarity™ Western ECL Substrate (Bio-Rad Hercules, CA, USA) using a 
Chemidoc-XRS imager, (Bio-Rad Hercules, CA, USA) and quantified using Quantity 




5.2.6 Intercellular lipid content determination 
On day 8 of differentiation, fully differentiated adipocytes were washed and fixed in 
neutral buffered formalin 10% (v/v in PBS) and stained with 0.7% (w/v) Oil-Red O 
solution (Sigma-Aldrich, St Louis, MO, USA) for 30 min at room temperature. The 
stained lipid was quantified by extracting the dye with 100% isopropanol and 
measuring the absorbance at 510 nm using a BioTek® ELX 800 plate reader and Gen 
5® software (BioTek Instruments Inc., Winooski, VT, USA). Plates were then de-
stained with 70% Ethanol. Lipid content was normalized to cell density according to a 
protocol adapted from Gillies et al 385. Briefly, the decolourised fixed cells were re-
stained with 0.5% Crystal Violet, the Crystal Violet extracted with 70% ethanol, and 
the absorbance read at 570 nm using the BioTek® ELX 800 plate reader. 
5.2.7 Statistical analysis 
Results are expressed as mean ± standard deviation (SD) of three independent 
biological experiments, unless otherwise stated. Two-way analysis of variance 
(ANOVA) was used to examine differences in cellular viability, mRNA- and protein 
expression and triglyceride content between normoxic and hypoxic conditions in 
response to three different insulin treatments (control, medium- [175 nM] and high-
insulin [1 µM] concentrations) with Tukey post hoc test. Differences were considered 
significant at p ≤ 0.05. Data were analysed using STATISTICA version 12 (Statsoft 
Inc., Tulsa OK, USA). 
5.3 RESULTS 
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5.3.1 Cell viability in the normoxic and hypoxic conditions and insulin 
treatments. 
Cell viability was evaluated under different durations of hypoxia exposure. Compared 
to the normoxic condition, cell survival increased similarly after 4, 8 and 12 hrs of 
hypoxia exposure (Figure 5.2), showing that hypoxia exposure (5% O2) did not have 
cytotoxic effects on the differentiated 3T3-L1 adipocytes. Eight hours exposure was 
selected as appropriate hypoxia exposure duration, as exposure beyond 8 hrs 
treatment did not result in further significant affects beyond 4 hrs exposure. Cell 
viability was evaluated in control, medium- [175 nM] and high- [1 µM] insulin 
concentrations in normoxic vs. hypoxic conditions. Under normoxic conditions, 
medium- and high-insulin treatment increased cell viability (treatment effect: p <0.001), 
whereas under hypoxic conditions, insulin treatment did not alter cell viability 
(condition x treatment interaction, p< 0.001).  
5.3.2 Effect of insulin treatment on HIF-1α, Col5a1 and Col6a1 mRNA and protein 
expression under normoxic and hypoxic conditions. 
To determine the effect of insulin on the abundance of HIF-1α, Col5a1 and Col6a1 
mRNA and protein levels under normoxic and hypoxic conditions, mature 3T3-L1 
adipocytes were incubated under control, medium- [175 nM] and high- [1 µM] insulin 
concentrations (Figure 5.3). In the untreated control groups (no-insulin- normoxia vs. 
hypoxia), hypoxia resulted in a significant increase in HIF-1α mRNA transcript levels 
compared to the normoxic condition. Insulin treatment was associated with higher HIF-
1α mRNA expression (treatment effect, p<0.001) in hypoxic and normoxic conditions. 
In the normoxic condition, HIF-1α mRNA levels were increased in the medium- and 
high-insulin treatments compared to the untreated control. However, the effect was 




HIF-1α mRNA expression was increased with high-insulin but not with medium-insulin 
treatment, compared to the untreated hypoxic control. HIF-1α protein expression was 
higher in the hypoxic vs. normoxic condition (condition effect, p=0.008). However, 
insulin treatment had no further effects on HIF-1α protein expression under the hypoxic 
condition compared to the normoxic condition (condition ˟ treatment interaction, p= 
0.03), whereas HIF-1α protein expression was increased in the high-, but not the 
medium-insulin treatment compared to the untreated normoxic control. Whilst insulin 
treatment was associated with lower Col5a1 mRNA expression under the normoxic 
 
Figure 5.2 MTT assay of insulin and hypoxia treated 3T3-L1 adipocytes. 
Cell viability of fully differentiated 3T3-L1 adipocytes was measured by MTT assay in A) 0-, 4-, 8- and 12 h hypoxia 
treatment (5% O2) (n = 60) and B) Control, medium [175 nM] and high [1 µM] insulin treatment in normoxic (21% O2) and 
hypoxic (5% O2) conditions (n = 16). Values are mean OD ± SD (read at 570 nm). OD, optical density. 
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condition, similar affects were not observed under the hypoxic condition (condition ˟ 
treatment interaction, p=0.01). In contrast, hypoxia exposure was associated with 
higher COL5A1 protein expression, but its expression was not altered by insulin 
treatment under either normoxic or hypoxic conditions. Col6a1 mRNA expression was 
not significantly different between any of the insulin treatments under either condition.  
In contrast, hypoxia exposure was associated with higher COL6A1 protein levels 
(condition effect, p< 0.001) but its expression was not altered by the insulin treatments 
under either normoxic or hypoxic condition.  
5.3.3 Effects of insulin treatment on lipid accumulation under normoxic and 
hypoxic conditions  
The effect of hypoxia and insulin treatment on lipid accumulation was measured in 
mature 3T3-L1 adipocytes (Figure 5.4). In the untreated control groups, hypoxia 
resulted in a significant increase in lipid content compared to the normoxic condition. 
However, after 8 hrs insulin treatment under normoxic conditions, lipid content was 
significantly reduced in response to the medium- [175 nM], but not the high- [1 µM] 
insulin concentration. This effect was exacerbated in the hypoxic condition where 
insulin treatment reduced lipid content in the medium- and high-insulin treatments 
(condition x treatment interaction, p < 0.001). 
5.4  DISCUSSION 
The aim of this study was to determine the effects of chronic insulin treatment in 
normoxic (21% O2) vs. hypoxic (5% O2) conditions on the expression of HIF-1α and 
ECM components in differentiated 3T3-L1 adipocytes. The main findings of this study 
were that chronic high insulin and hypoxia treatment significantly elevated HIF-1α 




Figure 5.3 HIF-1α, Col5a1 and COL6a1 mRNA and protein expression in hypoxia and insulin treated 3T3-L1 adipocytes. 
The mRNA and protein levels for HIF-1α (A and B), COL5A1 (C and D) and COL6A1 (E and F) were measured in mature 3T3-
L1 adipocytes in control, medium [175 nM] and high [1 µM] insulin treatments under normoxic (21% O2) and hypoxic (5% O2) 
conditions. Values are mean ± SD. mRNA expression relative to internal control genes and expressed in arbitrary units (AU). 
Protein expression relative to internal control, β-Actin. Results are representative of three independent experiments. Bars with 
different letters denote statistical differences between results (p<0.05). 
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hypoxia but not insulin treatment was associated with higher COL5A1 and COL6A1 
protein- but not mRNA expression. Further, exposure of adipocytes to 8 hrs insulin 
treatment resulted in significantly reduced lipid staining and the effect was 
exacerbated in the hypoxic- compared to the normoxic condition. 
Cellular adaptation to hypoxia is accomplished through the activation of an array of 
oxygen-sensing transcription factors, including HIF-1α 303, 304. Under normoxic 
conditions, HIF-1α is targeted for proteasomal destruction by proline hydroxylation by 
an E3 ubiquitin ligase complex containing the von Hippel-Lindau tumour suppressor  
protein (pVHL) 306. During hypoxic conditions, the lack of molecular oxygen, an 
absolute requirement for HIF-1α hydroxylation, results in increased HIF-1α protein 
accumulation. Accordingly, the association between hypoxia treatment and higher 
HIF-1 α protein accumulation observed in this study is in line with this oxygen-sensing 
 
Figure 5.4 The effect of 8 hrs insulin treatment on lipid content in mature 3T3-L1 adipocytes under normoxic 
and hypoxic conditions. 
Adipocytes were subjected to control, medium [175 nM] and high [1 µM] insulin treatments under normoxic and hypoxic 
conditions. Lipid was stained with Oil-Red O, and the intensity of the extracted stain was measured at 570 nm and 
results were normalized to cell density, as measured by crystal violet staining. Values are mean ± SD. Bars with different 
letters denote statistical differences between results (p<0.05). 
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function of the HIF-1 α protein- a finding also reflected in other studies in 3T3-L1 
adipocytes 294, 315, 370, 382. In contrast to the well-characterised post-transcriptional 
regulation of HIF-1α protein in response to hypoxia, the regulation of HIF-1α mRNA 
during low oxygen levels remain controversial and unexplored. Several studies 357, 372, 
386, 387, but not all 294, 307, 352, 370, 388, 389, report no change of HIF-1α mRNA in response 
to hypoxia in vitro. In this study, the expression of HIF-1α mRNA levels was higher in 
the hypoxic vs normoxic condition. Notably, increased HIF-1α mRNA expression in 
adipose tissue has been implicated as a consequence of a high fat diet (HFD)357 and 
has also been associated with its related metabolic abnormalities. Specifically, in 
human 301, 390 and rodent 310, 370, 372, 391 models, increased HIF-1α mRNA expression in 
adipose tissue has been associated with reduced adipose tissue PO2, increased BMI, 
increased macrophage infiltration, insulin resistance and the development of adipose 
tissue fibrosis. Moreover, higher HIF-1α mRNA expression has been demonstrated to 
have relevant implications in adipose tissue metabolism (Chapter 3 and 4) 301, 310, 370, 
372, 390, 391 although the effect of these remain largely uninvestigated.  
Although HIF-1α expression has mostly been investigated for its functions in the 
cellular response to tissue hypoxia, results from this study demonstrated a strong 
induction of HIF-1α mRNA expression with medium [175 nM] and high [1 µM] insulin 
treatment in the absence of hypoxia. Similar results have previously been noted in 
3T3-L1 adipocytes where 100 nM insulin treatment significantly elevated HIF-1α 
mRNA expression within 4 hrs after treatment 372 but the physiological significance of 
this insulin‐induced HIF-1α mRNA expression has not yet been investigated. 
Surprisingly, although HIF-1α (mRNA and protein) expression was increased by both 
insulin treatment and during exposure to hypoxia (5% O2), duel treatment did not result 
in an additive effect. Therefore, these findings imply that the induction of HIF-1α 
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through insulin and hypoxia exposure may result from two different pathways. 
Interestingly, recent evidence has indicated that certain growth factors such as insulin 
and IGF-1 may induce the transcriptional activity of HIF-1α in the absence of tissue 
hypoxia 380. Insulin induces the expression of genes containing the hypoxia response 
element (HRE) by formation of a HIF-1α /ARNT complex 380. These HRE occurs in the 
3’ regions of genes that regulate glycolytic metabolism such as glucose transporters 
(Glut1 and Glut3), several glycolytic enzymes in addition to genes such as 
erythropoietin (EPO) and vascular endothelial growth factor (VEGFα) which aim to 
restore tissue oxygen levels 380, 392-394. It may be hypothesised that the link between 
insulin signalling and its activation of gene transcription through HRE represents an 
evolutionary adaptive response 312 to enhance glucose utilization through the glycolytic 
pathway rather than producing ATP through the oxygen dependent β-oxidation in 
order to reduce adipocyte O2 consumption. In support, it was recently demonstrated 
that early in the course of high-fat diet (HFD) feeding and obesity, adipocyte respiration 
becomes uncoupled, leading to increased oxygen consumption and a state of relative 
adipocyte hypoxia 357. Under these circumstances, insulin may induce HIF-1α 
transcriptional activity through HRE aimed at inducing glycolysis and thereby lower 
oxygen utilization by the adipocytes.  
It has been suggested that hypoxia in adipose tissue may represent the driving 
phenomenon behind the development of fibrosis. Interestingly, Col5a1 and Col6a1 
mRNA levels were slightly decreased or unchanged in response to hypoxia vs. 
normoxia, while COL5A1 and COL6A1 protein expression were significantly 
increased. Discordant mRNA and protein expression has also been observed in other 
studies 395, 396. It may be suggested that differences in COL5A1 and COL6A1 protein 
and mRNA expression levels in this study reflect a time dependent mRNA response 
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where mRNA expression stabilized at a lower level after an initial increase. 
Nevertheless, several other studies suggest that hypoxia, through the induction of HIF-
1α protein, is a major initiator of excess ECM expression in adipose tissue and may 
underlie the development of inflammation and concomitant insulin resistance 307, 379, 
390. Conversely, genetic ablation of the HIF-1α protein through PX-478-treatment in a 
mouse model of obesity demonstrated a down-regulation of fibrillar collagens (and 
collagen type VI) and LOX (which plays an important role in collagen fibre formation) 
397. Although collagen type VI has been previously characterised for its effects during 
hypoxia 295, 323, no such reports have been found for collagen type V. Results from this 
study show that lower oxygen availability may result in higher levels of both type V and 
VI collagen expression in adipose tissue. Functionally, collagen type V has a structural 
role in collagen type I fibre diameter 237, 398. Collagen type I forms the major structural 
component of the interstitial ECM in adipose tissue and exists as a well organised and 
dense cobweb-like framework. In addition, adipocytes are also individually surrounded 
by a basement membrane 225. Collagen type VI has been shown to function as an 
anchor between the adipocyte basement membranes and interstitial ECM 399, 400. 
Taken together, these results demonstrate that hypoxia may result in alterations to the 
adipocyte microenvironment through altered collagen V and VI expression. 
Surprisingly, in this study insulin treatment did not result in changes to the expression 
of either COL5A1 and COL6A1 mRNA- or protein levels. These results are in contrast 
to a study done in 3T3-L1 adipocytes which demonstrated that insulin stimulates the 
gene expression of ECM processing enzymes and their regulators, such as the MMPs, 
but not the target ECM proteins themselves 376. This discrepancy may be explained 
by the longer duration of insulin treatment (48h) compared to 8hrs treatment as 
implemented in this study.  
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The main function of insulin in adipose tissue is to store energy in the form of 
triacylglycerol. However, increasing concentrations of insulin treatment reduced the 
lipid content in the 3T3-L1 cells (as measured by Oil-Red O staining) over 8 hrs 
incubation in both the hypoxic and normoxic conditions. MTT analysis indicated that 
the reduction in lipid content was not because of decreased cell-viability, but rather 
suggests an increase in lipolysis and/or an inhibition of lipogenesis. Insulin, a potent 
antilipolytic hormone 401 controls the accumulation of TG by inducing the expression 
of lipoprotein lipase (LPL) 151, 402 and inhibiting the activation of hormone sensitive 
lipase (HSL). However, chronic hyperinsulinemia, as opposed to its acute effects, has 
been shown to increase rather than decrease rates of lipolysis in vitro 403-406. Acute 
insulin treatment activates phosphodiesterase 3B, reduces cyclic adenosine 
monophosphate (cAMP) levels and quenches β-adrenergic receptor signalling 407. 
However, chronic insulin treatment amplifies cAMP production by downregulating β-
arrestin1 protein- a process that leads to lipolysis through cAMP production and 
enhanced protein kinase A (PKA) activation 408 and subsequent activation of HSL 405. 
In this study, the increased lipolytic effect of chronic (8 hrs) insulin as observed in the 
normoxic condition was further exacerbated by hypoxia exposure, resulting in a 
condition × treatment interaction effect. By using an HIF-1α inhibitor, digoxin, Zhao et 
al demonstrated a reduction in cAMP accumulation paired with suppression in PKA 
activity in hypoxic adipose tissue of HFD fed mice. These findings show an important 
inductive role for HIF-1α in lipolysis. These data may, in part, support why 
hyperinsulinemia may coexists with increased circulating nonesterified FFAs and 
increased adiposity in some obese and/or T2DM patients 409.  
Conversely, in absence of insulin treatment, TAG content was increased in hypoxic 
treatment (5% O2) compared to the normoxic condition. Hypoxia treatments in tissue 
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culture mostly range between 1% O2  and 2% O2 with 1% O2 the most widely employed 
O2 concentration in in vitro investigations 67. However, 5% O2 as used in this study 
may be more closely related to normal physiological O2 concentrations. For example, 
in obese mice, adipose tissue PO2 has been recorded to range between 15-22 mm 
Hg, which is equivalent to 3-5% O2 depending on the depot of measurement 294, while 
abdominal SAT in obese humans may range between 5-11% (23-84mmHg) 70, 309. In 
support, Weiszenstein et al.410, recently showed that adipocytes are sensitive to small 
changes in O2 concentration and that 3T3-L1 adipocytes cultured in 4% O2 not only 
had improved cell survival but also had increased triglyceride accumulation when 
compared to cells grown at 1% O2 or 20 % O2. This finding underscores the need to 
establish experimental protocols that more closely reflect human physiological ranges. 
As such, pH and temperature are tightly controlled to resemble physiological 
conditions in in vitro experiments. It stands to reason that the implementation of more 
physiological oxygen concentration ranges (4 - 6% O2,) as implemented in this study 
in contrast to the regularly implemented abnormal (1% O2) level of oxygen may provide 
more consistent results. Under these conditions, it may be hypothesised that the low 
oxygen condition (5% O2,) in obese adipose tissue may not be adequate to induce the 
proangiogenic response through VEGFα and pyruvate dehydrogenase kinase-1 
(PDK1) expression 312 as it is often reported from adipocyte- and tumour cell culture 
experiments conducted at 1% O2. In tumour biology, VEGFα expression in tumour 
cells 313 allows for vascular development and tumour expansion. However, in 
hypertrophic obese adipose tissue, even though HIF-1α protein increases, VEGFα 
does not increase 70, 294, 301, 307 and is rather accompanied by reduced capillary density 
116, 294.  
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Evaluation of hypoxia treatment on cell-survival duration in this study showed that 4 
hrs hypoxia treatment increased cell viability, which did not change after 8 and 12 hrs. 
When the effect of hypoxia and insulin was tested on the survival of these mature 3T3-
L1 adipocytes, it was found that both insulin stimulation and hypoxia treatment was 
able to increase cell survival compared to the untreated control. These results are in 
agreement with previously established functions of insulin on cell survival and anti-
apoptosis 411, 412. Notably, reduced cell survival and increased apoptosis have been 
described as hallmark effects of hypoxia treatment in some earlier studies 294, 310, 386 
but not all 315, 382. This discrepancy may be explained by differences in cell culture O2 
concentrations. In conclusion, the aim of this study was to determine the effects of 
insulin on HIF-1α, Col5a1 and Col6a1 mRNA and protein expression in 3T3-L1 
adipocytes and to determine whether these effects may be different under hypoxic vs. 
normoxic conditions. It was demonstrated that insulin was able to induce HIF-1α- but 
not COL5A1 or COL6A1, mRNA and protein expression in the absence of hypoxia and 
that co-treatment did not result in an additive effect. Chronic hyperinsulinemia is 
characteristic of insulin resistance and the metabolic syndrome. Assuming that these 
in-vitro findings may be generalised, it is tempting to speculate that the expansion 
capacity of adipose tissue is reduced by i) hypoxia induced alterations to the 
pericellular basement membranes by induction of ECM expression around the 
adipocytes resulting in mechanical stress-induced inflammation and  ii) by the 
exacerbation of the lipolytic effect of chronic hyperinsulinemia under hypoxic 





CHAPTER SIX  
ASSOCIATIONS BETWEEN COL5A1 AND COL6A1 GENE 
POLYMORPHISMS AND MEASURES OF BODY COMPOSITION AND 
INSULIN SENSITIVITY IN BLACK AND WHITE SOUTH AFRICAN WOMEN 
6.1 INTRODUCTION 
In this thesis (Chapter 2) and research from others 65, 366, it is argued that the excess 
generation and deposition of ECM components during excessive adipose tissue 
expansion in obesity may represent a mechanical limitation to adipose tissue 
expandability. However, factors which trigger the dysregulated ECM response that 
may lead to reduced adipose tissue insulin sensitivity are not known. As a structural 
tissue, adipose tissue protects organs and muscles from mechanical- and sheer 
stresses that are generated through movement. Similar to other connective tissues 
such as ligaments, tendons, fascia and bone 257, repeated mechanical loading may 
also result in alterations to the cellular components and ECM composition which would 
affect adipocyte physiology and metabolism in itself. Specifically, increasing adipose 
tissue mass during the development of obesity is indeed characterised by altered ECM 
expression and increased M1-activated macrophage infiltration (section 2.4.3).  
The expression/remodelling of structural proteins in soft connective tissues are 
regulated by signalling cascades in response to external stimuli such as repetitive 
mechanical loading and is often reported as a risk factor for soft tissue injuries 257 such 
as those that occur during sporting activities that involve sudden deceleration or 
change in direction 262. Although the mechanisms of these overuse injuries are poorly 
COL5A1 and COL6A1 SNP’s & IR 
113 
understood, the expression of collagens, proteoglycans and/or glycoprotein content 
have been demonstrated to be altered in tendinopathy and ligament injuries 248. The 
degenerative fibrotic changes in tendinopathy is suggested to be preceded by a 
chronic inflammatory state. 413, 414. 
Results from previous population studies published online in the NCBI database have 
shown significant differences in COL5A1 (rs12722) and COL6A1 rs35796750 allele 
frequencies between Europeans and populations of African or East Asian descent. 
The ancestral C- allele and the minor T- allele of the COL5A1 (rs12722) were reported 
to be equally distributed (45%-55%) in European populations whilst in the African and 
Asian populations, the C- allele was found to be more frequent (77% and 86%, 
respectively) than the T- allele (14 and 22%, respectively). In Europeans and East 
Asian populations, the T- allele of COL6A1 rs35796750 was more frequent than the 
C- allele (60% and 72%, respectively) whilst in the African populations, the C- allele 
was more frequent that the T- allele (67% vs 33%). (www.ncbi.nlm.nih.gov, accessed 
April 2017). 
Although these polymorphisms and their associated risk factors have been extensively 
studied for their associations with increased risk for developing soft tissue injury, to 
my knowledge, no such studies have been undertaken to determine whether 
associations exist between these polymorphisms and measures of adipose tissue fat 
mass and its distribution and/or insulin resistance that may be implicated in the risk of 
T2DM and cardiovascular disease. Given the similarities of ECM expression in 
adipose- and other soft connective tissues during their respective adaptive responses 
to mechanical stresses and the functional relevance of these two polymorphisms on 
the development of connective tissue diseases, it is hypothesised that the COL5A1 
rs12722 and COL6A1 rs35796750 polymorphisms are associated with differences in 
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body fat mass and its distribution in black and white women, and consequently their 
differences in risk for insulin resistance. Thus, the aims of this study are to i) examine 
differences in the frequencies of the rs12722 polymorphism within the COL5A1 gene 
and the rs35796750 polymorphism within the COL6A1 gene between black and white 
South African women, and to ii) examine the ethnic-specific associations with body fat, 
its distribution and insulin resistance. 
6.2 MATERIALS AND METHODS 
6.2.1 Participants 
A sample of 229 black and 188 white apparently healthy premenopausal South African 
women between the ages of 18 to 49 years were recruited from community centres, 
universities and church groups. Inclusion criteria were: no previous diagnosis of, or 
not taking chronic medication for T2DM, hypertension, HIV, or other metabolic 
diseases; and not currently pregnant or lactating. Ethics approval was obtained from 
the Human Research Ethics Committee of the Faculty of Health Science at the 
University of Cape Town and written informed consent was obtained from all 
participants prior to testing.  
6.2.2 Testing procedures 
 Body composition assessment 
All testing procedures, including assessment of body composition (BMI and DXA) and 
body fat distribution (waist circumference and CT) have been described in Chapter 3.  
 Insulin resistance (IR)  
Blood samples were collected after an overnight fast for determination of fasting 
plasma glucose and serum insulin concentration as described in Chapter 3. These 
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values were used to estimate homeostatic model of assessment of insulin resistance 
(HOMA-IR) using an online computer model available from 
(http://www.dtu.ox.ac.uk/homacalculator/) 415. For simplicity, this thesis uses the term 
HOMA-IR as a proxy for the frequently used term “HOMA2-IR” (which is mainly used 
to differentiate this algorithmically-adjusted estimation of insulin resistance from its 
predecessor, HOMA1-IR 415).  
6.2.3 Genotyping Analysis 
The two polymorphisms (COL5A1 rs12722 and COL6A1 rs35796750) were selected 
based on their functional relevance in soft tissue injuries 272, 277, position in and around 
the gene and usage in previous studies 269, 416, 417. COL5A1 rs12722, (C/T) BstU1 
restriction fragment length polymorphism (RFLP) within the COL5A1 3′-UTR was 
polymerase chain reaction (PCR) amplified according to a method described by 
Greenspan and Pasquinelli 418 and modified by Mokone et al.267. Each PCR reaction 
was performed in a final volume of 60 µl containing at least 100 ng DNA, 20 pmol of 
each primer (forward, 5’- GAA GAC GTT TCT GGA GGA TC-3’ and reverse, 5’-GAA 
GGC ACC TGC AGA ATG AC-3’), 20 mM Tris-HCl (pH8.4), 50 mM KCl, 1.5 mM 
MgCl2, 0.2 mM of each dNTP (dATP, dTTP, dCTP and dGTP), and 2.5 units of Taq 
polymerase (New England Biolabs, Ipswitch, Massachusetts, USA). PCR conditions 
were as follows: 3 min initial denaturing step at 94˚C followed by 35 cycles of 1 min 
denaturing at 94˚C, 1 min annealing at 53˚C and 1.5 min extension of the strand at 
72˚C, and the final extension step for 8 min at 72˚C (Thermal cycler, Hybaid, PCR 
Express, Middlesex, UK). The 667-bp PCR products were digested with the restriction 
endonucleases BstUI, to produce 351-bp and 316-bp fragments for the T- allele and 
316-bp and 271-bp and 80-bp fragments for the C- allele (Figure 6.1 A). The resultant 
fragments were separated on 6 % non-denaturing poly-acrylamide gels, together with 
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a 100-bp molecular weight marker, and were visualized under UV light with Ethidium 
Bromide nucleic acid gel stain. COL6A1 rs35796750 (C/T) was genotyped using 
custom designed Fluorescence-based Taqman® PCR assay probes and flanking 
primer sets (Assay ID: AH89JPA, Applied Biosystems, Foster City, CA, USA), and 
used along with a pre-made PCR mastermix containing ampliTaq® DNA polymerase 
Gold (Applied Biosystems, Foster City, CA, USA) in a final reaction volume of 8 µl. 
The PCR conditions were as follows: a 10 min heat activation step at 92ºC followed  
by 40 cycles of 15 sec at 92ºC and 1 min at 60ºC. The PCR reactions were performed 
on an Applied Biosystems StepOne Plus™ Real-Time PCR system (Life technologies, 
Applied Biosystems, Foster City, CA, USA), using the Applied Biosystems 
StepOnePlus™ Real-Time PCR software Version 2.1 (Applied Biosystems, Foster 
City, CA, USA) (Figure 6.1 B).  
 
Figure 6.1Genotyping COL5A1 rs12722 and COL6A1 rs35796750. 
Typical representation of A) 6% non-denaturing poly-acrylamide gel showing the genotypes of COL5A1 BstU1 RFLP. 
Digestion of the 667-bp PCR product with BstU1produced 351-bp and 316-bp fragments for the T-allele and 316-bp and 
271-bp and 80-bp fragments for the C-allele. Left lane contains the 100-bp molecular weight marker (MW) with appropriate 
fragment sizes indicated. The second lane contains the 667-bp uncut (UC) fragment, followed by CC-, TC-and TT-
genotypes in the lanes thereafter and B) Allelic discrimination plot using Taqman® genotyping assay for COL6A1 
rs35796750 (C/T) on the StepOnePlus™ Real-time PCR system 
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6.2.4 Statistical Analysis 
Values are presented as median and inter-quartile range. Where appropriate, skewed 
data (VAT (cm2), total SAT (cm2), SSAT, fasted insulin and HOMA-IR) were log 
transformed. Normal data are presented as mean and SD and non-normal data as 
median and interquartile range. If a parametric test was performed with non-normally 
distributed variables, Levene’s test of variation was used to determine homogeneity of 
continuous data. Chi-squared (𝜒2) tests were used to determine significant differences 
in genotype and allele frequency distributions between black and white women. In 
order to determine whether body fat mass, fat distribution and measures of fasting 
glycaemia by genotype/allele categories were different in black and white women, a 
two-way ANCOVA was performed that included an ethnicity ˟ genotype interaction 
term, adjusting for age (or age and fat mass), with Fisher least significant difference 
(LSD) post hoc analysis. In order to determine statistical power, post hoc power 
calculations were conducted in black and white women to determine the power to 
detect a significant interaction term between genotype and ethnicity on HOMA-IR. This 
was conducted for both COL5A1 rs12722- and COL6A1 rs35796750 polymorphisms 
using G*Power software V.1.2.4 ((http://www. gpower.hhu.de/) using an alpha of 0.05 
and effect size (Cohen’s𝑓2) 419 of 0.32-0.65 (HOMA-IR), and a sample size of 117-196 
(Supplementary Table 6.1. 1). Based on these calculations, the sample size of used 
in this study was found to have 99.9 % power to detect a significant interaction 
between genotype and ethnicity on HOMA-IR values. Tests for Hardy-Weinberg 
proportions (HWE) were performed using Gene-POP web version 4.0.10. 
(http://genepop.curtin.edu.au/). Data were analysed using STATISTICA version 13 
(Statsoft Inc., Tulsa OK, USA) and GraphPad Prism (version 5, GraphPad Software, 




6.3.1 Participant characteristics  
Body composition and fasting glycaemia in black and white women are shown in Table 
6.1. Black women were significantly younger, had a higher BMI and body fat mass (kg 
and %). However, as a percentage of total fat mass (%fm), black women had less 
central fat mass (%fm) but greater leg fat mass (%fm) compared to white women. 
Black women had greater total SAT (cm2) and SSAT, but similar DSAT (cm2) and VAT 
(cm2) compared to the white women. However, when adjusting for differences in total 
fat mass (kg) between black and white women, VAT (cm2) and DSAT (cm2) were lower 
and SSAT (cm2) was higher in the black women but total SAT (cm2) was similar 
between ethnicities.  
Black women had lower fasting glucose, higher fasting insulin but similar HOMA-IR 
values compared to the white women independent of differences in body fat mass 
between black and white women.  
6.3.2 Genotype distribution and allele frequency of COL5A1 rs12722 and 
COL6A1 rs35796750 polymorphisms in black and white women  
There were significant differences in the genotype distributions and allele frequencies 
between black and white women for the COL5A1 rs12722 and COL6A1 rs35796750 
polymorphisms (Figure 6.2). Specifically, the T- allele for COL5A1 rs12722 was 
significantly more frequent in white compared to black women (44% vs 13%, 
respectively). Accordingly, the genotype distribution for COL5A1 rs12722 in white 
women (CC- genotype 35%, TC- genotype 42% and TT- genotype 23%) was 
significantly different to the genotype distribution of the black women (CC- genotype 
76%, TC- genotype 22% and TT- genotype 2% ) (black vs white, 𝜒2=71.88, p<0.001). 
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Because of the rarity of the TT- genotype in the COL5A1 rs12722 polymorphism in 
black women (2%), the TT- and TC- genotypes, were combined in all subsequent 
analysis. 
The frequency of the T- allele of COL6A1 rs35796750 was higher in the white women 
compared to the black women (59% vs 30%, respectively). Genotype distribution for 
COL6A1 rs35796750 in white women (CC- genotype 20%, TC- genotype 43% and 
TT- genotype 37%) was significantly different to the genotype distribution of the black 
women (CC- genotype 49%, TC- genotype 41% and TT- genotype 10%) (black vs. 
white, 𝜒2 =59.07, p<0.001). The genotype distributions were in Hardy-Weinberg 
equilibrium for COL5A1 rs12722 (HWE, p=0.49 and p=1.00) and COL6A1 rs35796750 
Table 6.1 Participant characteristics of white and black women 
 White Black 
 
  n  n  p-value 
Age (years) 188 31.7 ± 8 229 27.3 ± 7.5 <0.001 
Body composition     a p-value 
BMI (kg/m2) 186 27.8 ± 6.6 226 30.2 ± 8.1 <0.001 
Waist (cm) 186 90.1 ± 15.1 225 90 ± 18.2 0.073 
Body fat mass (%) 185 35.5 ± 8.8 210 38.7 ± 8.9 <0.001 
Central fat mass (%fm) 185 47.8 ± 5.3 210 43.6 ± 5.3 <0.001 
Leg fat mass (%fm) 185 41.2 ± 6 210 45.8 ± 6.5 <0.001 
VAT (cm2)  114 80.4 (60 - 124) 135 66.0 (45 - 102) 0.142 
Total SAT (cm²) 110 290.8 (180 - 455) 132 340.7 (182 - 554) 0.002 
SSAT (cm²) 140 145.0 (86 - 235) 166 216.4 (117 - 320) <0.001 
DSAT (cm²) 140 155.0 ± 93.6 166 165.2 ± 114.3 0.112 
Fasting glycaemia      
b p-value 
Fasting glucose (mmol/l) 173 4.7 ± 0.4 212 4.4 ± 0.5 <0.001 
Fasting Insulin (mU/l) 174 6.9 (5.1 - 10.5) 217 8.6 (5.0 – 15.6) 0.003 
HOMA-IR 173 0.9 (0.6 - 1.3) 213 1.0 (0.6 - 1.7) 0.532 
Values are mean ± SD or median (interquartile range).  a p-values for body composition valuables adjusted for age; b p-
values for fasting glucose, fasting insulin and HOMA-IR are adjusted for age and body fat mass (kg). BMI, body mass 
index; DSAT deep subcutaneous adipose tissue; SSAT, superficial subcutaneous adipose tissue; VAT, visceral adipose 




(HWE, p=0.73 and p=0.35) polymorphisms, in both black and white women, 
respectively. 
6.3.3 Differences in body composition and fat distribution and fasting glycaemia 
in COL5A1 rs12722 and COL6A1 rs35796750 polymorphisms in black and 
white women 
When body fatness and body composition measures were compared between CC- 
and TC + TT genotype groups of the COL5A1 rs12722 polymorphism in black and 
white women (Table 6.2), participants with the T- allele had a lower BMI, lower body 
fat mass (kg) and less central fat mass characterised by smaller waist circumference 
(cm2), central fat mass (%fm), VAT and DSAT, compared to those in the CC- 
genotype, irrespective of ethnicity (allele effect, p< 0.05). Differences in waist 
circumference and VAT mass between CC- and TC + TT genotype groups were 
independent of differences in body fat mass in both black and white women. In 
addition, participants carrying the T- allele had lower insulin resistance, characterised 
by lower HOMA-IR and fasting insulin concentrations, but similar fasting glucose 
concentrations (allele effect, p< 0.05). These relationships remained significant after 
adjusting for differences in body fat mass. 
Post-hoc tests indicated that waist circumference (cm) and VAT (cm2) was significantly 
different between CC- and TC + TT groups in both the black and white women, 
whereas fasted insulin levels and HOMA-IR were lower in the TC + TT group of the 
white women only. Despite ethnic differences in body fatness and body fat distribution 
and genotype/allele frequencies between black and white women, the associations 
between genotype and body comp or HOMA-IR did not differ by ethnicity (no genotype 
x ethnicity interactions). 
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There were no significant associations between COL6A1 rs35796750 and any of the 
body fat mass or body fat mass distribution parameters or measures of fasting 
glycaemia or insulin resistance in black and white women (Table 6.3).  
 
Figure 6.2 Genotype distribution and allele frequency of COL5A1 (rs12722) and COL6A1 (rs35796750) polymorphisms 
in black and white women. 
Top: genotype distributions A) and allele frequencies B) of COL5A1 rs12722 (C/T) polymorphisms in black and white women. 
Because of the small sample size of the TT-genotype in the black women, the CC-genotype was compared with the combined 
CT- and TT- genotype groups in subsequent analyses. Bottom: Genotype distributions C) and allele frequencies D) of 
COL6A1 rs35796750 (C/T) polymorphisms in black and white women. The number of participants in each group is indicated. 




Table 6.2 Body composition and fasting glycaemia according to COL5A1 rs12722 C/T genotype in black and white women 
 
 White women Black women    
  CC  CT+TT  CC  CT+TT p-value 
 n  n  n  n  Genotype Ethnicity G ˟ E 
Age (years) 42 30 ± 8.4 79 31.5 ± 7.3 115 24 (21 - 31) 37 24 (21 - 28) 0.81 <0.01 0.19 
Body composition a p-value  
BMI (kg/m2) 42 29 ± 7.2 79 26.8 ± 5.6 113 30.3 ± 8.2 37 27.8 ± 6.8 0.01 0.01 0.77 
Waist (cm) 42 93.1 ± 16.5 79 87.8 ± 13* 112 91.3 ± 19.5 37 84.4 ± 15.7* <0.01 0.88 0.93 
Body fm (%) 42 37.5 ± 9.3 79 35 ± 8.7 105 38.7 ± 8.9 36 36.9 ± 7.9 0.06 0.02 0.55 
Body fm (kg) 42 30.9 ± 13.7 79 27.1 ± 12.3 105 30.9 ± 14.6 36 26.6 ± 12.1 0.02 0.27 0.88 
Central fm (%fm) 42 47.9 ± 5.8 79 46.8 ± 4.9 105 44.1 ± 5.4 36 42.6 ± 4.4 0.05 <0.01 0.95 
Leg fm (%fm) 42 41.1 ± 5.9 79 42.4 ± 5.7 105 45.5 ± 6.6 36 46.6 ± 5.7 0.10 <0.01 0.62 
VAT (cm2) 30 88.0 (58 - 153) 51 77.2 (57 - 104) * 72 67.8 (52 - 102) 28 57.0 (42 - 77)* 0.02 0.13 0.55 
Tot SAT (cm²) 30 313.0 (180 - 535) 49 297.0 (174 - 404) 69 380.8 (159 - 588) 28 325.7 (178 - 542) 0.26 0.05 0.59 
SSAT (cm²) 37 182.0 (90 - 270) 63 152.3 (77 - 216) 90 230.8 (118 - 327) 29 145.5 (108 - 300) 0.22 <0.01 0.48 
DSAT (cm²) 37 170.9 ± 106.5 63 144.8 ± 81.7 90 175.9 ± 118.5 29 135.6 ± 89.5 0.02 0.42 0.83 
Fasting glycaemia b p-value  
Glucose (mmol/l) 42 4.7 ± 0.4 75 4.6 ± 0.3 114 4.4 ± 0.5 35 4.4 ± 0.5 0.90 <0.01 0.25 
Insulin (mU/l) 42 10.1 (5.6 – 18.0) 75 6.3 (4.9 – 8.4) * 114 9.9 (5.4 – 16.9) 37 8.4 (5.1 – 12.7) 0.01 0.05 0.25 
HOMA-IR 42 1.2 (0.7 – 2.1) 75 0.8 (0.7 - 1.2) * 114 1.1 (0.6 - 1.8) 35 1.0 (0.6 - 1.3) 0.01 0.87 0.13 
Values are mean ± SD or median (interquartile range); a p-values for body composition valuables adjusted for age; b p-values for fasting glucose, fasting insulin and HOMA-
IR are adjusted for age and body fat mass (kg). DSAT, deep subcutaneous adipose tissue; SSAT, superficial subcutaneous adipose issue; VAT, visceral adipose tissue; % 





Table 6.3 Body composition and fasting glycaemia according to COL6A1 rs35796750 T/C genotype in black and white women 
 White women Black women  
  CC  CT  TT  CC  CT  TT p-value 
 n  n  n  n  n  n  Genotype Ethnicity G ˟E 
Age (years) 36 29.3 ± 6.5 76 32.8 ± 8.7 67 32 ± 7.8 104 27.8 ± 7.6 88 27.4 ± 7.8 20 25.4 ± 6.7 0.20 <0.01 0.06 
Body composition a p-value  
BMI (kg/m2) 36 28.5 ± 7.6 75 27.8 ± 6.3 66 27 ± 6.2 103 30.9 ± 7.8 87 29.9 ± 8.2 20 28.8 ± 8.7 0.19 <0.01 0.84 
Waist (cm) 36 90.4 ± 16.9 75 90.7 ± 15.3 66 88.8 ± 14 102 91.3 ± 16.5 87 88.6 ± 17.9 20 90 ± 24 0.52 0.11 0.66 
Body fm (%) 36 36.4 ± 9.6 75 35.3 ± 8.7 65 34.8 ± 8.5 96 39.9 ± 8.1 79 38.1 ± 9.1 18 35.4 ± 11.1 0.08 <0.01 0.86 
Cent fm (%fm) 36 30.3 ± 15.3 75 28.1 ± 12.5 65 27 ± 12.4 96 32.4 ± 14.2 79 29.9 ± 14.7 18 27.3 ± 17.1 0.90 <0.01 0.22 
Leg fm (%) 36 46.7 ± 4.8 75 48.6 ± 5.8 65 47.6 ± 4.7 96 44.1 ± 5 79 43.0 ± 5.4 18 42.4 ± 6 0.67 <0.01 0.13 
VAT (cm2) 15 75.7 (61 - 104) 49 90.2 (61 - 146) 45 82.8 (59 - 111) 63 70.2 (48 - 90) 52 61.0 (44 - 94) 10 59.9 (41 - 80) 0.56 0.03 0.22 
Tot SAT (cm²) 15 372.1 (196 - 497) 49 333.2 (167 - 450) 44 264.4 (182 - 423) 61 339.6 (190 - 560) 52 395.7 (192 - 549) 10 208.0 (144 - 517) 0.54 0.12 0.63 
SSAT (cm²) 26 182.1 (93 - 290) 55 152.3 (83 - 230) 53 143.6 (79 - 238) 78 200.9 (120 - 309) 63 258.1 (120 - 337) 15 136.5 (87 - 322) 0.51 <0.01 0.18 
DSAT (cm²) 26 161.8 ± 95.8 55 162.1 ± 100.6 53 145.7 ± 86.8 78 161.4 ± 102.6 63 173.5 ± 117.1 15 153.2 ± 150.8 0.72 0.11 0.59 
Fasting glycaemia b p-value  
Glucose (mmol/l) 35 4.6 ± 0.3 68 4.7 ± 0.4 63 4.6 ± 0.3 97 4.4 ± 0.5 80 4.4 ± 0.5 19 4.3 ± 0.4 0.11 <0.01 0.36 
Insulin (mU/l) 35 6.2 (4.2 - 10.5) 68 7.3 (5.6 - 11.1) 64 6.4 (4.5 - 11.6) 100 9.3 (5.0 - 16.0) 82 8.0 (5.0 - 15.5) 19 7.2 (5.2 - 15.3) 0.72 0.23 0.08 
HOMA-IR 35 0.8 (0.5 - 1.3) 68 0.9 (0.7 - 1.4) 63 0.8 (0.6 - 1.5) 96 1.2 (0.6 - 1.8) 81 0.9 (0.6 - 1.7) 19 0.8 (0.6 - 1.3) 0.31 0.47 0.06 
Values are mean ± SD or median (interquartile range).  a p-values for body composition valuables adjusted for age; b p-values for fasting glucose, fasting insulin and HOMA-IR are adjusted for age 
and body fat mass (kg). DSAT deep subcutaneous adipose tissue; SSAT, superficial subcutaneous adipose issue; VAT, visceral adipose tissue; % fm, a percentage of fat mass, HOMA-IR, homeostatic 
model of assessment of insulin resistance. *, p < 0.05 for post-hoc analysis. 
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6.4 DISCUSSION 
The main findings were that although allele and genotype distributions of the COL5A1 
rs12722 polymorphism, as well as body fat distribution were significantly different 
between black and white women, the T- variant of the COL5A1 rs12722 polymorphism 
was associated with significantly less central fat mass, characterised by a smaller 
waist circumference and lower VAT, and this effect was independent of ethnicity and 
overall body fat mass. In addition, T- variant of the COL5A1 rs12722 polymorphism 
was associated with lower fasted insulin concentrations and HOMA-IR in white but not 
in black women. In contrast, no genotype associations between COL6A1 rs35796750 
and any of the body fat mass, its distribution and insulin resistance measures in black 
or white women were reported. 
Numerous studies have investigated COL5A1 rs12722 for its role in musculoskeletal 
soft tissue pathologies including Achilles Tendinopathy (AT) 267, 268, carpal tunnel 
syndrome (CTS) 258 and exercise associated muscle cramping 420, where the T-allele 
has been associated with higher risk of developing these conditions. This COL5A1 3′ 
UTR rs12722 polymorphism, among others within this region 421, has been 
hypothesised to alter COL5A1 mRNA stability and thereby lead to increased α1 (V) 
chain production and by implication, type V collagen accumulation 272. As collagen 
type V regulates fibril diameter and packing density of collagen type I and III 422, it is 
reasonable to assume that this polymorphism may alter the mechanical properties of 
the connective tissues it functions in. Indeed, patients with cEDS have mutations within 
the COL5A1 gene that lead to significantly reduced type V collagen content in 
connective tissues and present with structural tendon pathology and low tendon 
stiffness 423. Conversely, individuals who carry the COL5A1 rs12722 TT- genotype and 
present with a higher incidence of tendon pathology and increased injury risk, have 
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higher connective tissue stiffness compared to individuals who carry at least one copy 
of the C- allele 422. Although an exact mechanism whereby increased type V collagen 
may influence adipose tissue metabolism has not been identified, it could be 
hypothesised that the T- allele of COL5A1 rs12722 polymorphism that associates with 
increased tensile strength of the collagen network in tendons and ligaments, may 
represent a mechanical limitation to adipose tissue expandability with a commensurate 
effect on body fat distribution. As each adipocyte is surrounded by a pericellular 
basement membrane, it might also be reasonable to suggest that increased tensile 
strength of the basement-membrane collagen-components may limit the lipid storage 
capacity of the adipocyte itself, resulting in smaller, more insulin sensitive adipocytes 
distributed within the depot. As the results of this study show an association between 
TT +TG- genotype groups and a propensity for smaller waist circumference and a 
lower VAT compared to individuals with the CC-genotype, it may be hypothesised that 
the T- allele of the COL5A1 polymorphism may influence body fat distribution through 
limiting lipid storage capacity in VAT depot. In support of this finding, Minchin et al 
recently showed that VAT-specific increased collagen type V expression in Plexin 
D1(plxnd1)- deficient zebra-fish resulted in altered morphology of VAT adipocytes, 
leading to a reduced VAT:SAT ratio and better glucose tolerance 424. As type V 
collagens are expressed in differentiating adipocytes and have effects on hyperplasia 
246, these results suggest a role for COL5A1 in hyperplastic adipocyte morphology. 
According to the adipose tissue expansion capacity hypothesis 58, 59, the establishment 
of an ECM microenvironment conducive to adipocyte hyperplasia would provide 
protection against the negative consequences of adipocyte hypertrophy such as 
increased inflammatory response and the exacerbating effects on insulin resistance. 
Indeed, women with the T- allele of COL5A1 had lower insulin resistance independent 
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of differences in body fat mass. Surprisingly, the associations between COL5A1 
genotype measures of insulin sensitivity were significant only in the cohort of white 
women and suggests that other factors may also be involved. Conversely, this finding 
may also be explained by the rarity of the T- allele in the black women. Further studies 
that include higher TT-genotype representation in ethnically diverse populations are 
needed to test the hypothesis that alterations to the collagen-fibre mechanical 
properties, as a result of COL5A1 (rs12722) genotype, modulate body composition 
and insulin sensitivity. Further, the effects of ECM expression on pre-adipocyte 
hyperplasia and its relationship with adipose tissue fibrosis and the development of 
insulin resistance requires further investigation. 
As COL6A1 is also one of the major adipocyte secretary proteins, and sequence 
variation in this gene is associated with multiple multifactorial conditions, this study 
investigated whether genetic variation in the COL6A1 rs35796750 polymorphism may 
be associated with differences in body fat mass, its distribution and measures of 
fasting glycaemia in black and white South African women. In contrast to the COL5A1 
rs12722 polymorphism, there were no significant associations between COL6A1 
rs35796750 genotypes and body fat and its distribution or measures of fasting 
glycaemia in either black or white women. Results from Chapter 3 and 4 of this thesis 
demonstrated that COL6A1 expression in the gluteal depot of black women associated 
with obesity and their higher insulin resistance. Both glucose intolerance and high BMI 
have been shown to be significant risk factors for the development of OPLL in two 
distinct Japanese populations where previous genome wide linkage studies have 
identified a T→C substitution at intron 32 [-29] (rs35796750) in COL6A1 that occurs 
near the branch site of the intron as the most strongly associated with the development 
of OPLL 274 273, 276. These results indicate that the COL6A1 (rs35796750) 
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polymorphism may not have significant effects on the Collagen VI expression levels 
between black and white women. 
This novel study was the first to investigate the associations between COL5A1 and 
COL6A1 polymorphisms and body fat, its distribution and insulin resistance in black 
and white women. However, it is important to keep in mind that there are limitations to 
this study. Firstly, the use of a candidate gene approach, where only one 
polymorphism within each of COL5A1 and COL6A1 genes were investigated for their 
associations with body fat mass, its distribution and insulin resistance in South African 
women instead of a genome wide association approach (GWA) may represent a 
limitation to this study. However, GWA studies require large numbers, are expensive 
to undertake and may not cover all the regions of the genome. In addition, ethnic 
populations such as those of African descent have been shown to have differences in 
disease-allele frequency and linkage (LD) patterns, differences in phenotypic 
prevalence rates, differences in effect sizes and differences in rare variants compared 
to populations of European decent 425. Although candidate gene association studies 
have identified several diverse risk factors for the development of insulin resistance, 
limited data is available for black South Africans. Moreover, despite the strong 
phenotypic relevance of these two polymorphisms in connective tissue biology, to my 
knowledge, these polymorphisms have not been previously investigated for the effects 
on adipose tissue biology and its possible link with insulin resistance in populations of 
either African or European descent. However, the relationships identified in this study 
warrant further investigation in larger multi-ethnic cohorts. Another limitation of this 
study was that HOMA-IR was used to estimate insulin resistance. Although HOMA-IR 
has been shown to correlate with the hyperinsulinemic-euglycemic clamp, the gold 
standard for assessing insulin sensitivity in white populations, the association is less 
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robust in a black population 426, 427, and therefore the results must be interpreted with 
caution. A strength of the study is the state-of-the-art measures of body composition 
(DXA) and body fat distribution (CT), in particular for the measure of VAT.  
In conclusion, although no allele or genotype effects were identified for the COL6A1 
(rs35796750) polymorphism, this study has identified an association between the T-
allele of the COL5A1 rs12722 polymorphisms and lower central fat mass, in particular, 





CHAPTER SEVEN  
SUMMARY AND PERSPECTIVES 
7.1 OVERVIEW OF RESEARCH QUESTION AND FINDINGS 
The mechanisms underlying the higher prevalence of T2DM in black African women 
compared to white women are currently being examined. Studies in South Africa 22, 23 
and the USA 109 have shown that the prevalence of insulin resistance, a major risk 
factor for T2DM, is higher in black compared to white women. Increased insulin 
resistance in black women is associated with an appropriately greater insulin response 
to maintain normoglycaemia 57, 428. The resultant hyperinsulinaemia in these women 
are partly due to increased insulin secretion from β-cells and reduced hepatic insulin 
clearance 94 51, 405. This compensation to higher insulin resistance has been proposed 
as a potential protective mechanism whereby black Africans can conserve β-cell 
function during prolonged exposure to insulin resistance, although it does not protect 
them from T2DM 15. 
One of the major determinants of insulin resistance is the centralization of body fat, 
specifically, increased VAT or intra-abdominal adipose tissue, while the accumulation 
of peripheral adipose tissue (gluteal/femoral) is considered to be protective (section 
2.2). However, contrary to the prevailing hypothesis, black women have less VAT and 
more SAT but are more insulin resistant compared to their white counterparts 57, 104. 
Subsequently, studies have shown that the correlation of VAT with insulin resistance 
in black women was not as strong as that shown in white women but was more closely 
correlated with abdominal SAT, specifically the DSAT depot 23, 40, 104. Moreover, lower-
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body fat distribution in African women does not seem to confer similar protective 
effects as shown in larger cohorts of white women who have lower-body fat distribution 
47, 105. This suggests that the relationship between body fat distribution and the risk of 
insulin resistance may be ethnic-specific.  
Although the exact mechanisms are still unclear, an increasing amount of evidence is 
showing that the differential relationships of body fat mass, its distribution and 
systemic insulin resistance has its origin in adipose tissue biology. In order to identify 
putative mechanisms that may explain the different insulin resistance phenotypes 
described in black and white women, the notion of adipose tissue expandability in 
relation to a model of insulin sensitive vs insulin resistant adipose tissue expansion 
was proposed (section 2.5). This model incorporated three major factors that may 
influence an insulin resistant (left) or insulin sensitive (right) mode of adipose tissue 
expansion:  
(1) reduced adipogenic capacity (section 2.4.1), 
(2) insufficient and inappropriate vascularization (section 2.4.2) and  
(3) aberrant ECM remodelling (section 2.4.3).  
Impaired/reduced adipogenic capacity in adipose tissue results in the partitioning of 
excess lipid into existing adipocytes and consequently results in the development of 
enlarged, insulin resistant adipocytes 429. The increased cell diameter of hypertrophic 
adipocytes has been proposed to increase the distance that oxygen has to diffuse 
from the vasculature to distal adipocytes 221 resulting in clusters of adipocytes 
becoming relatively hypoxic 69. Adipocytes respond to hypoxia by increased 
production and stabilization of HIF-1α, a transcriptional activator of pro-angiogenic 
genes such as VEGFα, with the aim of inducing neovascularization in order to restore 
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oxygen delivery to the adipose tissue. During obesity, however, chronically increased 
HIF-1α in adipose tissue is associated with the increased expression and deposition 
of ECM and lower angiogenic gene expression 307. Adipose tissue fibrosis, through its 
mechanical constraints on adipocyte expansion, is one of the main triggers for the pro-
inflammatory response 69 and concomitant insulin resistance that characterizes 
adipose tissue of obese humans 71. Together, these factors constitute pathological 
SAT expansion, during which the development of metabolic defects in adipose tissue 
ultimately lead to higher systemic insulin resistance and higher risk of developing 
T2DM.  
It is not known whether the expression of hypoxia and ECM genes may be differently 
expressed in black and white women. Previous studies have mostly been undertaken 
in Caucasian/white populations in whom the significant associations between body fat 
distribution variables and risk of insulin resistance relate almost exclusively to the 
levels of VAT- rather that SAT accumulation. In this context, this thesis hypothesised 
that the increased peripheral insulin resistance in black women may be a consequence 
of dysregulated gluteal SAT expansion as a function of higher adipose tissue hypoxia 
signalling, dysregulated ECM remodelling and higher pro-inflammatory (M1) 
macrophage infiltration which ultimately results from a lower TAG storage capacity in 
this depot with a concomitant redistribution of fat to the central depots.  
Chapter 3 
The first study in this thesis examined the hypothesis that ethnic-specific associations 
exist between insulin sensitivity measures and measures of body composition and the 
expression of ECM- and hypoxia-related genes in the SAT of black and white South 
African women. In addition, higher insulin resistance in black women may be 
associated with their higher insulin resistance compared to their white counterparts. 
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Given the reduced adipogenic capacity and greater adipocyte size observed in the 
gluteal SAT depot of black compared to white women 105, it was proposed that the 
gluteal SAT of black women has greater expression of ECM- and hypoxia-related 
genes than white women. Further, it was proposed that the expression of these genes 
differ between gluteal and abdominal SAT and differentially associated with insulin 
sensitivity in black and white women. Therefore, the primary aims of this study were 
to compare depot-specific expression of ECM and matrix remodelling components and 
genes relating to the cellular hypoxia response in normal-weight and obese black and 
white women, and to examine the ethnic-specific associations between these genes 
and measures of insulin sensitivity and secretion. The main findings of this study were 
that obese black women had higher hypoxia and ECM related gene expression in the 
gluteal SAT depot compared to the white women. Further, the expression of these 
genes was associated with higher insulin resistance in black, but not white women. 
These results suggest that the gluteal depot of black women may be more hypoxic 
than abdominal SAT and SAT of white women, which associates with lower insulin 
sensitivity in black women. Further, a secondary aim of this study was to investigate 
ethnic- and depot-specific associations between the expression of hypoxia and ECM 
related genes and the expression of a panel of inflammatory genes. The expression 
of the hypoxia and ECM genes associated with inflammatory gene expression in both 
the gluteal and abdominal SAT depots of black women, whereas the expression of 
these genes associated with the inflammatory gene expression mostly in the 
abdominal SAT depot of white women. Based on these findings, this study may 
suggest that reduced adipogenic capacity in the gluteal depot of black women may 
result in increased adipocyte hypertrophy, adipose tissue hypoxia and increased HIF-
1α expression, which in turn induces a fibrotic and inflammatory response, rather than 
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a compensatory pro-angiogenic response. Only a few studies have investigated depot-
specific expression of hypoxia and ECM components and the associations with insulin 
resistance. To my knowledge, this is the first study to show that the expression of 
these gene and their associations with reduced insulin sensitivity might also be ethnic-
specific.  
Chapter 4 
Because of its distinct cellular and metabolic characteristics compared to abdominal 
SAT (i.e. lipid metabolism (Table 2.3), its adipo/cytokine production (Table 2.4) and 
structural composition (Table 2.5)), it has been proposed that the gluteal/femoral SAT 
depot may have a better long term lipid storage capacity and a weaker association 
with the development of systemic insulin resistance (section 2.3). However, during the 
development of obesity, adipose tissue hypoxia and increased fibrosis may influence 
body fat distribution patterns by lowering the storage capacity for excess lipid in the 
gluteal SAT depot with a resultant expansion of the abdominal fat depots (section 2.4). 
Based on the cross-sectional, ethnic-specific associations between hypoxia and ECM 
gene expression in the gluteal SAT depots and SI shown in the previous chapter, this 
study hypothesised that over time, higher hypoxia and ECM related gene expression 
would associate with higher central fat mass accumulation in black women and that 
the expression of these genes would be associated with changes in the measures of 
insulin sensitivity in black women but not in white women. Thus, this longitudinal study 
aimed to determine whether changes in body composition and insulin sensitivity 
variables over a 5 year follow-up period associated with variations in hypoxia and ECM 
related gene expression in the gluteal SAT of black and white women. While previous 
cross-sectional studies have shown that black women may have a more favourable 
body fat distribution pattern compared to white women, this study showed that over 
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time, weight gain in the black women associated with a relative redistribution of body 
fat from their gluteal/femoral region to the central depots, highlighting that black 
women may be equally at risk of the metabolic abnormalities associated with the 
centralization of body fat mass with increasing age and fat mass. Importantly, 
increased fat accumulation associated with higher PPARy mRNA expression in the 
gluteal depot in white women, but not black women. This finding supports our previous 
finding that gluteal SAT of black women may have a lower adipogenic and lipogenic 
response to weight gain compared to that of equally obese white women. Further, to 
my knowledge, this is the first study to show that the changes in mRNA expression 
levels of hypoxia- and fibrosis-related genes (HIF-1α, COL6A1 and LOX) correlated 
with changes in fasting plasma insulin concentrations and insulin secretion over time. 
From these results, it may be speculated that hyperinsulinaemia in black women may 
not simply be a consequence of increased insulin resistance but may also contribute 
to the exacerbation of insulin resistance during obesity development by inducing the 
expression of hypoxia- and fibrosis-related genes in adipose tissue. This notion, 
however, remains to be investigated. Moreover, in humans, changes to ECM 
expression in adipose tissue in response to changes in adipose tissue mass have only 
been investigated in response to extreme weight-loss interventions such as bariatric 
surgery or in response to short bouts of over- or under feeding (4 to 16 weeks). Less 
is known about the changes (if any) to structural components within adipose tissue 
after a period of free-living during which fluctuations in body fat mass and composition 
occur independent of an external intervention. In this study increased body fat mass 
associated with the reduced COL5A1 mRNA expression in black women, whereas 
increased central fat mass associated with higher COL5A1 expression in the white 
women. Previous research has shown that increased peri-adipocyte fibrosis 
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associated with less weight loss one year after bariatric surgery, and suggests that the 
ability to effectively remodel the ECM around the changing adipocyte diameter is 
essential for structural adaptation to changes in adipose tissue volume 327, 366 .  
Chapter 5 
Although the independent effects of hypoxia and insulin treatment on HIF-1α 
expression have been investigated, less is known about the concurrent effects of these 
conditions, such as those that may occur in adipose tissue of hyperinsulinaemic obese 
individuals. It is not clear whether high circulating insulin may directly increase HIF-1α 
expression and contribute to the formation of excess ECM, or whether increased 
insulin may simply be a concomitant downstream effect of increased insulin 
resistance, as a consequence of increased fibrosis and the generation of inflammation. 
Therefore, the third study in this thesis hypothesized that the expression of HIF-1α, 
Col5a1 and Col6a1 will increase in a dose-dependent manner in insulin-treated 3T3-
L1 adipocytes under hypoxic- compared to normoxic conditions. The aims of this study 
were to determine the effects of chronic insulin treatment on HIF-1α, Col5a1 and 
Col6a1 mRNA and protein expression in 3T3-L1 adipocytes and to determine whether 
these effects were different during hypoxic vs. normoxic conditions. The main findings 
of this study were that chronic high insulin and hypoxia treatment significantly elevated 
HIF-1α mRNA and protein levels, but the observed effects were not additive. In 
addition, hypoxia, but not insulin treatment, was associated with higher COL5A1 and 
COL6A1 protein, but not mRNA expression. Further, exposure of adipocytes to 8 hrs 
insulin treatment resulted in significantly reduced lipid staining and the effect was 
exacerbated in the hypoxic compared to normoxic conditions. Chronic 
hyperinsulinemia is characteristic of insulin resistance and the metabolic syndrome. 
Assuming that these in vitro findings may be generalised, it is tempting to speculate 
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that the expansion capacity of adipose tissue is reduced by hypoxia-induced 
alterations to the pericellular basement membranes, a process also exacerbated by 
chronic hyperinsulinaemia during hypoxic conditions. Increased pericellular fibrosis 
would result in increased mechanical stress-induced inflammation, higher circulating 
nonesterified FFAs and reduced insulin sensitivity. 
Chapter 6 
Common genetic polymorphisms associated with the expression and remodelling of 
ECM components within soft connective tissue have previously been implicated in the 
development of connective tissue disorders (section 2.4.3). Higher susceptibility to 
these disorders is often dependent on the exposure to extrinsic risk factors such as 
repeated mechanical loading or overuse. The T-allele of COL5A1 rs12722 has been 
associated with a higher risk for developing exercise-related musculoskeletal soft 
tissue pathologies (section 2.4.3), possibly due to effects on connective tissue 
stiffness. In contrast, the COL6A1 rs 35796750 (T/C) SNP is strongly associated with 
OPLL and OLF, conditions characterised by ectopic bone formation in paravertebral 
ligaments, for which a high BMI after age 20 years, dietary habits and T2DM were 
independent risk factors for developing these disease states 274 273, 276. As in other 
structural connective tissues, adipose tissue ECM components and associated 
remodelling enzymes may also be regulated by signalling cascades in response to 
changes in mechanical and sheer stresses such as those associated with increased 
adipose tissue mass during obesity. In such a case, genetic variation associated with 
altered ECM and matrix remodelling gene expression in adipose tissue may result in 
ethnic-specific associations between ECM component gene expression and insulin 
resistance as described in chapters 3 and 4. Indeed, ethnic variation in the frequencies 
of the COL5A1 rs12722 and COL6A1 rs35796750 alleles have been such that the C-
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allele for both were more frequent in the black/African population compared to 
Europeans. Although these polymorphisms have been extensively studied for their 
associations with increased risk for developing soft tissue injury, to my knowledge, no 
such studies have been undertaken to determine whether associations exist with 
measures of adipose tissue fat mass and its distribution and/or insulin resistance. 
Given the similarities of ECM expression in adipose and other soft connective tissues 
during their respective adaptive responses to mechanical stresses, and the functional 
relevance of these two polymorphisms for the development of connective tissue 
diseases, the fourth study in this thesis hypothesised that the COL5A1 rs12722 and 
COL6A1 rs35796750 polymorphisms were associated with differences in body fat 
mass and its distribution in black and white women and consequently their differences 
in risk for insulin resistance. Thus, the aims of this study were to examine differences 
in the frequencies of the rs12722 polymorphism within the COL5A1 gene and the 
rs35796750 polymorphism within the COL6A1 gene between black and white South 
African women and to examine the ethnic-specific associations with body fat, its 
distribution and insulin resistance. Although allele and genotype distributions of the 
COL5A1 rs12722 polymorphism (CC- 35%, TC- 42% and TT- 23% in white women vs 
CC- 76%, TC- 22% and TT- 2% in black women), as well as body fat distribution were 
significantly different between black and white women, the T- variant of the COL5A1 
rs12722 polymorphism was associated with significantly less central fat mass, 
characterised by a smaller waist circumference and lower VAT, and that this effect 
was similar in black and white women. In addition, T- variant of the COL5A1 rs12722 
polymorphism was associated with lower fasted insulin concentrations and HOMA-IR 
in white, but not black women. This difference may also possibly be attributed to the 
significantly lower frequency of the T- variant of the COL5A1 rs12722 polymorphism 
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in black women. In contrast, no genotype associations between COL6A1 rs35796750 
and body fat mass, its distribution and insulin resistance were reported in black or 
white women. Although no allele or genotype effects were identified for the COL6A1 
(rs35796750) polymorphism, this study identified a novel association between the T-
allele of the COL5A1 rs12722 polymorphisms and lower central fat mass, in particular, 
less VAT, and lower insulin resistance. Further studies are required to verify these 
findings.  
7.2 PROPOSED MODEL OF INSULIN SENSITIVE VS INSULIN RESISTANT 
ADIPOSE TISSUE EXPANSION IN BLACK AND WHITE WOMEN 
The ethnic-specific associations of body fat mass, its distribution and the risk of insulin 
resistance between black and white women are not fully understood. In an attempt to 
identify putative mechanisms that could explain, at least in part, the different insulin 
sensitivity phenotypes described for the black and white women, the notion of adipose 
tissue expandability in relation to a model of insulin sensitive vs insulin resistant 
adipose tissue expansion was proposed. Thus, potential ethnic differences in the three 
major factors that could influence adipose tissue expansion in an insulin sensitive vs 
insulin resistant manner were investigated. These factors and their potential effects on 
insulin sensitivity are graphically represented in Figure 7.1 and summarised below:  
(1) Cellular proliferation and differentiation capacity 
During positive nutrient balance, excess energy is stored in SAT adipocytes by either 
the enlargement of the existing cell diameter (hypertrophy) and/or by the recruitment 
and differentiation of new adipocytes from the precursor cells from the SVF 
(hyperplasia). Increased PPARy expression during obesity development is associated 
with the generation of smaller more insulin sensitive adipocytes (insulin sensitive AT 
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expansion, right panel of Figure 7.1) whereas adipose tissue expansion characterised 
by lower expression of PPARy is associated with the enlarged, hypertrophic 
adipocytes which are more insulin resistant (insulin resistant  AT expansion, left panel 
of figure 7.1). Results from our laboratory have shown lower PPARγ expression in the 
gluteal depot of obese black women compared to white women which suggests that 
differences may exists in adipocyte proliferation and differentiation capacity between 
black and white women.  
(2) Adipose tissue PO2 and vascularization 
 
Figure 7.1 Model of insulin sensitive vs insulin resistant adipose tissue expansion. Insulin resistant adipose tissue 
expansion (Blue block to the left): Pathologic adipose tissue expansion results in local and systemic insulin resistance. 
Increased adipocyte cell size results in local hypoxic state in adipose tissue. Increased HIF-1α stabilization does not induce 
angiogenic response, but rather invokes an inflammatory state with a high degree of macrophage infiltration, limited 
vasculature development and fibrotic response. Such inflammatory activation ultimately results in systemic insulin 
resistance. Insulin sensitive adipose tissue expansion (Red block to the right): Healthy, insulin sensitive adipose tissue 
expansion encompasses the enhanced recruitment of adipocyte progenitors that may differentiate into small insulin 
sensitive adipocytes, appropriate increased vascularization, minimal induction of ECM and minimal inflammation. 
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Increased cell diameter has been suggested to reduce adipose tissue PO2 by 
increasing the distances that oxygen has to diffuse from the microvasculature to the 
cells causing a local hypoxic environment. Cellular adaptation to hypoxia involves the 
activation of the master regulator of the hypoxia response, HIF-1α. HIF-1α aims to 
induce angiogenesis through the expression of pro-angiogenic factors, such as 
VEGFα, in order to induce the formation of new vasculature in the adipose depot to 
quench the oxygen requirement of the expanding adipocytes. However, higher HIF-1α 
and reduced VEGFα expression in the gluteal depot of obese black women suggests 
increased adipose tissue hypoxia and reduced vascularization in this depot.  
(3) Adipose tissue ECM expression 
Increased HIF-1α activation, unable to elicit an effective pro-angiogenic response, 
results in the up-regulation of ECM components that underlie the formation of fibrosis 
in adipose tissue. Increased fibrosis may further reduce angiogenesis in the gluteal 
depot of black women by obstructing the formation of new vasculature in this depot. 
Notably, HIF-1α may also alter fibrosis through the induction of remodelling enzymes 
such as the collagen-crosslinking enzyme LOX.  
(4) Inflammation 
Hypoxia and ECM gene expression were positively correlated with higher expression 
of inflammatory genes in both the abdominal and gluteal SAT depots of black women, 
whereas hypoxia and ECM gene expression associated with inflammatory gene 
expression mostly in the abdominal depots of white women. Hypoxia, through the 
stabilisation of HIF-1α induces inflammatory gene expression from adipocytes and 
resident macrophages initially to induce angiogenesis and vasculature formation in 
adipose tissue in order to alleviate the effects of hypoxia. 
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(5) Limited adipose tissue expansion and insulin resistance 
Increased fibrosis accompanied by reduced angiogenesis and inadequate 
vascularization perpetuates the unresolved hypoxic state, resulting in the continual 
influx of M1-activated macrophages and a sustained low-grade inflammation 
response. Thus, a chronic high inflammatory state (through its effects on adipocyte 
apoptosis and reduced insulin sensitivity) along with increased pericellular fibrosis 
(through its effect on limiting adipocyte size) may limit the TAG storage capacity of the 
gluteal SAT.  
(6) Genetic factors 
Differences in the allelic frequencies of COL5A1 rs12722 and COL6A1 rs35796750 
polymorphisms between black and white women did not associate with ethnic 
differences in body fat mass, body composition, or variables of insulin sensitivity and 
secretion. However, the T- variant of the COL5A1 rs12722 polymorphism was 
associated with significantly less central fat mass, characterised by a smaller waist 
circumference and lower VAT, and this effect was independent of ethnicity and overall 
body fat mass. In addition, T- variant of the COL5A1 rs12722 polymorphism was 
associated with lower fasted insulin concentrations and HOMA-IR in white but not in 
black women. Although significant differences in allele frequencies were found in black 
and white women, genetic explanations for the phenotypic differences in body 
composition and disparity in metabolic disease risk between African and white 
populations remain to be elucidated.  
(7) Hyperinsulinaemia 
Finally, hyperinsulinaemia in black women may not simply be a consequence of 
increased adipose tissue insulin resistance but may also contribute to the exacerbation 
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of insulin resistance during obesity development by up-regulating the expression of 
HIF-1α, which may have exacerbating effects for ECM production as described in (3). 
In summary, the model of insulin sensitive vs insulin resistant adipose tissue 
expansion is presented in an effort to explain (at least in part) the disproportionate 
prevalence of T2DM and insulin resistance in black African women compared to their 
white/Caucasian counterparts. Based on previous research, plausible adipose tissue 
specific mechanisms are suggested that may differently regulate body composition 
and fat distribution patterns and associations with insulin sensitivity in black and white 
women. It should be noted, however, that the studies in this thesis which were used 
to create this model are largely cross-sectional in nature and as such, no causality can 
be inferred. Further studies in a larger cohort of black and white women are needed 
to determine the validity of this model. 
7.3 STERENGTHS AND LIMITATIONS  
The role of adipose tissue biology in the risk of developing metabolic disease such as 
insulin resistance is now well established (section 2.2). However, most of the 
previously established relationships between body composition measures and 
adipose tissue biology leading to insulin resistance were identified from studies 
performed almost exclusively in Caucasian/white populations in whom higher levels of 
VAT explain the largest risk for insulin resistance. This contrasts to studies in African 
populations in whom the relationship between obesity and VAT and the associated 
risk for insulin resistance is attenuated. This thesis provides novel insight into the 
ethnic-specific associations between body fat mass, its distribution and measures of 
insulin sensitivity and secretion by presenting a novel hypothetical model that 
highlights plausible biological mechanisms which may explain, in part, the increased 
prevalence of insulin resistance in black women.  
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Additionally, three different methodological approaches were used to further 
investigate this model namely, a gene expression analysis in a cross-sectional 
(chapter 3) and follow-up (chapter 4) design, a cell-culture based study (chapter 5) 
and a genotyping analysis (chapter 6). Further, state-of-the-art techniques (DXA and 
CT) were used to provide accurate estimations of body composition and fat distribution 
in the black and white women who are known to have different levels of VAT and 
abdominal SAT at equal levels of obesity and waist circumference. 
This thesis is the first to show ethnic differences in hypoxia and ECM related gene 
expression in three different SAT depots (SSAT, DSAT and gluteal SAT) and ethnic-
specific associations between the expression of these genes and body composition 
variables and measures of insulin sensitivity and secretion in black and white women. 
Further, this study was the first to show changes in the expression levels of hypoxia 
and ECM related genes and the associations with changes in body composition 
variables and measures of insulin sensitivity and secretion over a 5 year, free-living 
follow-up period in black and white women.  
The studies in this thesis also have some important limitations to consider. An 
important limitation may be that the generalizability of the findings are limited by the 
small sample size of the participants in the cohort (chapter 3), especially in the follow-
up study (chapter 4). Therefore, no ethnic comparisons could be made for changes in 
hypoxia and ECM related gene expression over the follow-up period. However, these 
studies may be viewed as a pilot study from which some novel relationships have been 
identified and may be verified in future. Another limitation is that protein expression in 
the adipose tissue samples could not be measured due to the small size of the fat 
biopsies obtained (chapter 3 and 4). Moreover, I am aware that there exists a general 
belief that hypoxia does not affect HIF-1α mRNA levels in contrast to its protein level, 
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which is broadly accepted to be post-transcriptionally regulated by oxygen dependent 
protein stabilization complexes 430. In contrast to HIF-1α protein expression which has 
consistently being shown to be higher in adipose tissue of obese humans and animals 
when compared to their normal-weight counterparts (for review see 67), several studies 
have also shown increased mRNA levels in response to hypoxia in several cell types 
307, 352, 388, 389. Moreover, higher HIF-1α mRNA expression has been demonstrated to 
have relevant implications in adipose tissue metabolism (chapters 3 and 4) 301, 310, 370, 
372, 390, 391 although the effect of these remain largely uninvestigated. 
In addition, the magnitude of oxygen partial pressure in adipose tissue is currently the 
subject of debate. Studies showing reduced oxygen partial pressure in obese 
humans70, 299-301 and animal models 72, 294, 310, 311 have recently been compared to a 
study showing increased oxygen partial pressure “hyperoxia” 309 in the SAT of obese 
compared to normal-weight individuals. However, similar to many other studies, PO2 
was only measured in one part of the adipose tissue depot and the authors conceded 
that the possibility exists that other parts of the same depot may still be hypoxic. 
Differences in PO2 within and between adipose tissue depots may be explained by 
differences in blood flow delivery to these areas 309. Further, factors such as age, 
gender, race, insulin sensitivity and adipose tissue depot volume may be confounding 
factors that affect PO2 in different adipose tissue depots throughout the body. The 
contribution of these factors to the variability in PO2 between lean and obese humans 
and its effects on adipocyte metabolism remains to be tested. 
The cell-culture analysis (chapter 5) has some shortcomings to consider. Firstly, due 
to budget restrictions and a lack of laboratory resources, mRNA expression, protein 
analysis and lipid content determination assays were prioritized in this study whereas 
other metabolic analyses could not be performed. Future analyses may include for 
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example, carbohydrate metabolism assays (determination of 2-deoxy-[3H]-D-glucose 
uptake) or intracellular ATP content determination. Secondly, the use of 5 % O2 for 
hypoxia incubation of the 3T3-adipocytes rather than the more frequently used 1% O2 
may be viewed as a limitation to this study. As mentioned (Table 2.7), adipose tissue 
PO2 has been recorded to range between 15-22 mm Hg, (equivalent to 3-5% O2 294), 
while abdominal SAT in obese humans may range between 5-11% (23-84mmHg) 70, 
309. Thus, 5% O2 as used in this study may be more closely related to normal 
physiological O2 concentrations. However, in this context, the regular use of 21% O2 
as normoxia (control condition) may also be questioned as this PO2 might be much 
higher (hyperoxia) than that to which even pulmonary cells are exposed to in vivo. 
Clearly, studies examining more physiological PO2 (3-11% PO2) ranges over longer 
periods of time are lacking and experimental protocols that more closely reflect human 
in vivo (physiological) PO2 ranges are warranted. 
Moreover, the use of a candidate gene approach (chapter 6), where only one 
polymorphism within each of COL5A1 and COL6A1 genes were investigated for their 
associations with body fat mass, its distribution and insulin resistance in SA women, 
instead of a GWA approach is another limitation to this study. However, GWA studies 
require large sample numbers, are expensive to undertake, and, due to limited 
resources and a lack of the appropriate technology, were not performed in this thesis. 
In addition, the use of HOMA-IR to estimate insulin resistance may represent another 
limitation to this study. Although HOMA-IR has been shown to correlate with the 
hyperinsulinemic-euglycemic clamp, the gold standard for assessing insulin sensitivity 
in white populations, the association is less robust in a black population 426, 427.  
Finally, although the hypothetical model was proposed based on previous research 
findings and the work of this thesis, the suggested mechanisms might not be the only 
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factors contributing to increased risk of insulin resistance and the development of 
T2DM. Further studies are warranted to evaluate this hypothesis that i) greater 
adipose tissue hypoxia and the accumulation of ECM components in peripheral body 
fat plays a role in the development of insulin resistance and ii) that ethnic specific 
differences exist which could explain the increased prevalence of insulin resistance 
and higher risk for T2DM in black women. 
7.4 CONCLUSION  
The burden due to T2DM in developing countries such as South Africa is unacceptably 
high. While intensive efforts have been made to improve health care delivery in South 
Africa, the development and implementation of effective preventative care strategies 
remain crucial to reduce the immense fiscal burden of the high T2DM associated 
morbidity and mortality rates in this country. As part of the 2030 Agenda for sustainable 
Development, ambitious targets have been set to reduce pre-mature mortality from 
NCDs (including T2DM) by one third by 2030 77. However, to achieve any realistic 
change to the incidence and prevalence of T2DM, an improved understanding of the 
relevant physiological and environmental risk factors on population level are needed 
to develop evidence-based, cost-effective preventative-care strategies which are 
relevant to the modern South African demographic. 
As such, this thesis provides preliminary evidence that physiological differences in 
adipose tissue between African and white populations may contribute to their 
increased risk of insulin resistance and T2DM prevalence. Specifically, it was shown 
that the gluteal depot of obese black women has higher expression of hypoxia and 
ECM genes compared to that of obese white women which also associates with their 
reduced insulin sensitivity and hyperinsulinaemia. Therefore, this thesis provides 
novel insight into the apparent paradox of reduced insulin sensitivity despite lower VAT 
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and greater peripheral SAT accumulation in black compared to white women. Based 
on these finding, future studies should investigate ethnic differences in the expression 
and deposition of other ECM components such as matrix remodeling enzymes and 
cell-surface integrins which may associate with other mechanosignal transduction 
pathways relevant in adipose tissue metabolism. Furthermore, prospective studies are 
required to determine whether the expression of these components are indeed 
associated with the development of insulin resistance and increased inflammation in 
larger cohors and whether an altered adipose tissue micro-environment could underlie 















Supplementary Table 4. a.  Insulin treatment concentration and duration as used in studies which have 








Acute insulin treatments 
HEK-293 and 3T3-L1-cells 0.01 - 100 nM 5 min Regazzetti et al 315 
ARPE-19 100 nM 4h Treins et al 373 
3T3-L1 100 nM 15 min Yin et al 310 
3T3-L1 100 nM 0- 24 h (intervals) He et al 372 
3T3-L1 0.02nM-1uM 2 min Smith et al 431 
Chronic insulin treatment 
3T3-L1 1 μM 48h Wang et al  376 
Rat adipocytes 500 nM 20 h vs 30 min Pryor et al 383 
Human adipocytes 1-1000 nM 48 h McTernan 405 
3T3-L1 100ng/ml 8h &12h Hupfeld et al 408 
3T3-L1 17nM 8h Zhang et al 432 
    
 
Supplementary Table 4. b. Reverse transcription reaction-mix used to generate cDNA with High Capacity RT-
PCR (Applied Biosystems) kit 
Kit component RT (+) (ul) RT (-) 
10 RT buffer 2.0 µl 2.0 µl 
25 x dNTP mix 0.8 µl 0.8 µl 
10 x random primer 2.0 µl 2.0 µl 
RNase inhibitor 1 µl 1.0 µl 
Nuclease –free water 3.2 µl 4.2 µl 
Reverse transcriptase 1 µl - µl 
RNA (1 µg) 10 µl 10 µl 
Total Volume 20 µl 20 µl 












Supplementary Table 4. c. List of antibodies and dilutions used for western blot 
Santa Cruz Biotechnologies Cat #   Protein size Dilution 
Primary antibodies 
Anti -COL5A1 sc-20648 220/140kD 1:1000 
Anti -COL6A1 sc-20649 140kD 1:1000 
Anti-HIF-1α  sc-53546 132kD 1:1000 
Anti-β-Actin  sc-47778 43kD 1:500 
Secondary antibodies 
Donkey Anti-mouse IgG-HRP sc-2318  1:4000 
Donkey Anti-rabbit IgG-HRP sc-2317  1:4000 
 
Supplementary Table 6.1. 1 Cohen’s 𝒇 𝟐 effect size for HOMA-IR values and power calculation in black and white woman as 
determined by multiple regression analysis F 





 Power (1-β err prob) 
 
All White Black All White Black All White Black All White Black 
COL5A1 rs12722 (C/T)    (n=266) (n=117) (n=149) 
HOMA-IR 0.052 0.098 0.017 0.283 0.338 0.270 0.322 0.362 0.319 1.000 0.999 0.999 
COL6A1 rs35796750 (T/C)    (n=362) (n=166) (n=196) 
 HOMA-IR 0.004 0.001 0.005 0.292 0.394 0.241 0.407 0.648 0.310 1.000 1.000 1.000 
𝑓2, effect size; R2A: Proportion of HOMA-IR variance accounted for by genotype alone; R2AB: Proportion of variance accounted for by genotype, age and fat 
mass (%) relative to model with no regressors. Power for given sample size calculated in G*Power by post-hoc analysis using linear multiple regression method 
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